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Summary: 
A critical deficit in many studies using iPS cell-derived neurons is the electrophysiological 
properties of these cells. Using short differentiation protocols this deficit is more significant, 
likely due to a lack of differentiated astrocytes in these cultures. As a strategy for 
combatting this deficit, this study utilises astrocyte secreted factors, in the form of astrocyte 
conditioned medium (ACM). ACM generated cultures of neurons producing spontaneous 
activity more reminiscent of neurons in vivo after only 3 weeks of differentiation. Further, 
this study finds that voltage activated Ca2+ currents are enhanced at a very early time point 
using ACM and these channels, along with GABAA receptors, are vital to neuronal functional 
maturation. This demonstrates an endogenous mechanism present in the early stages of 
functional development, where neurons exhibit excitatory responses to GABA which drive 
the activation of voltage activated Ca2+ channels. In addition to finding that astrocyte 
secreted factors evoke a gain of this endogenous, activity led mechanism for functional 
maturation, this study also investigates methods of enhance functional maturation by 
manipulating Ca2+ influx. However, in the absence of ACM, direct manipulation of this 
endogenous mechanism appeared limited by GABA becoming an inhibitory 
neurotransmitter as the cells functional matured. These strategies for enhance functional 
maturation are then assessed using iPS cell-lines generated for a Huntington disease study, 
finding that GABAA and increased Ca
2+ concentration in the medium evoked both increased 
and more consistent functional properties in theses neurons at week 2. In addition to 
developing enhanced protocols for neuronal differentiation, a novel protocol for producing 
cultures of iPS cell-derived astrocytes in the absence neurons. These cultures could provide 
an invaluable tool, alongside iPS cell-derived neurons, for modelling neurodegenerative 
disease mechanisms in both cell types. 
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Chapter 1: Introduction 
Pluripotent cells and disease modelling. 
In vitro modelling of diseases provides a more rapid and easily manipulated platform for 
understanding disease mechanisms and developing testing potential therapies. However, 
tissues from patients with neurodegenerative diseases are unavailable for ethical and 
practical reasons. Therefore, we must look to other methods for generating human, disease 
specific tissues for in vitro modelling of neurodegenerative diseases. 
The advent of induced pluripotent stem (iPS) cell technologies has opened new powerful 
opportunities for both disease modelling and drug discovery. The enormous potential of iPS 
cells comes from their ability to produce any cell type (pluripotency), combined with the 
ability to derive these cells from any individual 189. Limited use has been made of human 
embryonic stem cell technologies to develop in vitro disease models, as it is necessary either 
to use very rare embryos which genetically carry the disease, or to manipulate genetically 
the cells at the individual gene level, or using nuclear transfer 27,83,87,188. By contrast, iPS cells 
are now routinely generated from many healthy people and patients with genetic diseases, 
which allows comparisons between multiple wild-type and disease lines. Firstly, this 
provides a level of assurance that any findings in a dish are disease related and not 
abnormalities arising from each line’s genetic background, or from the iPS reprogramming 
procedure. Secondly, experimental findings made in iPS cell lines can be related to clinical 
information of the patient, from which the cell lines were derived, potentially giving insight 
into different disease manifestations.  
Focusing on neurodegerative diseases, many studies are now demonstrating disease-
specific phenotypes, which can be observed across many disease-specific iPS cell lines and 
that correlate well with previous clinical and animal studies (table 1.1). IPS cell studies are 
both providing new insights into disease mechanisms and helping to confirm the relevance 
of pathophysiological mechanisms observed in other disease models. Further, using reliably 
observed disease-specific phenotypes as assays, iPS cell models provide novel cell platforms 
for high throughput drug screening. IPS cell models are also far faster and cheaper to use in 
drug discovery than animal models. They are more effective compared to standard high-
throughput screening based on assay development in industry standard cell lines, such as 
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HEK293, HeLa or CHO cells. IPS cell-derived models provided unparalleled relevance and 
versatility. 
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Disease Stressors Assays References 
Huntington’s  Glutamate 
 BDNF withdrawal 
 Ca2+ dishomeostasis 
 Caspase-9 activity 
 Apoptosis 
218 
Parkinson’s  Hydrogen peroxide 
 MG-132 
 6- hydroxydopamine 
 Caspase-3 activity 
 Ubiquitin positive puncta 
 Impaired mitochondrial Parkin uptake 
 Increased PGC1-α expression 
 Increased oxidative stress-related gene 
expression 
 Increased α-synuclein expression 
 
25,139,173 
Rett syndrome   CDLK5 expression 
 Reduced synaptogenesis 
 Altered electrophysiological characteristics 
 Reduced neuronal cell soma 
3,119 
Spinal Muscular 
Atrophy (SMA) 1 
 Valproic acid 
 Tobramycin 
 Nuclear gem numbers (SMN protein 
complexes) 
57 
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 SMN protein expression 
 Reduced motor neuron population 
 Reduced synapse number 
 
 
 
Disease Stressors Assays References 
Alzhiemer’s  docosahexaenoic acid 
 
 Intracellular Aβ peptide aggregation 
 BiP and Caspase 4  
 Expression studies for stress markers 
 Reactive oxygen species generation 
 Cell survival 
97 
Amyotrophic Lateral 
Sclerosis (ALS) 
  TDP-43 protein aggregation 24 
Familial dysautonmia   Reduced neurogenesis 
 Reduced neuronal migration 
 IKBKAP splicing defect 
108 
Schizophrenia    Reduced glutamate receptor expression 
 Reduced neurite outgrowth 
 Reduced PSD95 protein expression 
22 
Table 1.1: A list of iPS cell-derived models for neurodegenerative diseases which have reported disease-specific phenotypes. 
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The ideal approach for iPS-cell modelling of neurodegenerative diseases is to use a rapid and 
reliable differentiation protocol that produces functionally mature cells of the correct type, 
enabling disease-specific phenotypes to be readily observed. Whilst a disease may take 
many years (or decades) to manifest in patients, it has been found that disease phenotypes 
can be promoted in cell models by applying appropriate stressors (table 1.1 24,25,218). These 
stressors are most often based on disease-specific observations from previous models of the 
disease. For example, glutamate pulses and withdrawal of BDNF are used as stressors in 
Huntington’s disease models (table 1.1 218). This system also provides the basis for rapid 
drug screening potential therapeutics 84. Standardised protocols could be written to provide 
plates of iPS cell-derived neurons across multiple disease and wild type lines. Then, disease-
specific stressors can then be employed to induce a disease phenotype and used as an assay 
for the potency of potential therapeutic drugs. This has the advantages of being fast and can 
be simultaneously used on many different patient derived cell lines. Therefore, by limiting 
further research to drugs found effective in iPS cell-derived models, it is possible to 
minimise the cost of animal testing to fewer, more promising drugs. Another fascinating 
feature of iPS cell-derived models being used for drug testing is that potential therapeutics 
can be tested for different causes and manifestations of each disease, allowing for new 
drugs to be targeted for different patients. This is particularly evident with many 
neurodegenerative diseases, as many are known to have  multiple causes, for example 
Parkinson’s disease, where iPS studies have thus far focussed on both PINK1 and LRKK2 
mutations 25,139,173. 
IPS cells are fundamentally capable of producing a powerful model system for drug 
discovery, since they can provide any cell type from any individual. However, to realise the 
full potential of this technology, there are still some hurdles to overcome. Firstly, methods 
for inducing pluripotency have required improvement, becoming more efficient and 
effective. Initially, iPS-cell reprogramming was performed using retroviral insertion of 
pluripotent factors, leaving a permanent new copy of these genes in the genome 189. In 
theory, these genes should become inactivated during development; however, some studies 
have found this not to be the case resulting in some level of transcription of the 
reprogramming genes post-differentiation. This issue was solved by the use of non-
integrating vector reprogramming techniques that have allowed cells to be reprogrammed 
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without leaving a permanent genetic mark on the cells 38. However, even though epigenetic 
remodelling underpins the mechanisms of reprogramming and differentiation, significant 
differences are observed between iPS-cell lines and embryonic stem cell lines using whole-
genome DNA methylation maps, which often correlate with the somatic cells from which 
they were reprogrammed 10,117,156. This provides evidence for inconsistent gene-regulatory 
differences between iPS-cell lines and natural embryonic stem cells. Further, this perhaps 
explains observations that certain iPS-cell lines favour certain lineages, and could influence 
the functional properties of differentiated cells post differentiation, resulting in iPS cell line 
specific abnormalities 161. This highlights the need to investigate diseases using multiple 
patient and wild-type iPS cell lines. Over time, reprogramming techniques and methods for 
assessing pluripotent stem cells are becoming more efficient and effective, allowing for 
more lines to be generated, more rapidly and with greater consistency. 
This study is focused on the terminal differentiation and functional maturation of iPS cell-
derived neurons, and it is here that we find other significant hurdles in iPS-cell technology. 
Firstly, an iPS-cell model requires cells of the correct type to be differentiated, ideally the 
correct mix of specific cell types typical of the tissue that is being modelled. In the case of 
neurodegenerative diseases, we would ideally produce a mix of the correct neuronal sub-
types and glial cell types. However, many studies are finding only comparatively low yields 
of particular cell types, often after even very lengthy differentiation protocols 8,29,134,218. 
Secondly, it is crucial that iPS-cell differentiation protocols generate cells that show mature 
functional attributes, which are necessary for these cells to form the basis of iPS cell-derived 
models that accurately recapitulate the correct neuronal tissue, and neurodegenerative 
diseases, in a dish. In particular, for models of neurodegenerative diseases to be 
informative, it is essential that iPS cell-derived neurons are electrophysiologically active and 
communicative through a synaptic network. These properties are critical to the function of 
neurons and also integral to the pathological dysfunction of cells in many 
neurodegenerative diseases. There have been a deluge of protocols developed for directed 
differentiation of different neuronal sub-types from iPS cells. However, largely these studies 
have focussed on generating cultures with a population of cells expressing cell markers with 
varying levels of specificity, starting with pan-neuronal markers, such as β3-tubulin and 
microtubule associated protein 2 (MAP2), followed by markers of specific neuronal sub-
  15 
types. Few studies have performed in depth analyses of the elecltrophysiological properties 
of iPS cell-derived neruons, and even more rare are studies where electrophysiological 
function used as a tool for differentiation protocol development91,130,190.  
 
Developing Neuronal differentiation protocols 
Neuronal differentiation from iPS-cells occurs in 3 phases: neutralisation, differentiation and 
maturation. Neuralisation, is partial differentiation to produce neural progenitor cells, which 
are capable of differentiation to any cells within the neural lineage. Neuralisation is 
currently most efficiently achieved by inhibition of transforming growth factor β (TGF-β) and 
bone morphogenic protein (BMP) signalling, by targeting both the SMAD 2/3 and 
SMAD1/5/8 pathways, using small molecules 30,214.  These neural progenitor cells are then 
differentiated, resulting in the cells exiting the cell cycle and initially producing cultures of 
immature neurons.  
Following differentiation, immature neurons must mature to develop the necessary 
machinery for functional electrophysiological activity and synaptogenesis. Key to these 
processes is the regulation of gene expression by the transcription factor, cAMP response 
element-binding protein (CREB). CREB activity is a central, and rate-limiting step in the 
multiple pathways which drive neuronal development, survival and synchronous functional 
integration 1,49,50,55,80,86,128,135,151. CREB activity is regulated by serine phosphorylation at 
three sites (ser 133, ser 142 and ser 143). CREB phosphorylation determines its ability to 
bind to CREB-response elements (CRE) in gene-promoters, either as homo- dimers with 
itself, or as hetero-dimers with the closely related CREM (cAMP response element 
modulator) protein. CRE site occupancy then drives gene-regulatory changes in conjunction 
with other transcription factors 28,46,74,75,99,124,170. Sustained ser133 phosphorylated CREB 
temporally correlates with the expression of immature, but postmitotic, neuronal markers 
(for example doublecortin and neuroD) and the loss of mitotic neural progenitor cell 
markers 68,80,86. The expression of immature neuronal markers becomes replaced over time 
by mature neuronal markers involved in neurotransmitter release and synaptic function. 
These changes in neuronal marker expression correlate with a loss of stable CREB 
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phosphorylation and a switch to activity-dependent, transient CREB phosphorylation 
72,80,86,128.  
There are three well documented pathways that regulate the phosphorylation of CREB, and 
together these pathways integrate developmental and activity-dependent cell signalling as 
stimuli for differentiation, survival and electrophysiological maturation. Brain derived 
neurotrophic factor (BDNF) is a secreted neurotrophic growth factor which initiates terminal 
differentiation and is maintained to allow neuronal survival 37,90,103. BDNF is a ligand for the 
tyrosine kinase B (TrkB) receptor, which upon binding initiates a protein kinase cascade 
leading to CREB phosphorylation. However, the TrkB receptor is also gated by cAMP, 
allowing for a second level of control of TrkB activity 21,90,149,174. During development, 
neurons express different pools of adenylyl-cyclases which are differentially activated or 
inactivated by calcium influx through calmodulin and G-protein coupled receptor activity 
42,77,121,172,184. There is evidence to suggest that this cAMP gating increases the activity-
dependence of neurotrophin signalling over time during maturation, due to changes in the 
expression of different adenylyl-cyclase isoforms 102,140. Studies have shown that CREB 
phosphorylation is also stimulated by ionotropic neurotransmitter responses, including 
those elicited by glutamate and GABA 68,86,88,89,197,199. Key to this mechanism is the influx of 
Ca2+ ions in response to neurotransmitter binding, which results in activation of calmodulin 
dependent kinases (CamK), which phosphorylate CREB 47,50,155,177,192,199. Ionotropic 
glutamate responses directly result in calcium influx, since ionotropic glutamate receptors 
are cation channels, but ionotropic GABA receptors are ligand gated chloride channels. 
Voltage-activated calcium Ca2+ channels provide Ca2+ influx in response to membrane 
depolarisations, usually excitatory neurotransmitter responses. Therefore, GABA-dependant 
depolarisation is able to elicit Ca2+ influx indirectly by activation of voltage-gated Ca2+ 
channels. However, Cl- currents are hyperpolarising in adult neurons, which would inhibit 
depolarisation instead of activating voltage activated Ca2+ channels. The direction of Cl- 
currents in mature neurons is due to mature neurons highly expressing the potassium-
chloride symporter 5 (KCC2), which co-tranports Cl- ions out of the cell (driven by the 
outward K+ gradient), compared to the potassium-sodium-chloride co-transporter 1 (NKCC1) 
which co-tranports Cl-  into the cell (driven by the inward Na+ gradient). This difference in 
the expression of these two ion transporters maintains a Cl- reversal potential more 
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polarised than the resting membrane potential 12,14,67. However, due to changes of both 
NKCC1 and KCC2 expression during development, the Cl- concentration gradient is 
augmented over time, resulting in Cl- currents moving from depolarising to hyperpolarising 
compared to the resting membrane potential. This means that the response to GABA by 
immature neurons is initially excitatory, and capable of eliciting voltage activate Ca2+ 
channel activity in immature neurons.67. In addition to ionotropic neurotransmitter 
responses, metabotropic neurotransmitter receptors can also drive CREB phosphorylation 
32,53,94. G-protein coupled receptors increase cAMP production through the activation of 
adenylyl cyclases, this then stimulates protein kinase A (PKA) phosphorylation of CREB 52,128.  
This provides a mechanism for metabotropic neurotransmitter receptors to influence CREB 
phosphorylation. 
Studies on CREB-phosphorylation and CREB activity suggest that the integration of these 
pathways is not merely additive. It appears that CREB activity responds differently to tonic 
and transient neurotransmitter, or neurotrophin–dependant stimulation 89,128. One 
potential distinguishing factor could be differential phosphorylation of different sites on the 
CREB protein. However, currently little is known about the mechanisms for phosphorylating 
the ser 142 and ser 143 sites 128. Another factor influencing the different responses to tonic 
and transient neurotransmitter stimulation is that voltage activated Ca2+ channels inactivate 
during persistent depolarisation and ionotrophic neurotransmitter receptors desensitise 
with persistent neurotransmitter stimulation. Functionally, this means that a neuron must 
repolarise in preparation for further electrophysiological events, providing a short delay 
before the following Ca2+ influx. Therefore, the electrophysiological activity-dependent 
pathways to CREB phosphorylation will respond differently to transient and persistent 
stimulation. 
CREB phosphorylation also appears to have different effects on neuronal functional 
development dependant on the developmental stage. This has resulted in sometimes 
conflicting results when studying the effects of CREB phosphorylation and synaptogenesis, 
as in one experiment it appears to inhibit a process that it later in development appears to 
promote1,144,195. It is unknown whether this disparity is primarily due to an increase in 
transient activity linked CREB phosphorylation, or loss of sustained CREB phosphorylation. It 
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is also unknown if differential phosphorylation of the different phosphorylation targets on 
the CREB protein are involved in this change. Importantly however, this allows CREB 
phosphorylation to orchestrate a synchronous development of functional maturation across 
multiple stages of functional maturation in neurons.  
Neurotrophins, including BDNF, initiate neurogenesis though the activation of a protein 
phosphorylation cascade. During maturation, electrophysiological activity becomes a more 
important driving force for development in neurons, by providing Ca2+ influx and 
neurotransmitter response-dependant CREB phosphorylation. Critical to this mechanism are 
neurotransmitters and voltage activated Ca2+ channels. Evidence suggests, that immature 
excitatory GABA responses provide an important stimulus to sustain stable levels of 
phosphorylated CREB for neurogenesis 128. The loss of stable phosphorylated CREB 
correlates well with the GABA-response switching from excitatory to inhibitory, and the 
appearance of NMDA receptor activity (a sub-type of glutamate receptor). Indeed, transient 
CREB phosphorylation in mature neurons is reliant on BDNF and glutamatergic synaptic 
drive stimulating action potentials 18,55. At later developmental stages, very different 
responses to persistent glutamate stimulation are observed compared with transient 
stimulation. Synaptic glutamate receptors respond to transient synaptic glutamate release, 
providing depolarisation (excitatory post synaptic potentials, EPSPs) for action potential 
initiation. In addition to promoting electrical activity, these transient, synaptic glutamate 
responses provide Ca2+ influx, which promotes neuronal survival via CREB phosphorylation. 
However, persistent synaptic glutamate release also results in the activation of post-
synaptic receptors. Further, by contrast to synaptic glutamate receptors, post synaptic 
NMDA receptor stimulation elicits Ca2+ dependent apopotosis, not survival78,120. This implies 
Ca2+ influx from different sources having different, or perhaps in some cases no, effect on 
CREB phosphorylation. However, during development it is entirely unclear when, or how, 
these different sources for Ca2+ influx come to evoke different responses. 
Difficulties in synchronising the terminal differentiation of iPS-derived neural progenitor 
cells have resulted in long differentiation protocols, containing persistent progenitor cell 
populations, which results in inconsistent maturity in cultured neurons. One approach to 
address this problem has been to supplement differentiation media with the γ-secretase 
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inhibitor DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester), in 
order to promote cell cycle exit by blocking notch-signalling. This has resulted in a more 
synchronous and faster initiation of terminal differentiation 20,138. However, a second issue 
confounding terminal differentiation protocols has been the temporal separation of 
neurogenesis and gliogenesis. In vivo, neurons require significant influences from astrocytes 
to become fully functional (see introduction, Astrocytes and Neuronal Functional 
Development). Critically, astrocytes are instrumental in both the formation and 
maintenance of synapses 201. Although neural progenitor cells are ultimately capable of 
producing both neurons and astrocytes, initially astrocytic genes are repressed by DNA 
methylation, making this fate choice impossible 96,180. However, following a period of 
neurogenesis, a switch in progenitor cell fate is regulated by signals, including hypoxia, 
retinoic acid and notch signalling, and these signals induce the transcriptional regulators 
NFIA (nuclear factor 1 A-type) and CREB to release the methylation repression of astrocytic 
genes, allowing astrogliogenesis to ensue 6,31,36,62,180,182. In many current differentiation 
protocols, there is a lengthy delay before a balance between astrocytes and neurons are 
observed in stem cell-derived cultures, and in short differentiation protocols very few 
astrocytes are observed 8,17,218. Consequently, current differentiation protocols, in the short 
term, lack astrocytic influences on developing neurons. Therefore, introducing astrocytes or 
astrocyte secreted factors to the differentiation protocol could be an effective strategy for 
more rapidly inducing functional maturation in stem cell derived neuronal cultures. At 
present, no studies have found specific astrocyte secreted factors which can be added to a 
defined protocol which replicates the developmental influence of astrocytes (see 
Introduction, Astrocytes and Neuronal Functional Development).  
By studying the electrophysiological characteristics of differentiating neurons treated with 
astrocyte-derived factors, we may better understand the mechanisms by which astrocytes 
influence neuronal development. Further, by understanding these mechanisms, and how 
they relate to other mechanisms in neuronal development, in which CREB appears central, 
we may be able to develop protocols which can be more directly influence functional 
development. 
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Astrocytes and neuronal functional development. 
Astrocytes are the most abundant subtype of glia in the central nervous system. They are 
morphologically intricate and are continuously remodelling very fine projections armed with 
a plethora of receptors which surround neurons and capillaries. Astrocytes form highly 
organised tissues; an individual astrocyte is both responsible for and possessive of its 
microenvironment. Their constant morphological renovation and their diverse compliment 
of receptors gives astrocytes immense capacity for monitoring their microenvironments. 
Therefore, it is not surprising that the original idea that astrocytes only filled space and 
transported nutrients to neurons was a gross underestimation of the cell type’s role. By 
contrast, it is now known that neurons and astrocytes are intimately and elaborately linked 
developmentally, functionally and metabolically 5,162,203. 
Focussing on the influence of astrocytes on the functional development of neurons, many 
studies have shown that astrocytes facilitate neuronal maturation 203. Studies using high 
resolution microscopy in hippocampal slices, have shown that astrocytes’ projections closely 
interact with dendritic outgrowths from neurons and, through Eph-Ephrin signalling, drive 
morphological maturation and survival of dendritic spines whilst negatively regulating new 
immature dendrites 142. Neurons in vitro, both stem cell-derived and ex vivo, demonstrate 
an excitable phenotype with somewhat polarised membranes and voltage activated 
currents. However, crucial to developing fully functional in vitro models, oftentimes very 
little synaptogenic activity is observed 69. Indeed, alone, iPS-derived neurons in vitro 
produce few synapses, which is reflected by only few cells showing spontaneous activity. 
Co-culture of neurons with astrocytes has been shown to increase dramatically the 
formation and maintenance of fully functional synapses in many studies 154,200,201.  Further, 
studies have shown that astrocyte projections contact and interact with neurons in vitro, 
and through a protein kinase C dependant mechanism these increase dendritic puncta 
formation, expression of synaptic markers and generation of miniature synaptic currents 76.  
As well as contact-dependant interactions, studies have also identified secreted factors from 
astrocytes that enhance and accelerate neurogenesis, neurite outgrowth and 
synaptogenesis in neurons. However, in stem cell derived cultures, the extent and 
mechanisms of their actions are not well understood 31,39,200. Wnt3 is one such factor, 
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although involved in the patterning of the nervous system early in development, it has been 
found to be expressed in adult hippocampal astrocytes and plays a crucial role in 
hippocampal neurogenesis 112. Another astrocyte secreted factor, thrombospondin 1A, has 
been found to be pro-synaptogenic when exogenously applied to neuronal cultures, but 
these synapses were found to be post-synaptically inactive, implying that thrombospndin 1A 
is alone is insufficient to produce active neuronal networks 40. There is likely a large 
compliment of factors secreted by astrocytes which influence neurons in different ways, it is 
also likely that certain members of this cocktail are both region and situation specific. 
Therefore, choosing astrocytes from the correct region and developmental stage may be 
important if they are to be used to benefit neuronal cultures. However, astrocyte regional 
specification is currently very poorly understood 133. Astrocytes may also change the panel 
of factors they secrete in response to certain events, for example brain trauma, which might 
be a feature expected of astrocytes which have been harvested by dissection 23,100.  
To model accurately neurodegenerative diseases in vitro, it is of critical importance that 
functional synapses be developed and maintained in culture. These specific structures are 
an essential functional feature of mature neurons in vivo, and especially complex in the 
central nervous system. To this end, astrocyte secreted factors have been employed, in the 
form of astrocyte conditioned medium (ACM), as a strategy to enhance functional 
maturation and synaptogenesis in iPS cell-derived neurons using a full complement of 
astrocyte-secreted factors.  
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Electrophysiological properties of neurons. 
Studying the electrophysiological properties of differentiated neurons is essential to 
producing accurate models for neurodegenerative diseases. There are many functional 
properties of neurons which, as a whole, allow neurons to both transmit and process 
information as part of neuronal circuits. Together, these functional properties form the 
complex, and diverse, electrophysiological phenotypes of neurons. These diverse features of 
neurons are also implicated in the pathophysiological mechanisms for many neurological 
diseases (see table 1.1). Therefore, studying in-depth the development of these features in 
iPS cell-derived models for neurodegenerative diseases is essential to assessing their validity 
as models. To this end, it is necessary for the development of better differentiation 
protocols which focus on producing more functional neurons. In addition to the mature 
function of these cells being absolutely essential to disease modelling, electrophysiological 
properties also play pivotal roles in the functional maturation of these cells due to the  
numerous links between electrophysiological activity, CREB phosphorylation and, ultimately, 
functional development.  
Firstly, neurons must be capable of maintaining and manipulating the voltage across their 
membranes. Therefore, it is important to understand how ionic concentration gradients and 
ion channels are used by neurons to manipulate membrane voltage, using ATP as an energy 
source. In addition to setting the voltage across the membrane at rest, a cell must be able to 
produce action potentials, a moving wave of voltage-gated ion channel led depolarisation 
followed by repolarisation. Therefore, it is essential to understand the electrophysiological 
machinery required to produce action potentials using energy stored in ionic concentration 
gradients. Action potentials are important information carriers in neurons, and neuronal 
circuits. Therefore, fine tuning action potential propagation is required of neurons in the 
central nervous system to integrate many signals, forming the basis for information 
processing within neuronal circuits. It is important to understand how multiple 
electrophysiological parameters are woven together to augment the sensitivity of neurons 
to action potential generation, and how this information is passed between neurons at 
synapses.  
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Ion channels and the membrane voltage 
Membrane voltage is fundamental to electrophysiological activity in neurons. Finely 
controlled changes in membrane voltage are essential for both transmitting and processing 
information across neuronal circuits. Therefore, understanding the electrophysiological 
parameters which cause and control membrane voltage is crucial to understanding how 
complex electrophysiological phenotypes arise in neurons. 
Ionic concentration gradients are used to generate voltages. ATP is used to pump ions 
across the membrane to produce concentration gradients, thereby storing energy from ATP 
in the form of electrochemical potential energy.  
Ion channels provide a conductance to ionic concentration gradients across the membrane, 
which by allowing a path for the current to flow allows the concentration gradient to apply a 
voltage across the membrane. The electochemical potential energy is slowly released by ion 
channels, producing a current through these ion channels. The reversal potential is the 
voltage required to oppose the electric field generated by the concentration gradient of an 
ion, resulting in no net current across the membrane for that ion. The reversal potential for 
the ion is calculated using the Nernst equation, and from this the driving force for the ion 
can be calculated (Vm - Eion). 
   
The Nernst voltage equation, where: T is the absolute temperature (K), R is the ideal gas 
constant, z is the valence of the ion, F is the Faraday constant and Eion is the reversal 
potential for that ion.  
Ion channels are trans-membrane proteins with a channel pore through the membrane 
which conducts ions. They can show different levels of ion-selectivity and can be opened or 
closed based on different conditions, for example, the binding of a ligand molecule or 
voltage. Some of these ion channels are also rectifying, meaning they will only permit a 
current in one direction; this is electrically similar to a diode, but with no appreciable built-in 
potential. 
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The current across the membrane for an ion is proportional to the driving force for the ion 
(Vm-Eion) and the conductance of the membrane to that ion (in accordance with Ohm’s law). 
This has the effect that ion channels provide a larger current the further from the reversal 
potential for an ion the real membrane voltage is (also known as the larger the driving 
force). However, the gradient of this relationship between driving force and current is 
determined by the conductance of the ion.  
Each ion channel has a single channel conductance that is relatively small, usually between 1 
and 100pS. However, the membrane has many of each ion channel across the membrane 
that can all be considered in parallel, so the total conductance is the single channel 
conductance multiplied by the number of ion channels. We can model a single 
concentration gradient and ion channels as a battery, and represent the ion channels with a 
resistor (figure 1.1).  
 
 
  
Top: the relationship between the total conductance across the membrane and both the 
number of ion channels and their single channel conductance. Middle: the relationship 
between conductance and resistance, and therefore the relationship between membrane 
resistance and both the number of ion channels and their single channel resistances. Bottom: 
Ohm’s law with respect to current as a relationship with voltage, and either resistance or 
conductance. Note: conductance = G, resistance = R, current = I, and voltage = V. 
 
In the case of a single ionic concentration gradient, this concentration gradient alone will 
determine the voltage across the membrane. However, a cell membrane maintains 
concentration gradients for Na+, K+, Cl- and Ca2+ ions, with ion channels which conduct them. 
Therefore, all of these concentration gradients are providing currents through the 
membrane. The further from each ion’s reversal potential the real membrane voltage, the 
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greater the driving force, and therefore the larger current for that ion. Therefore, it is the 
reversal potential and relative conductance of the membrane to each of these ions that 
determines the actual membrane voltage. This is because the relative conductance to each 
ion influences how much each ion’s driving voltage contributes to the membrane voltage, by 
augmenting the magnitude of current generated by the ion with changes in driving force. 
We can model this using a batteries equal to the reversal potential for each ion, each in 
series with a resistor representing the conductance of the membrane to each ion, and then 
each of these in parallel (figure 1.1). Assuming the resistance to each ion was the same, we 
would observe a membrane voltage equal to the average of these voltages, as each 
concentration gradient (battery) would be contributing equally to the total voltage. 
However, where the ion channel resistances are different, then each ionic driving voltage 
will have different contributions to the total voltage by each battery (figure 1.1). The total 
voltage will be the sum of the battery voltages each weighted by the proportion of the total 
conductance which is in series with each battery. The total voltage is therefore defined by 
the following equation, for this model: 
   
Where Eion is the battery voltage representing each ionic gradient, Gion represents the series 
conductance with each battery and Gtotal is . Note, this concept was well established 
before it’s application in electrophysiology.  
 
Figure 1.1: Developing models for membrane voltage dependant on each ions membrane 
conductance and reversal potential (driving voltage). On the left, an individual ionic 
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concentration gradient and conductance represented. On the right, all 4 of the major 
electrophysiologically active ions represented. 
 
Using this model, we can understand how the membrane both maintains and manipulates 
membrane voltage. Firstly, the cell stores energy as concentration gradients to each ion 
across the membrane. These provide electric fields with different magnitudes and directions 
across the membrane; these can be used to control membrane voltage by manipulating the 
relative conductance to each ionic concentration gradient. Further, changes in membrane 
voltage can be enacted by altering the conductance of the membrane to these ionic 
concentration gradients by opening or closing ion channels.  
To understand and model exactly how these concentration gradients and conductances 
function across biological membranes, it is necessary to consider the current across a 
biological membrane as the flux of charged particles in a concentration gradient. Therefore, 
is not as simple as modelling each ions contribution to membrane voltage as a constant 
voltage source applied over a resistor. There are two forces which drive flux (the movement 
of particles, in this case ions) across the membrane, which are: the diffusion of particles 
down a concentration gradient by pedesis, and secondly, the influence of an electric field on 
pedesis. Uncharged particles diffuse across a concentration gradient to result in a net flux 
towards areas of low particle density; this can be calculated using Flick’s first law of 
diffusion.  
  
Flick’s first law describing the flux due to the diffusion of a single uncharged particle with a 
single dimension concentration gradient. J is the particle’s flux, D is the diffusion coefficient 
(D=µKT - µ = mobility, K = the Boltzman constant and T = absolute temperature), C is the 
concentration and X is the diffusion distance. 
The addition of an electric field and charged particles influences this random motion, as it 
applies a vector force on any charged particle within the field, which scales linearly with the 
magnitude of the electric field. Ohm’s law states, that the flux is proportional to the voltage 
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applied, the charge density of the ion in solution and the mobility of the ion in solution. The 
charge density of the ion in the solution is the valence of the ion, multiplied by it’s 
concentration and the elementary electronic charge (z, c and e respectively). So, charge 
density multiplied by particle mobility (µ) and potential difference (E), give us a term for the 
flux due to an electric field (J). 
 
Flux due to the electric field: µ = mobility constant, E = potential difference, X = distance, z= 
ion charge, e = elementary electric charge and c = concentration.  
This summation of these two forces is termed electrodiffusion, and the Nernst-Plank 
equation uses the summation of these two fluxes to calculate the total flux, accounting for 
both factors 60.  
 
The Nernst-Planck equation. J= flux, µ = particle mobility, K = the Boltzmann constant, T= 
temperature, ΔC = change in concentration, ΔX = distance, z=ion valence, c= total 
concentration, e= electron charge, ΔE= change in potential. 
Later, Goldman, Hodgkin and Katz derived a limited solution to the Nernst-Planck equation 
for the flux through ion channels across a biological membrane, given any membrane 
voltage. This equation highlights an interesting feature of ionic concentration gradients, the 
flux due to an electric field and the force due to the concentration gradient do not scale 
equally in response to changes in membrane voltage. In the case of no concentration 
gradient (equal inside and outside concentrations), the relation between voltage and flux is 
linear, as predicted by Ohm’s law. This is because the only the flux is only due to an electric 
field. However, flux due to a concentration gradient influences the relationship between flux 
and membrane voltage, resulting in a non-linear relationship between flux and voltage. This 
means that, the gradient of the relationship between flux and voltage is also a function of 
the driving force (the difference between membrane voltage and the ions reversal 
potential). Where the voltage is pushing the ion against its concentration gradient, the 
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change in flux becomes smaller for the same change in voltage the further from the reversal 
potential the membrane voltage becomes. Conversely, where the voltage and the 
concentration gradient are pushing ions in the same direction the opposite relationship is 
true, the change in flux elicited by a change in voltage increases the further the membrane 
voltage is from the reversal potential. Therefore, in the case of a concentration gradient, the 
flux against membrane voltage curve is not linear, shows soft-rectification against currents 
opposing the ion’s concentration gradient, gain of currents with the ion’s concentration 
gradient, and crosses the X-axis at the point of the ion’s reversal potential. This 
phenomenon is known as Goldman-Hodgekin-Katz rectification 81.  
  
The Goldman-Hodgekin-Katz Flux equation. J= flux, P= permeability, z= valence, F= Faraday 
constant, R= the ideal gas constant, T= temperature, V= voltage. 
To understand how these ionic concentration gradients assert a voltage across the 
membrane, we must consider the energies involved where ions are moving across the 
membrane. From a thermodynamics standpoint, the net flux of an ion in either direction is 
either spontaneous or not, and can only be spontaneous in one direction. Therefore, we 
must consider the Gibbs free energy of ions in the solution inside and outside of the cell 
moving across the membrane. At equilibrium, where there is no movement across the 
membrane, these free energies must be equal, as there is no spontaneous net movement. 
Therefore, the direction of the difference between the Gibbs free energy for the flux of ions 
across the membrane from either side of the membrane defines which direction the ions 
must flow. The free energy for the movement of these ions must also be considered using 
the two concepts of electrodiffusion. The free energy for ions moving in an electric field is 
simply the electronic density (per mole) multiplied by the magnitude of the electric field. 
 
G is the free energy for the particles due to the electric field, E is the electric field strength, Z 
is the ionic valence. The constant e is the elementary electronic charge, multiplied by 
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Avagadro’s number, meaning the charge of mole of ion, this term can be replaced with F, 
Faraday’s constant. 
 
The energy due to diffusion can be considered an adiabatic thermodynamic process (no 
transfer of heat, enthalpy is therefore determined by work done in another respect). Ideal 
gas law shows the relationship between volume, pressure and temperature relationship for 
gasses. The entropy change of an expanding gas can be considered the integral of pressure 
against volume, from the initial to final volume. Therefore, the entropy change per mole is 
calculable when knowing the temperature is constant. This means, the Gibbs free energy for 
diffusion from each side of the membrane is considered in the case where there is none of 
the molecule on the opposing side. This means the free energy for diffusion is the difference 
between inside and outside the membrane. 
 
Where V = volume, m = gaseous mass, R = the ideal gas constant, T = temperature and p = 
pressure. 
 =  
Integral, S = entropy, changed between initial volume (Vi) and final volume (Vf). 
      
 
 
The free energy across the membrane due to electrodiffusion is the summation of both the 
energy for diffusion and energy as a result of the electric field, similar to flux.  
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Which can be simplified to: 
 
The voltage generated by a single concentration gradient can be considered the voltage at 
which the electric field generated by the concentration gradient is opposed, the reversal 
potential. This is the voltage at which the flux of ions is at equilibrium. Therefore, this 
equation must be rearranged to be voltage where ΔG is zero, and thus no spontaneous flux 
across the membrane from either side.  This yields a thermodynamic proof of the Nernst 
equation, which is used to calculate reversal potential. It can alternatively (and more 
canonically) be derived from the Nernst-Plank equation, where, using the Nernst-Einstein 
relationship, converting molar flux into an electrical current (in Amperes), finding the 
solution at current = 0, then integrating against the membrane width to find the voltage at 
which current = 0 occurs. However, in my opinion, this thermodynamic proof offers an 
alternative insight into the nature of the equilibrium potential. 
 
The Nernst equation. 
Using a similar principal as when modelling the membrane using simple batteries and 
resistors, the Goldman-Hodgekin-Katz voltage equation is used to calculate membrane 
voltage, taking into account all of the permeable ions. The voltage equation uses the 
reversal potential, calculated using the Nernst equation, for each ion and the relative 
membrane permeability of each ion.  
 
The Goldman-Hodgekin-Katz voltage equation: Vmembrane  = membrane voltage, Pion = 
permeability to an ion, Ptotal = , and Eion = the reversal potential for each ion. 
During the course of functional development iPS cell-derived neurons must develop mature 
ionic concentration gradients and the ion channels required to manipulate membrane 
voltage by altering the relative conductance of the membrane to each ion. Firstly, the cell 
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must maintain a polarised membrane potential at rest.  Inside the cell it must maintain a 
high K+ and low Na+ solution, whereas the outside of the cell is a high Na+ and low K+ 
solution. Physiologically, the reversal potential for K+ is very negative and for Na+ is very 
positive, roughly -75mV and +66mV respectively. At rest, the membrane of a neuron is 
mostly permeable to K+ ions, and very impermeable to Na+ ions. Therefore, the reversal 
potential to K+ ions will contribute most to the membrane potential of the neuron whilst at 
rest, which results in a resting membrane potential of approximately -70mV. The high 
conductivity of the membrane to K+ at rest, in neurons of the central nervous system, is 
largely due to low voltage and Ca2+ activated K+ channels known as M-channels and K+ leak 
channels that are constitutively open known as K2p channels (tandem pore potassium 
channels). Neurons have significantly more polarised membrane potentials than most other 
cell types, due to the development of a relatively high K+ leak current. This is likely a very 
important developmental step for permitting neuronal electrophysiological activity, and can 
easily be assessed using measurements of the native membrane potential at rest.  
 
Membrane capacitance 
Another essential property the cell membrane to electrophysiological activity is the 
capacitance of the membrane. The ability of ion channels coupled to ionic concentration 
gradients to manipulate membrane voltage has thus far been presented as time-
independent. The notion that changes in the relative conductance to each ion’s 
concentration gradient can be used to augment membrane voltage is true, but also only 
over time. The capacitance of the membrane is an essential electrophysiological parameter 
which influences the time-scale which ion channel currents manipulate membrane voltage. 
To explain how membrane capacitance is used to allow a cell to influence the rate at which 
membrane voltage changes occur, it is first necessary to understand how a capacitor works. 
A capacitor is a none-conductive electrical component (to DC currents), which stores a 
difference in charge and, consequently, electrical energy. Any two conductors separated by 
an insulator will have a capacitance across them, meaning that when you apply a voltage 
between the two conductors you will store a relative opposite charge on each conductor. A 
relative positive charge will accumulate on one conductor which is attracted to a relative 
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negative charge on the opposite conductor. The insulator between cannot conduct a 
current, but the electric field generated by the relative difference in charge provides a force 
to store charge. This is the simplest model of capacitance, referred to as a parallel plate 
capacitor isolated by a vacuum. The amount of charge stored by the capacitor is 
proportional to the voltage across. This is because a higher voltage means there is a greater 
force holding a charge difference across the capacitor. The relationship between voltage 
and charge difference stored is linear, referred to as the capacitance, and measured in 
Farads.  
 
The capacitance of a simple parallel plate capacitor is inversely proportional to the distance 
between the two plates and proportional to the surface area of the two facing sides of the 
plates. However, this model assumes the insulator does not respond to the electric field, for 
example in the case of a vacuum. In practice, insulators are comprised of molecules with 
some level of motility and either induced or innate charge differences within the molecules 
or particles of the insulator. This change in an insulator can be considered similar to iron 
filings or tiny magnets within a magnetic field; the molecules of an insulator can become 
aligned with the electric field, and therefore the whole insulator becomes polarised. 
However, this is very different from a conductor, which allows charges to move through it. 
This polarisation of the insulator by an electric field requires energy and charge from the 
source of the electric field, meaning the polarisation of the insulator can be considered an 
impedance to the electric field. Current is sunk into the capacitor from the voltage source to 
store energy and charge in the capacitor to polarise the insulating material. The more the 
insulator is able to respond to the electric field, the more energy can be stored by the 
insulator becoming polarised and the greater the impedance which is applied to the electric 
field. The measure of how much the insulating material responds, in terms of electric field 
impedance, is known as permittivity and a dielectric is an insulator which shows 
permittivity. A dielectric separating the conductive surfaces of a capacitor will influence the 
storage of charge across the capacitor, as the dielectric will store it’s own electric field from 
the source. The polarisation of the insulator, as well as the stored charge on the plates of 
the capacitor, produces an internal electric field which increases the force storing charge in 
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the capacitor. Therefore, dielectrics increase the capacitance of the capacitor compared to a 
vacuum and the higher the permittivity of the dielectric the larger this effect becomes.  
 
The capacitance of a parallel plate capacitor; C = capacitance,  = permittivity of the 
insulator, A = plate area and d = distance between the plates (thickness of the insulator).  
Applying a voltage to a capacitor charges the capacitor, this means storing an amount of 
charge determined by the voltage and the capacitance. How quickly the capacitor becomes 
charged is determined by the current (charge per second) entering the capacitor. The 
voltage across the capacitor only becomes equal to the input voltage once the capacitor is 
charged, as the capacitor’s internal electric field is not taking energy and current from the 
input voltage. Conversely, when you remove the input voltage the capacitor’s internal 
electric field initially maintains the voltage across it, resulting in a current if there is a 
conductive path in parallel with the capacitor. This current, over time, depletes the internal 
electric field across the capacitor, resulting in this field decaying. 
To add both concepts into one general case, we can consider the capacitor acting to initially 
resist, and therefore attenuate over time, any changes in voltage across it. This attenuation 
of voltage changes over time is because any changes in the voltage across the capacitor 
must first alter the internal electric field of the capacitor so that it matches that of the input 
voltage. The internal electric field of the capacitor is determined by the charge stored in the 
capacitor. Therefore, the charge stored across the capacitor must be changed before the 
internal electric field and input voltage match. This is done by current either entering or 
leaving the capacitor, known as charging or discharging, respectively. Another way of 
considering this disparity between the internal electric field and the input voltage, is that 
the internal electric field results in a net voltage between the input voltage and the plate of 
the capacitor, sometimes referred to as the “back voltage”. Therefore, a current will flow 
into (or out of) the capacitor in accordance with the back voltage. The current due to the 
back voltage results in the capacitor either charging or discharging until the back voltage, 
the difference between the capacitors internal electric field and input voltage, has decayed. 
Because a capacitor is non-conductive (to DC currents), the only current across a capacitor is 
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transient to facilitate changes in the charge stored across it, and thus the voltage across it. 
The transient current into or out of a capacitor is determined by the size of the capacitance, 
the magnitude of the voltage back voltage, and the resistance in series with the capacitor. 
Because current is charge over time and voltage is a function of charge and capacitance, 
therefore voltage becomes a function of current over time (the integral of current) and 
capacitance.  
 
  
For this reason, where voltage changes are very fast (or appear instantaneous) a very large 
current is required, and often limited by the power supply or a resistance in series with the 
capacitor. Voltage changes in fact cannot occur instantaneously across a capacitor, as this 
would require infinite current. More importantly however, changes in voltage across the 
capacitor are a function of the integral of current over time. A perfect capacitor that does 
not leak and does not break down at high voltages would continue to add charge whilst a 
static current is applied, and the voltage would increase linearly with time. This would result 
in a larger electric field being built up inside the capacitor due to the additional charge. This 
means that individual short currents may each only influence the capacitor’s voltage by a 
relatively small amount, but many such currents may cumulatively influence voltage 
significantly. 
Any resistance in parallel with the capacitance, whether as a result of the capacitor leaking 
or an actual component, will result in charge escaping the capacitor. The current leaving the 
capacitor is determined by the voltage generated by the capacitors electric field and the 
parallel resistance. A larger resistance will result in a smaller current, meaning that the 
charge will escape the capacitor slower. As charge escapes the capacitor through this 
current, the electric field across the capacitor weakens. This means the current across the 
resistor escaping the capacitor changes with time as the electric field weakens. Therefore 
this means the discharging of a capacitor is an exponential decay over time. The current 
charging the capacitor is determined by the resistance in series with the capacitor. The 
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voltage at the capacitor is determined by a hypothetical potential divider formed by the 
series resistor and the impedance of the internal electric field of the capacitor. However, the 
impedance of the internal electric field of the capacitor becomes larger as the capacitance 
charges, because it takes more energy to store the same quantity of charge the closer the 
capacitor is to being charged. This means that the voltage divider starts with a low voltage 
across the capacitor, due to the low impedance into the capacitor, and increases in an 
inverse exponential fashion as the impedance into the capacitor becomes larger compared 
with the series resistor. 
  
Discharging:  
Charging:  
 
Now that the properties of a capacitor are understood, it is necessary to understand how 
the capacitance of the membrane occurs and influences the electrophysiological properties 
of the cell. The lipid bi-layer of the membrane is a very good insulator, but it is also very thin 
and has dielectric properties, which makes the membrane of the cell an excellent capacitor. 
This is important for the electrophysiological function of the membrane, as the capacitance 
of the membrane allows the membrane to store charge differences and maintain an electric 
field. Therefore, the membrane voltage is not merely a function of the voltages generated 
by ionic concentration gradients and the relative conductance of the membrane to each ion, 
but also of absolute conductance of the membrane and time. This is because change in 
voltage across the membrane is a function of current over time, larger currents will 
influence membrane voltage faster than smaller ones. This allows the membrane to store 
changes in voltage for short periods of time. Therefore, a more accurate view of membrane 
voltage is that the Goldman-Hodgekin-Katz voltage equation predicts the eventual 
membrane voltage (if the conditions remain the same), but the absolute permeability of the 
membrane to the ions determines how quickly this voltage is met. Further, over a period of 
time individual currents may cumulatively change the membrane as the charge from each of 
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the previous currents is still stored at the membrane. However, leak currents at rest will 
over time cause these changes in voltage to decay. The rate at which a permeable ion 
influences the membrane voltage can be represented as a time constant: 
 
The thickness and permittivity (approximately 10Fcm-1) of the plasma membrane are 
relatively uniform, although slight variations are possible due to protein concentration and 
changes to the lipid mix 153,216. This means that the capacitance per unit area of the 
membrane will be very uniform. This has allowed a specific capacitance of the membrane to 
be calculated, and has been demonstrated to be around 1 µFcm-2. Therefore, the membrane 
capacitance is proportional to the cell surface area and influenced by cell size and 
complexity. The membrane capacitance is easily calculable using transient currents 
observed at the start and end of a voltage step, as a result of the membrane charging and 
discharging, respectively. 
The capacitance of the membrane adds an additional dimension to the influence ion 
channels have on membrane voltage. Rate of change of voltage is proportional to absolute 
permeability of the membrane to an ion. Therefore, small currents alter membrane voltage 
slower than larger currents, and multiple separate currents which occur over a short time-
scale can have a cumulative influence on membrane voltage. 
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Action potentials 
In addition to maintaining a resting membrane potential, changes in the relative 
conductance of the membrane to ions is critical to action potential propagation. Action 
potentials are a moving wave of depolarisation, allowing electrical conduction across the 
entire membrane of the neuron. The propagation of an action potential is evoked by a 
smaller localised depolarisation, usually at a post synaptic membrane. An action potential 
has two distinct stages, firstly the cell depolarises to membrane potentials above 0mV and 
then repolarises back to the resting membrane potential. In contrast to leak ion channels 
which set the membrane voltage at rest, during an action potential, high rates of change of 
voltage are required. This means, large conductance is used to rapidly change membrane 
voltage, with large currents, but also consuming larger amounts of energy.   
Voltage activated Na+ channels provide the conductance required for depolarisation. 
Voltage activated Na+ channels are gated by voltage, the channel pore is gated by the 
movement of a positively charged trans-membrane segment of the protein. Slight 
depolarisations of the membrane potential move this voltage-sensitive segment (S4) of the 
protein slightly away from the intracellular side of the membrane, resulting in a protein-
wide conformational change which opens the channel pore. The conductance of the 
membrane to Na+ ions increases rapidly at this point, so that the reversal potential for Na+ 
becomes the dominant voltage across the membrane. This results in this this part of the 
membrane becoming almost immediately depolarised. However, also in response to 
depolarisation an internal region of the channel protein is attracted towards the 
intracellular region of the channel pore. This internal region then plugs the channel pore 
from the inside, preventing further Na+ flux a short period of time following Na+ channel 
opening. The plug-region of the protein will only release itself from the channel pore in 
response to repolarisation, meaning the Na+ channel cannot open again until the cell has 
repolarised. It is these functional regions of the Na+ channel protein that result in the 
channel having three distinct states: closed, open and inactivated 81. The closed state is 
where the channel pore is closed, leaving the channel ready to open in response to 
depolarisation. Following a small depolarisation the channel enters the open state, where 
Na+ ions are flowing through the channel pore. Lastly, whilst the channel pore is still in the 
open configuration the plug region of the protein plugs the channel pore resulting in the 
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inactivated state, from this state the channel must close again in response to membrane 
repolarisation before being able to activate again. Open and inactivation are as a result of 
changes to the conformation of two regions of the protein, and these conformational 
changes are voltage dependant. It is possible using voltage-clamp electrophysiology to 
specifically measure the relationship between these two events and membrane voltage. 
Studies have also shown that different sub-types of voltage activated Na+ channel have 
different opening and inactivating voltages, however for each channel there is a relatively 
small difference between their activating and inactivating voltages 167.  
Inactivation of Na+ channels is essential for the transition from the depolarising stage of the 
action potential to the second, repolarising, stage of the action potential. Inactivation closes 
the large membrane conductance to Na+, meaning that K+ is once again the most permeable 
ion, meaning that eventually the membrane voltage will return to its resting value. 
However, the resting (constitutively open) K+ conductance is relatively small, thus allowing 
for a smaller current and less energy being used at rest. This means that the current due to 
the resting K+ conductance alone would take a very long time to restore the resting 
membrane voltage, due to the charge stored across the membrane capacitance. Therefore, 
the cell employs voltage activated K+ channels to rapidly repolarise the cell using a much 
larger current. These channels activate slightly slower and at a more depolarised voltage 
than voltage activated Na+ channels, so that they come into effect as the Na+ current is 
inactivating. The voltage activated K+ channels have a very significantly larger conductance 
than the resting K+ conductance, resulting in a much larger current that is able to rapidly 
change the voltage across the membrane. These K+ channels inactivate only after a much 
longer timescale, and would not be expected to inactivate during an action potential, as the 
resting membrane potential should have been reached, meaning the channels will close 
before inactivation occurs. The K+ conductance is sufficient to significantly under-shoot the 
threshold voltage for an action potential, and often undershooting the resting membrane 
potential itself due to an even more extreme bias towards K+ being the most dominant ion 
whilst the massive voltage gated K+ conductance is open. This is important for allowing the 
voltage activated Na+ current to recover for the generation of a second action potential. 
  39 
An action potential, although considered a single signalling event is not a static single event. 
Action potentials travel across a neuron, caused by the depolarisation in a local region of the 
membrane activating nearby voltage activated Na+ channels in a travelling wave. The nature 
of this action potential wave is modelled use active-cable theory models. However, it is 
critical for a neuron to produce functional pools of both Na+ and K+ channels in order to 
generate action potentials. It is also crucial for a neuron to express the correct mixture of 
sub-types of both ion channel to facilitate the correct behaviour in response to different 
voltage changes. These channels can be studied directly using voltage clamp protocols, and 
the ability of a cell to fire action potentials can be studied using forced depolarisation using 
current steps.  
 
 
Neuronal excitability 
An important parameter for neurons is their sensitivity to action potentials. Taking together, 
the electrophysiological parameters which influence membrane voltage over time and the 
machinery which initiate action potential propagation, this section will discuss how these 
parameters form an integrated system for fine tuning action potential generation. This 
system is essential for reliably and efficiently processing and conducting information in the 
nervous system. In the case of many neurons in the central nervous system it becomes 
increasingly complex, as multiple sources of information are integrated as changes in 
voltage over time to influence action potential propagation. 
Sensitivity to action potential generation means how much energy is needed to initiate an 
action potential. Action potentials are usually propagated at post-synaptic membranes in 
response to ligand activated ion channel activity. The ligand gated ion channels (ionotropic 
neurotransmitter receptors) provide the depolarising stimulus required to activate Na+ 
channels. This initiates the action potential wave through the cell. Ligand activated ion 
channels are tied to ionic concentration gradients, but they are only activated in response to 
neurotransmitters binding to a region of the protein. Neurotransmitters are secreted from 
vesicles binding to the pre-synaptic membrane, they then cross the synaptic gap to bind to 
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their associated ligand gated ion channels. In response to neurotransmitter binding, they 
induce small currents at the post synaptic membrane to influence membrane voltage. The 
current injected by these ligand gated ion channels is determined by the driving force for 
the ion they conduct and the collective conductance of the open ligand gates ion channels. 
Further, within a brief space of time the membrane capacitance will store the charge 
contributions of these neurotransmitter responses, resulting in a cumulative depolarisation. 
Therefore, a single synaptic event need not, and usually does not, evoke an action potential. 
Neurons have carefully developed their specificity and sensitivity to chemical stimuli at a 
synapse, by developing the magnitude of voltage changes in response to neurotransmitter 
binding and their sensitivity to them in terms of action potential propagation. If the synapse 
were too sensitive the neuron would be firing more action potentials than necessary, which 
would be energy inefficient. If the synapse were too insensitive then signalling between 
neurons would become slow and unreliable. The balance between energy efficiency and 
sensitivity is a debated subject amongst neuroscientists. 
Ion channels opening results in increased conductance across the membrane. However, the 
resistance of the membrane at rest (inverse of conductance), due to leak conductance, is 
considered the input resistance. The input resistance is important, because it influences, 
along with the membrane capacitance, the magnitude of voltage response across the 
membrane due to currents. In accordance with Ohm’s law, a higher input resistance will 
result in a larger change in voltage in response to the same current. When integrated by the 
membrane capacitance, this means that the rate of change of voltage is faster the higher 
the membrane resistance is (for the same current). The absolute membrane resistance 
changes significantly over voltage, as voltage activated ion channels significantly reduce 
membrane resistance when open. However, it is the input resistance at rest caused by leak 
conductance, which is obviously considerably larger, that is important for setting the 
sensitivity to an action potential.  
The sensitivity of a synapse is essentially how easily the post synaptic membrane initiates an 
action potential in response to excitatory post-synaptic activity. There are several factors 
which control this sensitivity, and to explain how they integrate into a system for finely 
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tuning action potential propagation it is necessary to model the membrane’s capacitance, 
resistance and the ion channels involved. 
Firstly, to propagate the action potential a stimulus must raise the membrane potential of 
the cell from the resting membrane potential to the threshold for an action potential. 
Therefore, the most obvious factor influencing sensitivity is how large the difference is 
between the resting membrane potential and the threshold for an action potential. Simply, 
the more the voltage across the membrane has to change in order to reach threshold the 
more charge has had to be moved, meaning more energy used.  Therefore, to increase 
sensitivity, one might expect the resting membrane potential and threshold voltage for an 
action potential to be relatively close. However, the threshold for activating an action 
potential is set by the activation voltage of voltage activated Na+ channels. This means, the 
threshold voltage and resting membrane voltage cannot be too close, because voltage 
activated Na+ channels inactivate at a similar voltage to their inactivation. This would mean 
that, if the resting membrane potential were too depolarised (too close to threshold) the 
voltage activated Na+ current would be inactivated, and thus ineffective at driving an action 
potential. Therefore, there has to be at least a minimal difference between the resting and 
threshold voltages. However, there is some evidence to suggest that neurons do minimize 
the difference between resting membrane voltage and threshold voltage in certain 
membrane regions. There are different sub-types of Na+ channel which respond to different 
voltages, in terms of both activation and inactivation. Immunostains have observed that one 
of the typical neuronal type Na+ channels, Nav1.6, tends to be localised at dendrites (in the 
CNS) and nodes of Ranvier (in mylinated neurons) 26. Further, studies using TTX 
(tetrodotoxin) resistant forms of the protein to isolate and study the voltage dependant 
activation and inactivation of Nav1.6 and another common neuronal Na
+ subtype Nav1.2 
demonstrated that Nav1.6 activated at a significantly more polarised membrane potential 
than Nav1.2 
167. This would suggest deliberate localisation of Nav1.6 in places where the cell 
needs a low threshold voltage to increase sensitivity, including post synaptic membranes. If 
this is the case then perhaps populations of Nav1.6 are acting as pre-amplifiers to the cell, 
responding to the smaller stimuli at synapses to induce an action potential, which is then 
easily sufficient to spread by activation of other Na+ channel sub-types across the rest of the 
neuron. 
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Another important aspect of synaptic sensitivity is how readily changes in membrane 
voltage occur in response to current injection from ligand gated ion channels. The 
magnitude of the current is determined by the collective conductance of the channels and 
the driving force for the ion across the membrane. We must also consider the resistance of 
the passive leak channels, also referred to as the input resistance, and the driving force for 
the leaky ions. Kirchoffs current law states that the currents passing a node must always 
cancel to preserve the conservation of charge. Therefore, the current into the membrane 
capacitance, current across the passive conductance and the synaptic current injection must 
meet a net 0 current. This means that all of the current from the opening of synaptic, ligand 
gated ion channels must either flow across the leak resistance, or it must flow into the 
membrane capacitance (see figure 1.2).  
   
Each term in isolation: 
 and  
   
 
 
Figure 1.2: A schematic representing the key properties of the membrane which together 
form a circuit which allows depolarisation due to ligand binding. Firstly, the ligand gated ion 
channel is represented as a variable conductance, which increases upon ligand binding. A 
battery represents the driving force of the ion, or ions, which the ligand gated ion channel 
conducts. Secondly, the passive leak conductance of the membrane, and driving force of the 
  43 
leak conductance is represented in parallel to the representation of the ligand gated ion 
channel. Lastly, the capacitance of the membrane is parallel to both. 
 
In the absence of a membrane capacitance the synaptic injected current must be equal and 
opposite the current through the leak channels. In this case, the change in voltage evoked 
by neurotransmitter binding would be instantaneously building and decaying. However, this 
is useful because it tells us the eventual membrane voltage once, should the membrane 
capacitance fully charge. In this regard we can consider the leak and synaptic channels to be 
in series, and therefore a voltage divider. However, we must then consider the voltages due 
to the leak and synaptic currents to be in series, and in opposite directions. The voltage 
across the membrane at this point is the summation of the voltage across the synaptic and 
leak resistance, which if both were equal resistances would be equal and opposite and the 
voltage across the membrane would be the average of the leak and synaptic driving forces. 
However, the leak resistance is far larger than the synaptic resistance, meaning the synaptic 
resistance will contribute most to membrane voltage. 
The resistance across the synaptic ligand gated channels and the ionic driving force 
determine the current injected by the synaptic event. This be modelled by a voltage source 
representing the driving force for the ions and a variable resistance representing the ligand 
gated ion channels. As previously discussed, in the absence of the membrane capacitance 
the voltage across the membrane would instantaneously change in response to current 
injection proportional to the membrane resistance, according to Ohm’s law and the driving 
force of the leak ions.   
The voltage driving the leak current is essentially the average of the reversal potentials for 
ions conducting at rest, weighted by the relative permeability to each by the leak channels. 
Therefore, it is approximately equal to the membrane potential at rest, with a high 
resistance in series. This higher resistance compared to that of the ligand gated ion channels 
has the consequence that the voltage due from the synaptic currents contributes more to 
membrane voltage.  
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As previously shown, the current is split between the input resistance and charging the 
capacitance of the membrane, because the input resistance and capacitance are in parallel. 
The combined resistance of the capacitance and input resistance in parallel however, are in 
series with the synaptic current. Although it is useful to remember a capacitor does not 
have a real resistance, the back voltage due to impedance to changes in its electric field has 
the same effect when considering only one time point during the capacitors charging. 
Further, the effective resistance into the capacitor increases as the capacitor approaches 
fully charged. This means that initially the effective resistance of the leak channels and 
capacitor in parallel is very low, and increases asymptotically to the resistance of the leak 
channels. Therefore, initially as the capacitor starts to charge the synaptic current is actually 
very high, but the change in membrane voltage is very small, this is because most of the 
voltage drop is across the synaptic resistance now as the membrane resistance (due to the 
charging of the capacitor) is very small. Once fully charged, the capacitance of the 
membrane is cannot accept more charge and the current may now only flow across the 
input resistance. Therefore, as the capacitor charges the current flowing into the capacitor 
falls, as the imaginary resistance of the capacitor increases (exponentially). This means that 
asymptotically all of the current flows through the membrane leak resistance, which is a 
much larger resistance, resulting a smaller synaptic resistance, but a larger change in 
membrane voltage. 
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For a time point during capacitor charging: 
 
  
 
The voltage across the membrane is a function of the current and resistance across the 
membrane, and until charged the capacitance of the membrane can be considered a 
resistance in parallel with the input resistance, starting at 0 and ending with infinity and 
increases exponentially against time in-between. This means that the voltage across the 
membrane is also an inverse exponentially increasing function of time, until it reaches a 
maximum determined by the input resistance. Splitting the voltage divider between the 
voltage across the synaptic and leak resistances gives us two terms, Vm – Vleak and Vm – 
Vsynaptic , as well as being able to represent the change in Vm across the capacitor. Applying 
Kirchoffs current law, but represented in terms of voltage, it is possible to construct an 
equation for voltage changes across the membrane due to ligand gated ion channels. Note 
that the resistance charging the capacitance is that of the synaptic resistance and leak 
resistance in parallel, because it is charging with respect to the membrane voltage (and, in 
all cases a voltage divider is functionally identical to the parallel resistance with a source 
voltage equal to that generated by the voltage divider, figure 1.2). Therefore, I can design a 
time constant for the membrane voltage, consider the starting membrane potential at rest 
and a final membrane potential determined by the synaptic and input resistances in the 
steady state when the capacitor has charged. 
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The rheobase current is the minimum current, if sustained indefinitely, required to raise the 
membrane potential from rest to the threshold to fire an action potential. Therefore, the 
rheobase current is the current required to raise the membrane voltage from resting to the 
threshold in the absence of capacitance (Vfinal). The rheobase current is determined by the 
input resistance and is not influenced by the capacitance. However, in practice synaptic 
currents are too short to raise the membrane potential to Vfinal as a single event, and thus 
require the membrane capacitance to store the voltage contributions of multiple currents to 
raise the voltage to the threshold. However, the input resistance in parallel with the 
membrane capacitance allows the charge across the membrane to leak, so that the voltage 
decays back to the resting membrane potential. This means, that after a synaptic current 
the voltage will fall back to the resting membrane potential. However, this decay will be 
slower than the voltage gain during the synaptic current because it is discharging through 
the input resistance alone, not both the synaptic channels and the input resistance in 
parallel.  
 
The difference between the gain and decay speed of a synaptic input is directly proportional 
to the ratio of synaptic and leak resistances. However, this has the effect that within a 
limited time the membrane will add up the changes in voltage due to multiple synaptic 
currents before they decay. This allows a series of short and small synaptic currents to be 
added to depolarise the cell sufficiently. Consequently, this also adds an additional level of 
complexity to neuronal excitability. It is therefore necessary to consider that there are 
multiple different methods of eliciting the voltage change required to start an action 
potential. Firstly, the cell can use a small continuous current, the rheobase current, to elicit 
an action potential, but this would be incredibly slow. Secondly, the cell can use one very 
large current to elicit an action potential almost immediately, this would be significantly 
faster, but has little flexibility to fine tune sensitivity. Put simply, by this second method an 
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action potential would always happen in response to synaptic input, and would result in two 
neurons in series firing action potentials at exactly the same rate in all circumstances, which 
would limit the ability of a neuronal circuit to process information. Thirdly, the synapse 
could rely on the frequency of synaptic currents to control membrane voltage and 
sensitivity. Due to membrane integration, bursts of individual synaptic currents will raise the 
membrane voltage almost as quickly as a single short current. Further, a persistent 
frequency of synaptic events would also produce a persistent depolarisation, which means 
that a smaller burst of synaptic events would be required to reach threshold. However, 
there are neurotransmitters which are hyperpolarising compared to the resting membrane 
voltage, meaning the frequency of these hyperpolarising stimuli could reduce sensitivity. 
 
Voltage gated Ca2+ channels 
Another set of voltage activated channels are the voltage activated Ca2+ channels. Ca2+ 
signalling in the cell plays a pivotal role in many electrophysiological processes, but is also 
critical to many molecular cell mechanisms and regulation of gene expression. Considering 
its role in both electrophysiological and molecular signalling, it is not surprising that it 
provides an important link between electrophysiological activity and gene expression. Ca2+ 
influx is vital to neuronal development, stimulating CREB phosphorylation in response to 
electrophysiological activity 45,99. However, it also plays a role in neurodegenerative 
diseases, including apoptosis in Huntington’s disease 212. Therefore, investigating the 
function of Ca2+ channels is important for developing models for neurodegenerative 
diseases, but also potentially for developing improved protocols for functionally maturing 
iPS cell-derived neurons. There are 5 different sub-types of Ca2+ channel, L-, N-, P/Q-, R- and 
T- type channels, all of which are expressed in neurons (table 1.2).  
L-type Ca2+ channels are amongst the most prevalent of neuronal Ca2+ channels. There are 4 
L-type Ca2+ channel genes, Cav 1.1 to 1.4, which can be distinguished by their 
electrophysiological characteristics. Cav 1.1 and 1.2 are high-voltage activated, whereas Cav 
1.3 and 1.4 are activated at relatively lower voltages, and considered highly sensitive 116. 
Voltage activated Ca2+ channels usually show significantly slower activation and inactivation 
compared to Na+ channels. Most neurons express one of either Cav1.2 or 1.3 where they 
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contribute to a diverse set of functions. Cav1.3 responds to smaller depolarisations than 
Cav1.2, this means that Cav1.2 will respond only to action potential propagation, whilst 
Cav1.3 responds to changes in voltage that are sub-threshold for an action potential116. 
Further, although both channels generally contribute little to the depolarisation evoked 
during a neuronal action potential, Cav1.3 is capable of providing a small enhancement to 
synaptic depolarisations to facilitate the voltage reaching the threshold for an action 
potential. Crucially, L-type Ca2+ channels are capable of providing Ca2+ influx in response to 
both action potential propagation and sub-threshold depolarisations, depending on which 
sub-types are expressed. These Ca2+ influxes function primarily as a link between 
electrophysiological function and other functions of the cell, including gene expression, 
influencing synaptogenesis and cell survival 50,66,120,164. L-type Ca2+ channel activity has also 
been shown to accelerate the differentiation of neurons from neural stem cells, resulting in 
more functionally active neurons 45. Indeed, the function of voltage activate Ca2+ channels in 
neuronal development best explains the link between depolarising activity and the 
development of neuronal function 51; an idea consistent with the potential effects of both 
neuronal activity and Ca2+ influx on BDNF potency 21,114,174. This link between BDNF signalling 
and Ca2+ influx, is attributed to Ca2+ modulating adenylyl cyclase activity and cAMP gating 
the function of the TrkB receptor 48,159.  
Another prevalent sub-type of Ca2+ channel in neurons is the N-type. These Ca2+ channels 
associate with the snare protein A syntaxin 1 at pre-synaptic membranes 110. Snare proteins 
and N-type Ca2+ channels interact functionally as part of a complex, providing a link between 
N-type Ca2+ channel activity and synaptic vesicular release 110,131,157,178,207.  Demonstrating 
this link, studies have shown that synaptic vesicle release is inhibited by N-type Ca2+ channel 
blockade 16,85.  
T-type Ca2+ channels are low voltage activating, and have a relatively small single channel 
conductance compared to other voltage activated Ca2+ channels 152. There are three T-type 
Ca2+ channels: Cav3.1, 3.2 and 3.3. Cav 3.1. Cav3.2 shows a distinctive change in activation 
and inactivation rates with changes in membrane voltage. Near the activation threshold 
voltage of these channels, around -60mV, they show very slow rates of activation and 
inactivation. However, both activation and inactivation get faster as voltage increases, until 
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around -30mV where the activation rate stabilises at significantly faster rates than other 
Ca2+ channels 152. This allows T-type Ca2+ channels to produce a very short depolarising spike 
which elicits a fast train of action potentials, known as burst spiking 152. By contrast, Cav3.3 
is expressed in far fewer neuronal sub-types and shows very slow inactivation 7. These 
channels are essential for regulating the oscillatory frequency of the thalamus 7. Therefore, 
the expression of these different T-type Ca2+ channels is important for defining features in 
the spontaneous activity of neurons, as they can facilitate burst spiking and biphasic 
membrane potentials in some neuronal sub-types. However, pharmacologically T-type 
channels are more difficult to identify, because of the poor specificity of the common T-type 
Ca2+ channel blocker mibedrafil. 
The R-type Ca2+ channel, Cav2.3, is a high voltage activating channel expressed in most of 
the central nervous system 148. This channel is differentially found at pre- and post- synaptic 
regions of neurons in different neuronal sub-types 148. Functionally, R-type Ca2+ channels 
provide activity-linked Ca2+ influx, similar to L-type channels. Their localisation to spines, 
both axonal and dendritic depending on the neuronal sub-type, allows these channels to 
produce localised Ca2+ influxes and support plasticity 211.  
P/Q- type Ca2+ channels in neurons have functional similarities with N-type channels. P/Q-
type channels are high voltage activated Ca2+ channels that associate with SNARE proteins 
similar to N-type channels 33,157. 
The different sub-types can generally be identified electrophysiologically using specific 
antagonists: 
Name Gene (α1 subunit) Antagonist 
L-type (Cav1.1 – 1.4) CACNA1- S,C,D or F  Nifedipine 
N-type (Cav2.2) CACNA1B Ѡ-Conotoxin 
P/Q-type (Cav2.1) CACNA1A Ѡ-Agatoxin 
R-type (Cav2.3) CACNA1E SNX 482 
T-type (Cav3.1 – 3.3) CACNA1- G,H or I Mibedrafil (less selective) 
Table 1.2: A list of the voltage-gated Ca2+ ion channels, their genes and typical antagonists 
used to study them. 
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Neurotransmitter receptors 
Neurotransmitters are an essential part of neuronal function, providing mechanism for 
information transfer between neurons. IPS cell-derived neurons must develop the capability 
to both secrete and respond to neurotransmitters to accurately model neuronal tissues, and 
potentially neuronal circuits, which may play pivotal roles in many neurodegenerative 
diseases. 
There are two basic types of neurotransmitter receptor, metabotropic and ionotropic. 
Metabotropic receptors respond to neurotransmitter binding by initiating a series of 
intracellular molecular events, usually using a G-protein as an intermediate 143. By contrast, 
ionotropic receptors are ion channels which are gated by the binding of a neurotransmitter, 
also called ligand gated ion channels (these were previously discussed with regards to 
neuronal excitability). Ionotropic receptors can also be sub-divided into those which provide 
depolarising and hyperpolarising currents in response to ligand binding. Depolarising 
ionotropic receptors are permeable to cations; they vary from being broadly permeable to 
Na+, K+ and Ca2+, to being somewhat selective. The mean reversal potential of these ions is 
more depolarised than the resting membrane potential of the cell, resulting in a 
depolarising current when they open. Hyperpolarising ionotropic receptors are ligand gated 
Cl- channels. In mature neurons, a concentration gradient of Cl- ions is maintained such that 
Cl- currents are hyperpolarising from the resting membrane potential. However, during the 
course of differentiation, the concentration gradient is significantly augmented, resulting in 
a switch from depolarising to hyperpolarising compared to the resting membrane potential 
(see Introductions, Electrophysiological properties of neurons, Neurotransmitter receptors, 
GABA receptors).  
In the central nervous system there are several common neurotransmitters, including: 
glutamate, γ-aminobutyric acid (GABA), glycine, acetylcholine (ACH), serotonin and 
dopamine. Receptors can be located at the post synaptic membrane or extrasynaptically. 
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Extrasynaptic receptors respond to neurotransmitter release at the synapse with significant 
delay as the neurotransmitter diffuses from the main cleft and provide different functions 
for augmenting sensitivity.  
Glutamate receptors 
There are multiple types of both ionotropic and metabotropic glutamate receptor. 
Ionotropic glutamate receptors are generally categorised by non-physiological ligands which 
are specific to each subtype. Specifically: α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid (AMPA), kainic acid (kainate) and N-Methyl-D-aspartic acid (NMDA). Ionotropic 
glutamate receptors are permeable to cations, but NMDA receptors are somewhat more 
selective for Ca2+ 107. All three sub-types of ionotropic glutamate receptor are excitatory, 
eliciting depolarisation in response to glutamate. NMDA receptors also require the binding 
of either Glycine or serine, depending on the neuronal sub-type,  as a co-transmitter and are 
almost as sensitive to aspartate as they are glutamate 107. Further, NMDA receptors are 
unique in that at the resting membrane potential Mg2+ ions flow into, and block, the open 
channel pore, which prevents a current in response to ligand binding 132.However, 
membrane voltage changes from AMPA or Kainate receptor-driven activity will cause 
conformational changes in the NMDA receptor to release the Mg2+ ions and unblock the 
channel 123,210. AMPA or Kainate receptors provide immediate current responses at post 
synaptic membranes, whereas at rest, Mg2+ ions heavily inhibit responses from NMDA 
receptors, but as activity increases the NMDA current rapidly becomes uninhibited due to 
Mg2+ leaving the channel pore 11,65. Extrasynaptic NMDA receptors provide continuous 
activity dependant Ca2+ influx, this stimulates protein kinase activity at the post-synaptic 
membrane to induce a phosphorylation-dependant increase in the activation of K+ channels 
and AMPA receptors, increasing synaptic sensitivity immediately, providing one mechanism 
for phase 1 long-term potentiation 185. Over longer periods of time this results in gene-
regulation changes effecting the same K+ channels, AMPA receptors and also modulating 
synaptic structural proteins, increasing synaptic sensitivity more permanently, resulting in 
the second phase long-term potentiation 185. In some neuronal sub-types, metabotropic 
glutamate receptors mediate long-term potentiation. This mechanism also allows neurons 
of the central nervous system to initiate responses from two spatially distant but temporally 
similar signals on the dendritic arborisations of the cell. If spatially close, the membrane 
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would easily integrate the two currents and reach threshold. However, given a large enough 
spatial distance, each response may have decayed. Therefore, back-propagating, sub-
threshold depolarisations remove the inhibition of NMDA receptors along a dendritic 
arborisation, enhancing their activity for subsequent, sub-threshold depolarisations. This 
results in the dendritic arborisation becoming more sensitive, and allowing an integration of 
both signals where membrane capacitance alone could not have due to spatial distance; this 
concept is known as coincidence detection 92,183.  
There are three sub-types of metabotropic glutamate receptor. Group 1 are localised post-
synaptically, and increase the sensitivity of the post-synaptic membrane by increasing 
NMDA-receptor activity as well as other ion channels 41,59,179. Group 2 and 3 are usually 
localised pre-synaptically, and depress both NMDA-receptor activity and neurotransmitter 
release at the synapse 2,181. Further characterisation can be performed using specific 
pharmacological antagonists for of these sub-types. Group 2 and 3 providing a feedback for 
neurotransmitter release and group 1 augment synaptic plasticity and excitability.  
 
GABA receptors 
There are two classes of GABA receptor, ionotropic GABAA and metabotropic GABAB 
receptors. GABAA receptors are ligand gated Cl
- channels and their activity results in a direct 
hyperpolarisation of the membrane by Cl- influx. Now considered part of the GABAA class, 
there is also a sub-class of GABA receptors which are exclusively composed of rho-type 
subunits, known as GABAA-Ρ. GABAA-P receptors are pharmacologically differentiated by their 
insensitivity to allosteric modulators of general GABAA receptors, such as benzodiazepines 
and barbiturates 105.  GABAB receptors are G-protein coupled receptors, and hyperpolarise 
the membrane indirectly through increased activation of inwardly rectifying K+ currents and 
further inhibit neurotransmitter release by inhibiting pre-synaptic voltage activated Ca 2+ 
currents 93. 
GABA is active in very early stages of neurogenesis 205. However, initially GABAA activity 
results in GABA-dependant depolarisation, rather than hyperpolarisation. Therefore GABA is 
an excitatory neurotransmitter at these early stages of development 12,197. In response to 
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repeated GABA stimuli, expression of the Na+,K+ & 2Cl- co-transporter 1 (NKCC1) is reduced, 
and expression of the K+ & Cl- co-transporter 2 (KCC2) is increased. The net effect is a 
developmental change in the Cl- concentration gradient, changing the reversal potential of 
Cl- relative to the cell’s membrane potential at rest 67,196. This results in GABA becoming an 
inhibitory neurotransmitter later in post-natal neuronal development.  
Further, excitatory GABA has been shown to promote synaptogenesis and integration of 
new neurons (which have not yet developed a mature, inhibitory GABA response) in the 
adult central nervous system 68. This is likely due to GABA-dependant depolarisations driving 
Ca2+ influx, which then enhances synaptogenesis.  
 
Huntington’s disease 
In addition to studying the development of electrophysiological maturity in iPS cell-derived 
neurons, this study also aims to develop enhancements in differentiation protocols to 
produce more functionally mature neurons. Using iPS cell lines generated for a Huntington’s 
disease study, this study will attempt to use these protocol enhancements to produce a 
more consistent, and more mature functional outcome at a standardised time point.  
Huntington's disease (HD) is a genetically dominant neurodegenerative disease, directly 
caused by an expansion of a CAG codon repeat in the Huntingtin gene 4. The CAG repeat 
encodes a string of glutamine (Q) residues in the primary structure of the protein, which 
causes a severe abnormality in the protein’s structure. Increases in the length of this repeat 
correlate well with both the age of onset and severity of the disease. This relationship 
between the disease manifestation and CAG repeat length is likely due to increasingly 
aberrant protein structure as the repeat length increases 4. The disease results in motor 
control loss and chorea due to a progressive loss of Medium spiny neurons in the striatum. 
It is currently unclear the normal function of the Huntingtin protein is, and studies have 
linked the protein to multiple different processes. It is therefore unclear whether the 
disease phenotype is as a result of loss of the protein’s function or gain of aberrant 
functions, or both. However, these effects may be linked to the protein being cleaved within 
the poly Q-repeat, resulting in a truncated version of the protein. Further, the likelihood of 
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this cleavage appears to increase with poly Q repeat length, which potentially provides a 
mechanistic link between Q-repeat length and disease progression 166. A combination of 
protein-protein interaction and localisation studies, including yeast 2 hybrid, co-immuno 
precipitation and affinity chromatography, have shown the Huntingtin protein interacts with 
transcription factors, membrane trafficking proteins and some signalling proteins 111. These 
interactions include, direct association with the machinery for clatherin vesicle endocytosis 
at synapses and interaction with the dynein-protien complex during vesicle transport along 
axonal microtubules 79. Further, a study has shown inhibition of axonal transport with 
increased CAG repeat length due an increased toxic function of the truncated Huntingtin 
protein 186. This directly implicates Huntingtin protein in transport to the plasma membrane 
and potentially a disease related phenotype involving mis-regulated movement of ion 
channels to or from the membrane. It has been speculated that this could lead to an 
electrophysiological phenotype, most likely at or near the synaptic membranes, which 
perhaps inlcudes augmented transport of different neurotransmitter receptors to the 
synaptic and post-synaptic membranes. Huntingtin also has a role in regulating apoptosis 
through inhibition of Caspase-9 activity, a reduction in this function potentially evoking an 
increase in the cell’s sensitivity to Ca2+ dependant apoptosis 163. Huntingtin has many 
functions in the cell, and it appears likely that the disease is induced by both toxic new 
functions of the protein and loss of its wild type function. Therefore, developing iPS cell-
derived models for this disease requires generating functional cells which readily reproduce 
these phenotypes.  
Neurotransmitter excitotoxicity is one of the leading hypotheses which attempts to explain 
the increased apoptosis of medium spiny neurons in HD. Work in transgenic mice has shown 
increased NMDA type Glutamate receptor dependant excitotoxicity with expanded CAG 
repeats 212,213.  Further, studies have found increased extrasynaptic NMDA currents in HD 
cells, which correlates with increased rates of apoptosis, assayed using increased tunnel 
positive cells, caspase 3 activity and  caspase 9 activity 212. Perhaps the increased rates of 
apoptosis are due to both to mis-regulated transport of NMDA receptors and increased 
sensitivity to increased intracellular Ca2+ as an apoptotic stimulus due to mis-regulation of 
caspase activity. 125,147.  
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Astrocyte function has also been linked to the mechanisms in Huntington’s disease. Studies 
in mice have shown glutamate uptake by astrocytes is impaired, as well as increased Ca2+ 
dependant glutamate release by astrocytes 63,109,113,118. The increased availability of 
glutamate for extrasynaptic NMDA receptor activation and increased NMDA receptor 
density at the membrane, taken together result in much larger Ca2+ influx from 
extrasynaptic NMDA receptors. Further, Medium spiny neurons of the striatum are also 
more sensitive to Ca2+ influx driving Caspas-9 mediated apoptosis. Interestingly, Ca2+ 
responses from synaptic glutamate receptors have been shown to be neuro-protective, 
compared to post-synaptic receptor activation which appears to be excitotoxic 78,171,215. This 
is likely due to the specific compartmentalisation of the two separate Ca2+ influxes having 
different effects on cAMP synthesis and therefore CREB activation, perhaps influencing 
different pools of adenylyl cyclase which are differentially regulated by Ca2+ 78,146. In addition 
to augmented glutamate activity, HD also significantly reduces BDNF expression in the 
striatum, reducing the pro-survival influence of BDNF 64. Therefore, Huntington’s disease 
disturbs the balance of post-synaptic and synaptic NMDA receptor Ca2+ influxes, resulting in 
reduced Trk-B receptor activity, reduced CREB activation, increased Ca2+ dependent 
caspase-9 activity and increased apoptosis.  
 
Medium spiny neurons of the Striatum 
Approximately 95% of the neurons of the striatum are medium spiny neurons, the 
remainder being cholinergic interneurons. However, it is medium spiny neurons that are 
selectively lost as a result of Huntington’s disease. Since the functional properties of 
medium spiny neurons underpin the disease mechanisms, it is vital that these functional 
properties be investigated in any iPS-cell derived model for the disease.  
Medium spiny neurons are GABAgenic neurons, meaning they secrete GABA from pre-
synaptic membranes to supress activity, by hyperpolarisation, in subsequent neurons. 
Activity in medium spiny neuron is finely controlled by multiple neurotransmitters, including 
GABA, glutamate, ACH and dopamine.  
  56 
Action potential activity in striatal medium spiny neurons is dependent on a bi-phasic 
membrane potential. Short trains of action potentials are observed during an up, 
depolarised state, which is near to the threshold for action potential initiation. These short 
trains and up-states are separated by longer stretches of a more polarised membrane 
potential closer to the reversal potential for K+ ions. The initiation of action potentials during 
the up-state is determined by the voltage during the up-state; they do not generate any 
spontaneous activity if the up-state is not depolarised sufficiently 208. The amplitude of the 
upstate is determined by the magnitude of depolarisation from the glutamatergic synaptic 
input and the magnitude of repolarisation caused by KCNQ channels 176,208. Since the 
magnitude of the KCNQ current is regulated by muscarinic receptor activity (hence they are 
often called M-channels), the magnitude of the up-state can be regulated by ACH from 
cholinergic interneurons 176. This allows cortical stimulation of cholinergic interneurons to 
augment the length of action potential trains in medium spiny neurons, in addition to the 
hyper-polarising stimulus of GABA from fast spiking interneurons 98,187. However, in 
functionally immature medium spiny neurons GABA and ACH may show different effects on 
activity. Firstly, the resting membrane potential may be significantly more depolarised, 
meaning that M-channel activation may actually increase activity by reducing Na+ channel 
inactivation. Secondly, GABA is initially an excitatory neurotransmitter, which would allow 
GABA to initially evoke action potentials.  
Medium spiny neurons of the striatum can be differentiated by the expression of either D1 
or D2 type dopamine receptors 101. Both types of medium spiny neurons respond to 
dopamine secreted from projections which extend from dopaminergic neurons of the 
Substantia Nigra. In response to dopamine stimulation, Dopamine- and cAMP-regulated 
neuronal phosphoprotein (DARPP-32) mediates the modulation of multiple currents to 
augment the activity of medium spiny neurons 101. D1-type dopamine receptors up regulate 
DARPP32 activity through cAMP-dependant phosphorylation, by contrast D2-type dopamine 
receptors down-regulate DARPP32 activity 115,141,204. This allows each type of medium spiny 
neuron to orchestrate opposite responses to dopamine, where dopamine results in a 
depression of activity in D2-type medium spiny neurons but increases activity in D1-type 
medium spiny neuron. 
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The differential responses of medium spiny neurons of the striatum to dopamine are an 
important functional aspect of striatal physiology. The striatum functions as part of two 
parallel circuits in the basal ganglia, the indirect and direct pathways. How these two circuits 
integrate to a common function is most easily imagined in the case of motor control in the 
caudate of the striatum. Each pathway is a series of inhibitory and excitatory synapses 
culminating a negative (indirect pathway) and a positive (direct pathway) stimulus for the 
motor region of the cortex, which controls the motor output. Glutamatergic projections 
from the cortex provide the input into the striatum for both the direct and indirect 
pathways. Once in the striatum, the two pathways are distinguished by the sub-type of 
medium spiny neuron which are used, the direct pathway utilises D1-type medium spiny 
neuron and the indirect pathway utilises D2-type medium spiny neurons, this separation is 
crucial to the regulation of each pathway 54. The direct pathway results in increased output 
from the thalamus to the cortex, which is a positive stimulus for motor action in the cortex 
54. D1-type medium spiny neurons from the striatum repress, via GABAergic projections, 
activity in neurons of both the external globus  pallidus and substantia nigra reticulata54. 
Reduced activity from the external globus pallidus and substantia nigra are translated to 
reduced GABAergic output by both in the thalamus. By contrast, the indirect pathway 
results in reduced output from the thalamus to the cortex, acting to repress motor action 54.  
D2-type medium spiny neurons inhibit neurons of the internal globus pallidus that have 
GABAergic projections into the sub-thalamus 54. The sub-thalamus then has glutamatergic 
projections which excite neurons of  the external globus pallidus and substantia nigra 54. 
Therefore, where the direct pathway is inhibiting GABAergic projections of the globus 
pallidus and substantia nigra, the indirect pathway is stimulating these inhibitory outputs to 
the thalamus, resulting in reduced output from the thalamus to the cortex. D1 and D2 type 
neurons are at the start of the direct and indirect pathways, respectively. This allows 
dopamine secretion in the striatum to simultaneously augment the sensitivity of each 
pathway at their start. Due to the different responses of D1- and D2- type medium spiny 
neurons to dopamine, this means that dopamine in the striatum will increase the output of 
the direct pathway and reduce the output of the indirect pathway. This puts the substantia 
nigra in a position to fine tune the strength of each pathway through the basal ganglia, and 
therefore the sensitivity of the system overall to initiate motor activity.  
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DARPP-32 provides a dopamine-dependant mechanism for mediating of activity in D1 and 
D2 type medium spiny neurons. This mechanism influences function of multiple ion 
channels by intracellular modifications, which together augment the cell’s 
electrophysiological activity. In the D1 type medium spiny neurons, dopamine stimulation 
increases the peak currents for L-type Ca2+ channels, increases NMDA receptor peak 
currents, decreases GABAA currents, traffics more AMPA receptors to the membrane, 
reduces N-type Ca2+ channel peak currents and augments Nav1.2 currents 54. By contrast, in 
the D2 type medium spiny neurons, dopamine stimulation results in reduced L- and N-type 
Ca2+ channel currents, reduced AMPA receptor peak currents, increases Kir3 currents and 
augments Nav1.2 currents 54. These changes allow dopamine to increase the sensitivity of 
D1 type medium spiny neurons and simultaneously reduce the sensitivity of D2 type 
medium spiny neurons. Cholinergic interneurons also express dopamine receptors, which 
augments their activity, increasing the secretion of ACh to supress medium spiny neuron 
activity by increasing KCNQ current magnitudes 193. 
 
Aims of the study 
This study aims to provide new insights into the development of electrophysiological 
function of iPS-cell derived neuronal cultures. Astrocyte secreted factors, in the form of 
astrocyte conditioned medium (ACM), will be used as a strategy for improving the function 
of short protocol-derived neuronal cultures. The benefits to electrophysiological function 
evoked by ACM will be closely scrutinised as a protocol for enhancing short differentiation 
protocols. Further, enhanced functional properties evoked by ACM will be considered as 
defined strategies for directly enhancing functional maturation by activity-linked means. 
In addition to enhancements developed for short protocol differentiation of neurons from 
iPS cells, protocols will be considered for deriving astrocytes from iPS cells. iPS cell derived 
astrocytes could prove invaluable as a tool for enhancing iPS cell derived neuronal cultures 
and for modelling disease mechanisms in either cell type in mixed cultures. 
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 Further, enhanced short differentiation protocols will be assessed by examining the 
consistency and functional maturity activity observed in iPS-cell derived neurons developed 
for studying Huntington’s disease (HD). 
 
Chapter 2: Methods 
Electrophysiology 
The electrophysiological phenotype of differentiating neurons was characterised using 
whole cell patch clamp at weeks 1, 2 and 3 post plate-down. Recordings and protocols were 
performed using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, California, 
USA), an Axon Digidata 1320 DAC/ADC converter (sampling at 10 Khz) and the 
accompanying Clampex 9.2 software (Molecular Devices, Sunnyvale, California, USA) with a 
Bessel low-pass filter applied at 10 Khz. The Axopatch 200B amplifier supports both current 
and voltage clamp, during current clamp the amplifier dictates the current through the 
membrane and records evoked voltage changes. Conversely, in voltage clamp the amplifier 
dictates the membrane voltage across the membrane and records evoked currents. The 
analyses of all recordings were performed offline using Clampfit 9.2 software (Molecular 
Devices, Sunnyvale, California, USA). Glass micropipettes for patch clamp were drawn from 
WPI borosilicate glass capillaries (WPI,) using a Narishige PP-830 two stage pipette puller 
(Narishige Int. Ltd., London, UK), the heat settings used to draw pipettes were aiming at 
producing tip resistances (when in the bath solution) between 5 and 8 MΩ. Although not 
routine, micropipettes were heat polished when facing certain more difficult cell cultures or 
time points using a Narishige Microforge, the heat settings of the pipette puller were also 
adjusted to account for changes in resistance due to heat polishing the tip. The internal 
solution contained (in mM, all from Sigma-Aldrich, Poole, Hants., U.K.) 117 KCl, 10 NaCl, 2 
MgCl2, 1 CaCl2, 11 EGTA, 2 Na2.ATP and 11 HEPES, and the external solution (ECS) contained 
(in mM, all from Sigma-Aldrich, Poole, Hants., U.K.) 135 NaCl, 5 KCl, 5 HEPES, 10 glucose, 1.2 
MgCl2 and, 1.25  CaCl2.  The pH of both solutions were measured using a digital pH meter, 
and then by stepwise addition of aqueous NaOH (1 M) to the external solution or KOH (1 M) 
for the internal solution the pH was increased to 7.4. The junction potential generated by 
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these solutions was calculated using clampfit 9 as 3.9 mV, which was considered relatively 
small. To assure the quality of the whole cell patch data, recordings were made only from 
cells where the access resistance was below 25 MΩ and the leak current was very small 
(aiming for a total resistance above 1 GΩ at rest, held at -70 mV). Recordings were 
performed at room temperature and in the ECS, but each coverslip of cells was replaced 
after 3 hours. 
Cells which had clear and accessible cell bodies which appeared alive were selected for 
electrophysiological measurement. Although no deliberate bias was used to select cells with 
very obvious and mature neuronal morphologies, cells which were clearly undifferentiated, 
dead or showing morphology very different to neurons were ignored.  
Membrane capacitance was calculated using the shape of the transient current elicited 
during the charging or discharging of the capacitance. The change in the charge stored 
across the capacitance is the integral of the current over time during this transient current. 
The capacitance therefore could be calculated using the change in charge stored across the 
capacitance divided by change in voltage. The series resistance, or access resistance to the 
cell by the patch pipette, was considered the only considerable resistance in series with the 
membrane capacitance. Therefore the non-linear change in current during the charging of 
the capacitor had a time-constant determined by the capacitance and the access resistance 
of the cell. In practice, the patch-clamp amplifier used a variable capacitance and resistance 
in the positive feedback of the amplifier, which iteratively changed the values of its series 
resistance and capacitance until they matched that of the cell and pipette. This allowed this 
circuit to charge whilst the membrane capacitor discharged and discharge as the membrane 
capacitor charged, cancelling out the effects of membrane capacitance during voltage clamp 
recordings, as well as measuring these parameters. Very high access resistances (above 25 
MΩ) resulted in the cell being rejected as such high access resistances would result in 
voltage-inaccuracies due to the effective voltage divider caused by the access resistance and 
ion channels. 
Using current clamp the membrane potential at rest and the presence, or absence, of 
spontaneous action potentials were recorded. The current was maintained at 0pA in 
standard ECS over 1-2 minutes of recording, allowing for a recording of the cells natural 
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electrophysiological behaviour. The resting membrane potential was calculated by taking 
the mean voltage during the recording. Spontaneous action potentials were represented by 
depolarising spikes that reached or exceeded 0mV and then rapidly returned to the baseline 
voltage. To measure the ability to fire action potentials (induced action potentials), a current 
step protocol was employed; continuous current injection was used to artificially hold the 
membrane voltage at approximately -70 mV, from this a 100 ms current step was applied to 
depolarise the cell, which increased stepwise from 0 pA to 180 pA in 10 pA increments and 
then between each step at least 100 ms was allowed for recovery. Induced action potentials 
were represented by rapid depolarising spikes that were elicited during a more gradual 
depolarisation caused by the membrane capacitance charging in response to the current 
step. Cell input impedance was measured using sub-threshold voltage injections during 
current step protocols and Ohm’s law, this data was corroborated by low voltage data in 
voltage ramp protocols and Ohm’s law. The analysis of action potential shape and threshold 
is explained in the Analysing induced action potentials section of the methods.  
Using voltage clamp, the magnitude and presence of both voltage activated Na+ and K+ 
currents were measured. A voltage step protocol was used to activate both currents, from 
being held at -70 mV a 200 ms step was applied which increased from -120 to +50 mV in 10 
mV increments per sweep. Eight pre pulses (P/N = 8) were used prior to each so that the 
leak current can be subtracted from the final current recording online using Ohm’s law. 
Isoosmotic replacement (135 mM) of NaCl with N-methy-D-glutamine chloride (NMDG, 
Sigma-Aldrich, Poole, Hants., U.K.) was used to confirm the presence of voltage activated 
Na+ currents by removing the ion which the channels are permeable to. The addition of 
10mM tetraethyl ammonium chloride (TEA, Tocris, Bristol, Avon, U.K.) to the ECS was used 
to confirm the presence of voltage activated K+ currents because TEA is a potent antagonist 
of voltage activated K+ channels. In the absence of NMDG, Na+ currents were represented as 
a fast activating inwards spike at the start of voltage steps above -40 mV, the magnitude of 
the Na+ current at each voltage was measured using the peak inwards current at the start of 
the voltage step. In the absence of TEA, K+ currents were a slower activating current rose to 
an outwards plateau during voltage steps above -20 mV, the average current during this 
plateau was measured to give the magnitude of the K+ current. The presence or absence of 
spontaneous miniature synaptic currents was assessed using continuous recording for 10 
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minutes in voltage clamp, holding at -80, -20 or +20 mV to avoid the generation of action 
potentials. To further distinguish these currents from whole action potentials 0.1 µM 
Tetrodotoxin (TTX, Tocris, Bristol, Avon, U.K.), a potent antagonist of voltage activated Na+ 
channels, was added to the ECS. The addition of 10 µM bicuculline ( Tocris, Bristol, Avon, 
U.K.), an antagonist of GABAA receptors, was used to determine the presence of GABA-
dependant synaptic activity. Miniature synaptic currents, regardless of the type of synapse 
involved, were observed as small inwards (downwards) rapidly activating and more steadily 
inactivating currents, roughly -50 pA peak at -80 mV due to the concentration gradients of 
the ions in the patch clamp solutions. At +20 mV their currents were in the opposite 
direction.  The voltage dependant profile of activation and steady state inactivation for the 
cells’ Na+ current was measured using a dual voltage step protocol; from a holding of -90 mV 
a 200 ms variable (from -120 to 0 mV in 5 mV increments) step was performed followed by a 
100 ms constant 0 mV step. The current evoked by the first step was used showed the 
voltage dependant activation of the Na+ current, whilst the current evoked by the second 
step was used to show the voltage dependant inactivation of Na+ current as this current was 
lost as the first step increased in magnitude. In order to increase accuracy the errors in the 
step voltages were removed offline by subtracting the junction potential (calculated using 
Clampfit 9.2) was subtracted and the voltage loss due to the series resistance (the access 
resistance into the cell) was accounted for mathematically (see series resistance 
compensation equation). Using the adjusted voltage, evoked currents and the driving force 
for Na+ at each voltage in the patch clamp solutions, the evoked Na+ currents were 
converted mathematically to conductance and then normalised them against maximal 
conductance (G/Gmax). For both the activation and inactivation of Na+ channels the 
normalised conductance was plotted against adjusted voltage and the point at which the 
two curves transect was recorded as the voltage of the peak Na+ window current (referred 
to as the Na+ window).  
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Series resistance compensation equation. Vm = membrane voltage, Vt = total voltage, 
Rseries = series resistance and I = current. 
In order to record voltage activated Ca2+ currents, temporal isolation of the voltage 
activated Ca2+ currents from voltage activate Na+ currents was achieved using their different 
activation voltages on a voltage ramp protocol; from a holding of -70 mV the voltage 
stepped to -120 mV momentarily and then performed a continuous linear change in voltage 
over time from -120 to 50 mV over 500 ms. A modified ECS containing 27 mM BaCl2 (Sigma-
Aldrich, Poole, Hants., U.K.), isoosomotically replacing NaCl, was used to amplify the 
magnitude of voltage activated Ca2+ channels and inhibit their steady state inactivation, this 
was used to both confirm their identity and increase their visibility. The addition of 2 µM 
nifedipine (Tocris, Bristol, Avon, U.K.) was used to determine the contribution of L-type Ca2+ 
channels to the total evoked Ca2+ current. The presence of ionotropic GABA (GABAA) 
receptors was determined by a current evoked by a 5s application (using an Intracel RSC160 
rapid perfusion system) of 300 µM ɣ-amino buyturic acid (GABA, Sigma-Aldrich, Poole, 
Hants., U.K.) in ECS during voltage clamp with a holding voltage of -70mV. To produce a 
current-voltage relationship curve of the GABA evoked current, 300 µM GABA was applied 
using the rapid solution changer during the step of a voltage step protocol; a 10 second 
voltage step from a holding of -70 increasing in 20 mV increments from -100 to 20 mV.  
The patch-clamp protocols were performed in such an order as to minimise the effects of 
each protocol on other electrophysiological parameters being measured. To this end, the 
current clamp protocols (gap free and current steps) were performed first, as these 
protocols did not involve the addition of pharmacological reagents. Importantly these 
protocols were used to measure the neuron’s native membrane potentials, spontaneous 
activity and their native ability to fire induced action potentials. Following this, the voltage-
clamp protocols were performed, most of which required solution application from the 
rapid solution changer. Firstly, the voltage step protocols were used to measure the voltage 
activated Na+ and K+ currents, and the activation and inactivation profiles for the Na+ 
current. However, both the NMDA and TEA used during these experiments were shown to 
have very fast and effective wash-off. A voltage gap-free protocol was then used to measure 
miniature synaptic currents, if any were observed then bicuculline and TTX were applied, 
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which again both showed effective and rapid wash-off. Following this GABAA currents were 
assessed whilst being held at -70 mV and then Ca2+ currents using a voltage ramp protocol 
and high BaCl2 solution. The GABA showed rapid wash-off, but the BaCl2 solution sometimes 
showed inhibition of voltage activated K+ currents which washed off more slowly. Therefore, 
following each cell being measured, subsequent cells were then chosen away from the flow 
of the rapid solution changer flow to reduce the effects of solutions applied during the 
previous sample.   
Analysing induced action potentials 
During functional maturation the shape of induced action potentials varies significantly. The 
shape of action potentials varies in the speed and extent of both depolarisation and 
repolarisation. A mature neuronal action potential should show a very fast depolarisation 
resulting in a peak significantly above 0 mV, followed by a rapid repolarisation which 
reaches voltages significantly more polarised than the threshold voltage. By contrast, 
immature neurons show slow events that reach voltages only very slightly above 0 mV and 
do not significantly hyperpolarise the cell. During functional maturation these multiple 
features of action potentials are augmented, resulting in action potential shapes that are 
increasingly fast and sharp.  
Qualitatively it is relatively easy to recognise an immature neuronal action potential 
compared to a mature one (figure 2.1 A). Developing a quantitative measure for action 
potential sharpness is more complex, as there are many individual features of action 
potentials which can be measured and together give an accurate picture of the action 
potential shape. Ideally however, we would generate a standard method of analysis which 
takes into account these multiple factors and can be considered a direct measure of 
sharpness and depolarisation extent.  
To assess and develop a standard method for action potential shape 10 evoked action 
potentials were selected which showed increasing sharpness qualitatively (figure 2.1 A and 
B). Since action potential sharpness is essentially as a direct result of the rates and length of 
depolarisation and repolarisation over voltage, orbital plots where the differential of voltage 
against time (dV/dT) is plotted against voltage (figure 2.1 B). These plots show us how the 
rapidly the membrane voltage changes during the action potential. Time progresses around 
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the orbit in these graphs. The orbital graph starts with a slightly changing voltage due to 
graduated change in voltage elicited by the current step protocol. Once threshold is 
reached, an upwards inflection is observed as the voltage activated Na+ channels open and 
the depolarisation phase of the action potential begins. This rises to a positive peak 
representing the maximal rate of depolarisation before declining back towards 0 mV/ms. 
The point at which it reaches 0 mV/ms represents the very peak of the action potential 
where the Na+ channels inactivate and the K+ channels become the dominant force and 
begin to repolarise the membrane potential. This leads to a negative peak which represents 
the repolarisation of the cell, significant voltage activated Ca2+ currents will split this peak 
into a less negative plateaux followed by a more negative peak when the Ca2+ channels have 
inactivated. The peak then decays back towards 0 mV/ms, in the case of a mature action 
potential this is significantly more polarised than the threshold.  
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Figure 2.1: A series of evoked action potentials assessed for their maturity, from least sharp 
to most sharp.  
A) Voltage traces during the current-step protocol showing the evoked action potential. 
B) Orbital graphs (dV/dT against V) for each of the evoked action potentials from panel A. 
From the voltage trace (voltage against time) during an evoked action potential we can 
directly measure a few characteristics. Firstly, the width of the action potential at half height 
is a measure of how fast the action potential occurred. To measure this we calculated the 
voltage half way between threshold and peak, then the difference between the times at 
which this voltage is reached during depolarisation and then repolarisation. In this study the 
half voltage was chosen between the peak and the threshold, instead of between the peak 
and the peak overshoot after repolarisation, because the threshold value was found to be 
more consistent and many immature action potentials showed no overshoot following 
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repolarisation. To assess the extent of the action potential depolarisation and 
repolarisation, the peak voltage and extent of overshoot can be measured directly. Using 
the orbital graphs, it is possible to measure the maximal rates of both depolarisation and 
repolarisation during an action potential. Interestingly however, the modulus of the area 
inside the orbital graph is determined, in part, by all of these factors. The height of the 
upper peak is the rate of depolarisation, the height of the lower peak is the rate of 
repolarisation and the width of both peaks is the extent of depolarisation. So therefore, the 
area inside the orbit can be considered to be proportional to the speed and the extent of 
the action potential. However, the rates of both depolarisation and repolarisation are highly 
sensitive to noise during the action potential. Therefore, the data was smoothed by 
substituting averages for every 5 data points in. 
 
Number Peak (mV) Undershoot 
(mV) 
Width (ms) Peak dV 
(mV/ms) 
Peak –dV 
(mV/ms) 
Orbit Area 
(mV2/ms) 
1 4 0 10 10.1 -5 269 
2 8.9 -0.4 7.4 31.1 -7.3 722 
3 5.3 -2.2 4.4 35.5 -9.8 1172 
4 13.6 -5.6 3.2 41 -15.2 1727 
5 14 -7.6 3.4 39.7 -16.3 1738 
6 16.3 -4.1 3.4 73 -23.1 2612 
7 27.5 -8.1 3.1 98 -22.6 4365 
8 24.3 -13.8 1.9 103 -44.2 5542 
9 33.8 -15.2 1.5 144 -51.1 8201 
10 43.3 -15.7 1.4 189 -56.2 10884 
Table 2.1: Measured shape properties of 10 action potentials from figure 2.1. Peak: the 
absolute highest voltage achieved during the action potential. Undershoot: Following 
repolarisation how far was the membrane voltage hyperpolarised compared to threshold. 
Width: the difference in time from the half height voltage (between threshold and peak) 
during depolarisation to hyperpolarisation. Peak dV: Peak positive rate of change of voltage 
(max depolarisation rate). Peak –dV: Peak negative rate of change of voltage (max 
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repolarisation rate). Orbit area: The modulus of the sum of the integrals of dV/dT against V 
from threshold to overshoot, resulting in the area inside the orbit. 
Following these analyses, it is immediately clear that they correlate well with each other, 
where action potentials are qualitatively appear sharp, short widths (at half height) are 
observed. Further, this correlates well with increased maximal depolarisation and 
repolarisation rates (table 2.1, figure 2.1). These data also correlate well with a higher peak 
voltage and undershoot following repolarisation. The area inside the obit (sum of the 
modulus of the integrals of dT/dV against V) also correlates very well with all of these 
measures. Further, the area under the curve appears most able to distinguish differences in 
the action potential shape across all levels of maturity. This is because certain measures 
become less able to distinguish action potential shapes as they reach plateaux at either end 
of the spectrum, or are simply more variable. For example, peak depolarisation and peak 
voltage show plateaus when assessing action potentials 1-5 whereas the peak repolarisation 
shows a plateau when assessing action potentials 8-10. The half width shows very little 
sensitivity and appears only useful to demonstrate very significant differences in shape. The 
area inside the orbit however, remains sensitive across all maturities whilst correctly 
identifying very similar action potentials, for example in the case of 4 and 5. This is largely 
because the area inside the orbit is actually dependant on multiple of the above factors. 
Therefore, the area inside the orbit is potentially a powerful quantitative technique for 
providing a single measure of action potential maturity. 
The threshold for an action potential is the voltage at which the action potential is initiated 
due to the response of voltage activated Na+ channels. The threshold can be estimated 
using the original voltage trace, but this is fairly inaccurate. The dV/dt vs. V orbits generally 
shows a more obvious inflection at the very start of the threshold voltage, because the 
orbital graph is representing the action potentials in terms of rate of change of voltage. The 
second order differential was also attempted but produced very variable results from some 
action potential shapes.  
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Calcium imaging 
To produce a more complete profile of the functional expression of voltage activated Ca2+ 
channels, Fura-2 Ca2+ imaging was used to detect depolarisation dependant Ca2+ influx at 
week 1.  Fura-2 AM (Invitrogen) was loaded into cells for 30 minutes at 37 oC at 4 µM in 
culture medium (with 0.04% DMSO, Sigma-Aldrich, Poole, Hants., U.K.). Once loaded, the 
cells were moved to a perfusion chamber mounted on the stage of an inverted Olympus IX-
70 microscope (Olympus Microscopy, Essex, U.K.) and continuously perfused in ECS. Fura-2 
was alternately excited by 50-100 ms pulses of light at 340 and 380 nm using a 
monochromator (Cairn Instruments, Faversham, Kent, U.K.) through a 400x quartz, oil 
immersion objective. The resulting re-emission at 505 nm evoked by excitation at either 340 
or 380 nm was recorded using a CCD camera (Hamamatsu Orca, Hamamatsu Photonics K.K., 
Hertfordshire, U.K.) every 3 seconds, online 2x binning was used to increase the signal 
intensity at the expense of resolution but without sacrificing the signal to noise ratio. Off-
line, the image acquisition software (OptoFluor, Cairn Instruments, Faversham, Kent, U.K.) 
was used to analyse the captured images, measuring the fluorescent intensities evoked by 
excitation at 340 and 380 nm within regions of interest which circled the cell bodies of 
neurons. The background fluorescence from each excitation frequency was independently 
measured using regions of interest circling an empty region of the coverslip. The background 
fluorescence was then subtracted from the fluorescence intensities measured at each of the 
cell bodies of interest. The ratio of fluorescence intensities (i380/i340, background 
subtracted) was calculated against time for each cell and used as an indication of changes in 
intracellular Ca2+ concentration over time.  A 10 s application of a modified ECS where 
50mM KCl was added (high K+), isoosmotically replacing NaCl, was applied directly to the 
cells using the rapid perfusion system. The high K+ solution was used to depolarise the cells, 
evoking Ca2+ influx through voltage activated Ca2+ channels, which was measured as a sharp 
increase in the ratio of the fluorescent intensities (i380/i340) of Fura-2. Following a high KCl 
application and given 200 s to recover in ECS, the same high K+ solution was applied with the 
addition of a specific antagonist to one sub-type of voltage activated Ca2+ channels (10 µM 
nifedipine, 0.1 µM conotoxin, 0.1 µM agatoxin and 0.1 µM SNX482 (all from Tocris, Bristol, 
Avon, U.K.) for L-, N-, P/Q- and R- type channels respectively) and again allowed to recover 
in ECS. Subsequently high K+ solution applications were added alternately with high K+ 
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applications with different antagonists to voltage activated Ca2+ channel sub-types, and 
allowed to recover for 200s inbetween. For each application of high K+ solution, with or 
without an antagonist, the area under the Fura-2 fluorescent ratio (i380/i340) against time 
curve was calculated by taking the sum of the integrals of each 3s linear line joining each 
data point from the start of the application to the ratio having reached baseline. The 
baseline Fura-2 fluorescent ratio was calculated by linear regression of the Fura-2 
fluorescent ratio prior to an application of high K+ and after the cell has returned to baseline 
following high K+ application (usually approximately 150 s). The integral of the baseline Fura-
2 fluorescent ratio line was then calculated between the same time limits as the integral of 
the actual curve during an application of high K+, to give the assumed area under the curve 
had the application not occurred. The assumed area under the curve had a high K+ 
application not occurred was then subtracted from the actual area under curve for each 
high K+ application, leaving only the increase in intracellular Ca2+ due to the high K+ 
application. The antagonist free high K+ applications were used to demonstrate the 
presence and magnitude of each cell’s voltage activated Ca2+ response, and further to show 
run down of this response with time. Linear regression was used to calculate the run down 
over time for the high K+ induced Ca2+ influx which was used to estimate the expected area 
under curve for each high K+ application without the antagonist, from which the observed 
area under curve (with the antagonist) could be subtracted to calculate the amount of 
inhibition. The amount of inhibition was used as a measure of the contribution to the total 
Ca2+ influx from each sub-type of Ca2+ channel.  
Fura-2 based Ca2+ imaging was also used as an indirect measure of the direction of chloride 
currents from GABAA stimulation. During neuronal development, in response to GABA 
stimulation, the Cl- concentration gradient switches from being depolarising (Cl- moving 
outwards) to hyperpolarising (Cl-  moving inwards). Therefore, GABA responses switch from 
being excitatory to inhibitory for neurons firing an action potential. Using the same Ca2+ 
imaging set up as before (above), the cell responses to GABA were measured indirectly, 
using the Ca2+ influx due to GABA-evoked depolarisation. In this protocol, 10s applications 
(using the rapid perfusion system) of high K+ solution, 300 µM GABA both in normal ECS and 
a low Cl- ECS, NaCl was isoosmotically replaced with Na ∙ isethionate (Sigma-Aldrich, Poole, 
Hants., U.K.). The high K + solution was used as a positive control for voltage activated Ca2+ 
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cells, to exclude cells not able to respond. In the presence of the low Cl- then the Cl- 
concentration gradient will always be outwards (depolarising) and therefore elicit a 
response from the voltage activated Ca2+ channels. By contrast a Ca2+ response to GABA in 
ECS will only be observed in cells where their native concentration gradient to GABA is 
outwards (depolarising). Therefore a cell which showed a Ca2+ influx response to GABA in 
both ECS and low Cl- have a natively excitatory response to GABA, whereas cells which only 
showed a Ca2+ response to GABA in low Cl-  have a natively inhibitory response to GABA.  
Immunostaining 
The media was aspirated off, replaced with 4% paraformaldehyde (Sigma-Aldrich, Poole, 
Hants., U.K.) and fixed for 10 minutes at 4 oC in a lab refrigerator. The cells were then 
washed 3 times in PBS before the blocking solution (PBS (Sigma-Aldrich, Poole, Hants., U.K.) 
with 10% BSA (Sigma-Aldrich, Poole, Hants., U.K.) and 1% Triton X-100 (Sigma-Aldrich, 
Poole, Hants., U.K.))  was added and incubated for 1 hour at room temperature. Following 
the blocking solution, 3 PBS washes were performed and the primary antibodies prepared 
(PBS with 10% BSA, 1% Triton X-100 and primary antibody at the dilution in Table 2.1).  The 
samples were incubated over night at 4 oC with the primary antibodies. The following day 
the primary antibodies were removed and the cells were given 3 PBS washes, the secondary 
antibodies were then added (PBS with 10% BSA, 1% Triton X-100, secondary antibodies at 
the dilution in Table 2.2, and 10% normalised serum of the same species (Life Technologies, 
Paisley, U.K.)) and incubated at room temperature for 1 hour. Three PBS washes were 
performed and the Hoechst nuclear stain was added for 30 minutes at room temperature. 
The cells were PBS washed 3 times and then mounted in a drop of fluoromount G (Life 
Technologies, Paisley, U.K.) solution on a glass microscopy slide. Samples were then 
mounted in fluoromount G on microscopy slides were dried at 4 oC overnight, then stored 
like that in a slide rack. The cells were imaged on a Leica DMI microscope with Leica 
fluorescent microscopy camera (Leica, Milton Keynes, Buckinghamshire, U.K.). 
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Target Cell Type Manufacturer Dilution Species Lot No. 
Map2ab Neuron Sigma-Aldrich 1:200 Mouse 048k4836 
β3 tubulin  Neuron Sigma-Aldrich  1:1000 Mouse 088k4799 
GFAP Astrocyte Dako 1:1000 Rabbit Z0334 
S100β Astrocyte Abcam 1:500 Mouse AB66028 
Nestin Progenitor Millipore 1:1000 Rabbit LV1635955 
DARPP32 Neuron(MSN) Cell Signalling 1:400 Rabbit 2306 
Table 2.2: A list of primary antibodies used. 
 
Target label Manufacturer Dilution Species Lot. No. 
Rabbit AF 488 Life 
Technologies 
1:2000 Donkey A21203 
Mouse AF 594 Life 
Technologies 
1:2000 Donkey A21206 
Table 2.3: A list of secondary antibodies used. 
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Cell Culture 
Coating and preparing, coverslips, culture dishes and multi-well plates 
Human induced pluripotent stem (iPS) and embryonic stem (ES) cell cultures were grown on 
matrigel coated 6-well plates or 6cm dishes. The matrigel (BD Biosciences, Oxford, U.K.) was 
diluted (using the recommended dilution factor for each batch of matrigel) in DMEM:F12 
(1:1, Life Technologies, Paisley, U.K.), as quickly as possible to avoid the thawing matrigel 
from aggregating, the plates or dishes were then flooded with 2 ml of diluted matrigel. The 
plates or dishes were then incubated at 37 oC for 1 hour before being aspirated off 
immediately before adding cells. 
Poly-L-lysine (PLL) was used as a substrate for stem cell derived neuronal and astrocyte 
differentiation plate downs. The PLL (Sigma-Aldrich, Poole, Hants., U.K.) was diluted to 100 
µg/ml in sterile water (Invitrogen), placed on the coverslip as an 80 µl droplet and then 
incubated at 37 oC for 30 minutes. The PLL droplet was then aspirated off the coverslip and 
the coverslip was left to dry in a tissue culture hood overnight.  The coverslip was then 
washed with a droplet of PBS to remove excess. In addition to PLL coating the coverslips 
were coated with laminin. The laminin (Stemgent, Cambridge, MA, U.S.A.) was diluted to 
50µg/ml in PBS (Life Technologies, Paisley, U.K.), placed on a 13mm glass coverslip as an 80 
µl droplet and then incubated at 37 oC for at least 30 minutes. The laminin was not removed 
until ready to drop cells on the coverslips, when ready the laminin on the coverslip was 
aspirated, the coverslip was quickly washed with an 80 µl PBS droplet and then the cells 
placed on the coverslip to avoid the laminin drying. The PBS droplet was then aspirated 
immediately prior to adding the cells. 
In the latter part of chapter 3, where the rosette differentiation was used, Poly-D-lysine and 
Matrigel were used in preference to PLL and Laminin. The coverslip was poly-D-lysine 
(Sigma-Aldrich, Poole, Hants., U.K.) coated using the same protocol as poly-L-lysine (above). 
The coverslip was matrigel coated using the same protocol as for coating tissue culture 
plastic with matrigel (above) for the iPS and ES cells, except using 80 µl droplets on the 
coverslips instead of flooding the well.  
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Poly-hema was used to coat tissue culture flasks to avoid the EZ-sphere cultures from 
adhering to them. The poly-hema (Sigma-Aldrich, Poole, Hants., U.K.) was dissolved in 95% 
ethanol with sterile water at 10 mM overnight by incubation at 37 oC. The poly-hema was 
then added to tissue culture flasks, 3 ml for a T25 flask, and left to dry in a tissue culture 
hood overnight with each flasks screw top open. 
Human iPS and ES cell culture: 
Fibroblasts extracted from an individual not genetically predisposed (33 and 18 CAG 
repeats, referred to as HD33) to Huntington’s disease and a sibling suffering with adult 
Huntingdon’s disease (66 and 18 CAG referred to as HD66) as well as two childhood onset 
patients with much longer repeat lengths (extended alleles of 109 CAG repeats and 180 CAG 
repeats, referred to as HD109 and Q180 lines respectively) were all reprogrammed by 
retroviral insertion of  klf-4, Oct3/4, c-myc and sox-2 218.  Genetic analysis revealed no 
further repeat expansion or contraction as a consequence of reprogramming and cell 
culture and normal karyotypes 218. These induced pluripotent stem cells (iPS) cells were a 
kind gift of Prof. Clive Svendsen of the Regenerative Medicine Institute at Cedars Sinai 
Medical Centre (Los Angeles, California, USA). As well as the human iPS cell lines, H9 human 
embryonic stem (ES) cell cultures were also cultured. Both the human ES and iPS cells were 
cultured in Matrigel (BD Biosciences, Oxford, U.K.) coated 6 well tissue culture plates in 
mTeSR 1 medium (Stem Cell Technologies, Grenoble, France), in a standard tissue culture 
incubator (37 oC, 5% CO2). To avoid differentiation the pluripotent stem cell colonies were 
visually inspected using a phase contrast microscope every day, any differentiating colonies 
were removed physically with a sterile p200 pipette tip. Every week the cells were passaged 
into new Matrigel coated 6 well tissue culture plates using Versene(Life Technologies, 
Paisley, U.K.) and cell scraping. 
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Astrocyte isolation, culture and conditioned medium 
Striatal astrocytes were isolated from P1 or P2 post natal mice (wild type, Black 6). Striata 
were dissected and then triturated using a 1 ml pipette in Hank’s buffered saline 
(Peprotech, London, U.K.) to fragment the tissue. A single cell suspension of striatal cells 
was then produced by enzymatic dissociation using TrypLE express (Life Technologies, 
Paisley, U.K.) and DNAse1 (0.1 mg.ml-1, Sigma-Aldrich, Poole, Hants., U.K.) for 
approximately 20 minutes at 37 oC with intermittent trituration by 1ml pipette. The 
digestion was stopped by centrifuging the cells to a pellet (1000 rpm, 1.5 minutes) and 
washing out the enzyme with astrocyte growth medium (DMEM supplemented with 1% 
Glutamax (Life Technologies, Paisley, Strathclyde, U.K.), 10% fetal bovine serum (Sigma-
Aldrich, Poole, Hants., U.K.) and 1% of a cocktail of penicillin, streptomycin and fungizone 
(Anti-Anti, Life Technologies, Paisley, Strathclyde, U.K.). The cells were cultured in standard 
tissue culture flasks in a standard tissue culture incubator (37 oC, 5% CO2) and given 
astrocyte growth medium twice a week. The cultured striatal cells were allowed to reach 
confluency before being passaged at a 1:3 ratio using TrypLE express. Following the second 
passage and being grown to confluency, the astrocytes were used to condition medium for 
use as the medium for differentiating neuronal cultures. To condition medium, the astrocyte 
medium was aspirated and the astrocytes were washed with PBS, to remove any remaining 
astrocyte medium and avoid contamination in the neuronal medium. The astrocytes were 
then cultured in the base neuronal medium (DMEM:F12 (1:3 or 1:1, see neuronal 
differentiation medium) and 2% B27) for 3 days. The medium was then removed and 
filtered through a disposable Nalgene 0.22 µm suction filter (120-0020 Sterilization Filter, 
Nalgene), then frozen at -80 oC in 25 ml aliquots for later use. Using quantitive ELISA 
(Quantikine Mouse CCL2/JE/MCP-1 immunoassay, R & D Systems, Abingdon, Oxon., U.K.) for 
an astrocyte secreted factor found not to be influenced by Huntington’s disease, CCL2 
(chemokine C-C motif ligand 2), the astrocyte conditioned medium was standardised by 
dilution with neuronal base medium. The standardised conditioned medium was then mixed 
1:1 with neuronal base medium and supplemented with factors defined in the neuronal 
differentiation media section. 
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EZ sphere differentiation 
Induced pluripotent stem cells and human embryonic stem cells were partially 
differentiated into an easy to maintain, non-adherent culture of neural progenitor cells 
known as EZ spheres 56. The EZ spheres were made form physically lifted ES or iPS cell 
colonies (using a cell scraper) from the Matrigel coated 6 well plates using a cell scraper and 
were allowed to settle at the bottom of a 14 ml Falcon tube. The medium was then replaced 
with EZ-sphere medium (In Stemline (Sigma-Aldrich, Poole, Hants., U.K.), 100 ng.ml-1 EGF  
(Millipore GF144, Merck Millipore, Billerica, MA, U.S.A.) 100 ng.ml-1 bFGF  (Millipore GF003, 
Merck Millipore, Billerica, MA, U.S.A.) and 5 µg.ml-1 heparin  (H3149, Sigma-Aldrich, Poole, 
Hants., U.K.)), washed with the same medium again to remove any remaining MtESr 
medium and the cells were then placed in poly-hema (see poly hema coating) tissue culture 
flasks. The EZ spheres were fed with EZ sphere medium every other day and passaged 
weekly using a mechanical tissue chopper (Mcllwain tissue chopper, Mickle Engineering, 
Gromshall, UK) in 0.2 mm by 0.2 mm pieces. The EZ spheres were allowed to grow through 
at least 4 passages prior to use, and mostly only used between 10 and 30 passages as this 
resulted in the most consistent differentiation. 
The EZ spheres were used to produce terminally differentiating cultures of neurons. To 
inhibit apoptosis during plate down, prior to plating 1µM Rho Kinase inhibitor Y-27632 
(ab120129, Abcam, Cambridge, U.K.) was added to the EZ sphere medium for 20 minutes at 
37 oC. The EZ spheres were then disaggregated by incubating them in 2ml TrypLE express at 
37 oC in a heated water bath for between 5 and 10 minutes, depending on how quickly a 
single cell suspension was formed. The enzyme was then washed out twice in neural 
differentiation medium by centrifuging the cells to a pellet (1000rpm, 1 minute). The cells 
were then counted using a haemocytometer and phase contrast light microscope, dead cells 
were excluded by staining the cells by mixing them 1:1 by volume with trypan blue (Life 
Technologies, Paisley, U.K.). The cells were then plated at a density of 20,000 cells per well 
in 80µL drops on poly L-lysine (see PLL coating) and laminin (see laminin coating) coated 
coverslips in 24 well tissue culture plates. After between 2 and 4 hours in a drop on the PLL-
Laminin coverslips the wells were flooded with 400µL of differentiation medium (see 
neuronal differentiation media). The differentiated neurons were culture for up to 3 weeks, 
having a full media change every 3 days. 
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Astrocyte EZ differentiation, culture and hACM 
EZ spheres were differentiated into astrocytes using a novel 3 step protocol. Similar to 
neural differentiation the EZ spheres were disaggregated with TrypLE express and plated on 
PLL-Laminin coverslips at a density of 40,000 cells per well. In the first week the cells were 
bathed in DMEM:F12 (1:1) medium with 2% B27 and 10 µM Ara-C (Tocris Bristol, Avon, 
U.K.), resulting a loss of mitotic cells, the medium was replaced every 3 days. Following the 
first week the medium was changed with DMEM:F12 (1:1) medium with 2% B27 and 10µM 
leukaemia inducible factor (human recombinant LIF-1, Life Technologies, Paisley, U.K.) and 
replaced every 3 days. Following the second week the medium was changed with 
DMEM:F12 (1:1) with 10% foetal bovine serum (FBS, Life Technologies, Paisley, U.K.) and 
10µM LIF-1, this medium was then changed every 3 days and used as the standard medium 
for continually culturing the human astrocytes. The cells could then be lifted from the glass 
coverslips using TrypeLE express and passed into standard Nuncylon coated tissue culture 
flasks. The cells were then passaged every week using TrypeLE express. After 1 passage the 
cells could be used for producing astrocyte conditioned medium, using the same protocol as 
employed for the mouse isolated astrocytes. 
From rosette neuronal differentiation 
Human iPS or ES cultures which have reached 70% confluence in 6 well, matrigel coated 
plates or 6cm culture dishes were used for differentiation, this is considered day 0.  To 
remove factors present in the mTeSR medium the cultures were washed 3 times in PBS. 
From Day 0 to 4 the cultures were given the first differentiation (advanced DMEM:F12 (1:1) 
with 2% B27, 10 µM SB431542 (ab120163, Abcam, Cambridge, U.K.), 1 µM LDN 193189 (04-
0019, Stemgent, Cambridge, MA, USA) and 1.5 µM IWR1 (3532, Tocris Bristol, Avon, U.K.)) 
medium, which was replaced daily. The cells were treated with 10 µM ROCK (Rho Kinase) 
inhibitor Y-27632 for 1 hour at 37  oC, then rinsed with PBS twice before being passaged at a 
1:2 ratio using neat accutase into more matrigel coated plates and rinsed with ADF 
(DMEM:F12 (1:1) with 2% B27). From day 4 to 8 the cells were fed daily with the first 
differentiation medium (see above) and 10 µM ROCK inhibitor (Y-27632). At day 8 the cells 
were passaged again and fed with the second differentiation medium (advanced DMEM:F12 
(1:1) with 2% B27, 0.25 µM LDN 193189 and 1.5 µM IWR1). At day 16 the cells had formed 
neural rosettes which could be expanded for a limited number of passages, frozen or 
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continued to terminal differentiation. Terminal differentiation was performed on nitric acid 
etched, poly D-lysine and matrigel coated glass coverslips in 24 well tissue culture plates. 
The neural rosettes were disaggregated using accutase at 37 oC for 5 minutes, then collected 
by centrifugation, re-suspended in advanced DMEM:F12 with 2% B27 and counted (using 
trypan blue to ignore dead cells). The cells were re suspended at 1x106 cells per ml and 
plated on the glass coverslips in 80µL drops, which were left at 37 oC for 2-4 hours before 
being flooded with 500 µL of neural differentiation medium for week 1 (see neuronal 
differentiation medium). The medium was changed every 2 days, after 1 week the media 
was changed to the second neural differentiation medium (see neuronal differentiation 
medium). 
 
Neuronal differentiation media 
For chapters 1 and 2 a low Ca2+ (0.6 mM) base medium was chosen, to which any 
modifications were added, consists of DMEM:F12(DMEM:F12 (1:3, Life Technologies, 
Paisley, Strathclyde, U.K.) with 2% B27 (+ RA, Miltenyi Biotec Ltd., Bisley, Surrey, U.K.), 1% 
none essential amino acids (Life Technologies, Paisley, Strathclyde, U.K.), 10ng/ml brain 
derived neurotrophic factor (BDNF, Peprotech, London, U.K.), 10 ng/ml glial derived 
neurotrophic factor (GDNF, Peprotech, London, U.K.) and 200 M ascorbic acid (Sigma), 10 
µM DAPT (Tocris, Bristol, Avon, U.K.) was also added for week 1 only. This medium was also 
chosen for the ACM experiments, although BDNF, GDNF, ascorbic acid and DAPT were 
added post-conditioning. In order to test the effects of calcium on differentiation an 
additional 0.6 and 1.2 mM CaCl2 was added to the medium, resulting in 0.6 mM Ca
2+ 
medium (control), 1.2 mM Ca2+ medium and 1.8 mM Ca2+ medium. The higher 1.8 mM Ca2+ 
medium (with 1.2 mM CaCl2 added) was found to be more effective and therefore used in 
subsequent experiments involving specific blockade of ion channels. Both the ACM and 1.8 
mM Ca2+ media were supplemented with nifedipine, agatoxin, conotoxin, SNX482 and 
bicuculline individually to specifically block L-, P/Q-, N- and R- type Ca2+ channels, and 
GABAA channels respectively. GABA and Bay K8644 (Tocris, Bristol, Avon, U.K.) were added 
to the control (0.6 mM Ca2+) to specifically activate GABAA and L- type Ca
2+ channels 
respectively. In addition to simple pharmacological experiments to assess the activation / 
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inhibition of one channel, experiments were also performed where inhibition was combined 
with activation of a different channel to affect a rescue of function. Specifically, to the high 
Ca2+ (1.8 mM) both conotoxin and GABA were added to block N- type Ca2+ channels and 
activate GABAA receptors, and, separately, both bicuculline and Bay K8644 were added to 
block GABAA channels and activate L-type Ca
2+ channels.  
In chapter 3 initially a moderately higher Ca2+ (1.25 mM) medium was chosen for modelling 
the development of HD: DMEM:F12 (1:1) with 2% B27, 1% none essentially amino acids, 10 
ng/ml BDNF, 10 ng/ml GDNF,  200 M ascorbic acid and 10 µM DAPT (Tocris, Bristol, Avon, 
U.K.) for the first week. Astrocyte conditioned medium was also created for this medium 
from the mouse isolated astrocyte cultures. In latter experiments however, the EZ-sphere 
differentiation was dropped for a straight from iPS-cell differentiation, with a neural rosette 
intermediate which could be frozen down and thawed when needed (see from rosette 
differentiation). In addition to dropping the use of EZ spheres, the differentiation medium 
was also altered, incorporating techniques developed in chapter 2, as well as other work to 
enhance the functional outcome of differentiation.  This new differentiation occurred in two 
steps, the first medium for week 1 (Advanced DMEM:F12 (1:1, Life Technologies, Paisley, 
U.K.) with 2% B27, 200mM L-glutamine (Life Technologies, Paisley, U.K.), 2 µM PD0332991 
(Tocris, Bristol, Avon, U.K.), 10 µM Forskolin (Tocris, Bristol, Avon, U.K.), 3 µM CHIR 99021 
(Tocris, Bristol, Avon, U.K.), 300 µM GABA (Tocris, Bristol, Avon, U.K.), +0.6 mM CaCl2 (to 1.8 
mM, Sigma-Aldrich, Poole, Hants., U.K.), 10 ng/ml BDNF,  200 µM ascorbic acid and 10 µM 
DAPT). And then a second medium for all subsequent weeks (Advanced DMEM:F12 (1:1) 
with 2% B27, 200 mM L-glutamine, 2 µM PD0332991, 3 µM CHIR 99021, +0.6 mM CaCl2 (to 
1.8 mM, Sigma-Aldrich, Poole, Hants., U.K.), 10 ng/ml BDNF and  200 µM ascorbic acid). 
Statistics 
For continuous data-sets where 2 means were compared the data were checked for an 
approximate fit to a Gaussian distribution. Assuming an approximately Gaussian distribution 
a two sample unpaired, two tailed, T-test was performed. If the data distribution was 
significantly distinct from a Gaussian distribution then data transformations were 
considered in order to apply a T-test. However, if there was no obvious data transformation 
which resulted in an approximately Gaussian distribution then the medians were compared 
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using a Mann-Whitney U test. For binomial data sets comparing two proportions of cells, 
two-tailed Chi2 tests were used. Statistics were reported as means or the probability value, 
test statistic and degrees of freedom (if relevant) were included for any statistical test 
performed. Statistics and graphical representations of the data were performed using either 
R (x64) version 2.14.0 with the default installed libraries or Graphpad Prism version 5.01 (La 
Jolla, Ca. USA.). 
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Chapter 3: Secreted factors from isolated mouse astrocytes enhance 
the extent of functional maturation in iPS-derived neurons. 
Specific Introduction 
Astrocyte secreted factors and neuronal differentiation 
In vivo, astrocytes provide both contact and secreted signals to allow neurons to 
differentiate and functionally mature (see introductions, Astrocytes and Neuronal 
Functional Development). However, in the short protocol for differentiating neurons few 
astrocytes are observed, due to the delay between neurogenesis and astrogliogenesis in 
neural progenitor cells. The mechanisms by which astrocyte secreted medium (ACM) 
operate to enhance functional maturation in neurons is not yet fully understood. Further, 
no single secreted factor has demonstrated the ability to recapitulate the full effects of ACM 
in a defined protocol. Therefore, to assess the changes in the electrophysiological function 
evoked by a full complement of astrocyte secreted factors, conditioned medium was 
generated using post-natal isolated mouse astrocyte cultures. The conditioned medium 
from these astrocytes then conferred the full mixture of astrocyte secreted factors to the 
iPS cell-derived neuronal cultures. Therefore, the hypothesis was tested that the functional 
influences of astrocytes can be incorporated in short differentiation protocols using ACM, 
evoking increased functional maturity. Many different electrophysiological parameters have 
been analysed. However, most crucial to generating more functional iPS cell-derived 
neurons is increased spontaneous activity. Further, by investigating the functional 
properties of ACM neurons, if a significant functional enhancement is observed, it may be 
possible to assess which functional properties are responsible for ACM-evoked increases in 
spontaneous activity.   It is also plausible that ACM evokes functional changes early in the 
differentiation protocol, which by augmenting electrophysiological activity at these early 
stages, enhance functional maturation over time. 
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Specific methods 
Mouse astrocyte conditioned medium 
Human iPS cell derived neurons were differentiated using a standard terminal 
differentiation protocol from EZ-sphere neural progenitor cell cultures. Post natal day 1 or 2 
isolated astrocytes were cultured and expanded and then used to condition the neuronal 
base medium, producing mouse astrocyte conditioned medium (ACM, see methods). The 
astrocyte conditioned medium was then used in parallel with a standard, established 
differentiation protocol (see methods), for comparison. During the 3 week differentiation 
protocol for terminal differentiation, the cell physiological parameters were measured each 
week using a combination of whole cell patch clamp and fura-2 Ca2+ imaging.  
 
Differentiation using mouse ACM 
Cells from EZ-spheres were plated as a single cell suspension on PLL/laminin-coated glass 
coverslips and cultured in standard medium (Control). As expected, the cells appeared 
disperse and lacked any morphological complexity at day 1. During the first week, they 
remained disperse but began to extent neurites. At weeks 2 and 3, cells were more 
morphologically complex and tended to aggregate into colonies, extending processes 
between colonies of cells.  
 
Voltage-activated Na+ and K+ channels and the ability to generate action 
potentials 
Considered the most basic electrophysiological function of a neuron is the ability to 
generate an action potential. To assess the ability of each cell to generate an action 
potential, a current step protocol was employed, which measured changes in membrane 
voltage evoked by current injection. In order to measure induced action potentials (iAPs), 
the resting membrane was first clamped at approximately -70 mV, using continuous current 
injection, and followed by 100 ms depolarising current steps, which varied from 10 pA up to 
120 pA (in 10 pA increments). The depolarisation of the membrane evoked by the current 
step was graduated in a non-linear fashion due to charging of the cell capacitor across the 
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pipette resistance (figure 3.1 A). This graduated depolarisation conveniently allowed for a 
more gradual rise of the membrane voltage until the threshold for an action potential was 
reached, allowing voltage threshold estimations to be performed later. The current injection 
required to depolarise the cell sufficiently to elicit an action potential was determined by 
the input resistance, since, in the absence of voltage activated ion channel activation, the 
extent of depolarisation (after the membrane capacitance had charged) is determined by 
Ohm’s law. The input resistance of the membrane was measured using the voltage change 
elicited by sub-threshold steps. In the case of a successful action potential, a sudden rapid 
depolarisation, which overshot 0 mV, was observed once the threshold voltage was met, 
which was then followed by a rapid repolarisation which sometimes undershot the 
threshold voltage. On some occasions, the undershoot was sufficient to allow a second 
small action potential, this second action potential was often considered abortive, as it 
usually failed to reach 0 mV. In rare cases (and only in ACM), a full second action potential, 
or action potential train, was observed (see figure 3.1 A for examples of each type of 
response).  
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Figure 3.1: Evoked action potentials across all 3 weeks of differentiation in ACM and control 
medium. 
A) Voltage recordings of induced action potentials (top) during current steps (bottom) for 
cells differentiated in control and ACM medium at each week of differentiation. Arrow 
indicates the first action potential, the circle indicates a second initiated action potential 
(only seen in ACM at week 3). 
B) Bar graph showing the portion of cells able to fire a single (or more) action potential in 
response to the current steps protocol (% cells) for ACM and control cells over all 3 weeks (n 
= 122). Chi2 tests were performed at each week.  
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The ability to fire action potentials was assessed using current step protocols over all 3 
weeks of differentiation, in both control and ACM – treated cells. At week 1, roughly half of 
the cells in both ACM (ACM: 41.1% (n = 24)) and control medium (52.3% (n = 21), ns, chi2= 
2.52) were able to fire action potentials (figure 3.1B). At week 1, the cells showed slow 
depolarising events, starting at a relatively consistent threshold voltage, which reached a 
peak voltage slightly above 0mV (marked with an arrow) followed by a relatively slow 
repolarisation, which did not significantly undershoot the threshold voltage (figure 3.1 A). 
The remainder of cells at week 1, showed either no physiological response to the current 
step (so only measuring the slow depolarisation of the current injection charging the 
membrane capacitance) or they showed very small responses that could be considered 
abortive action potentials (where the action potential does not depolarise the cell 
sufficiently to reach 0mV). By week 2, almost all cells in both media (89.5% (n = 19) in 
control and 89.7% (n = 29) in ACM, ns, chi2<0.001) demonstrated action potentials elicited 
by the current step protocol (figure 3.1B). More strikingly, these action potentials showed 
faster depolarisation, with peaks that reached more positive voltages, followed faster 
repolarisation stages that significantly undershot the threshold voltage (figure 3.1A). At 
week 2, in some cases in both cultures, but more prevalent in ACM-treated cultures (32% (n 
= 19) in control vs. 70%(n = 20) in ACM, P<0.05, Chi2=5.8), the repolarisation overshoot was 
significant enough to allow an abortive second action potential, which although did not 
reach 0mV did show an initiation of a second electrophysiological event. At week 3, again 
almost all cells were able to fire action potentials (80% (n = 15) in control and 93% (n = 14) 
in ACM, ns, chi2=1, figure 3B). These responses also showed fast depolarisations, more 
polarised peak voltages and faster repolarisation stages with larger undershoot. By week 3, 
most cells showed an initiation of a second abortive action potential (53% (n = 15) in control 
vs. 71% (n = 14) in ACM, ns, Chi2=1). However, a significant number of the ACM-treated cells 
showed a second completed action potential (0% (n = 15) in control vs. 43% (n = 14) in ACM, 
P<0.01, Chi2=8.1; marked with a dot, figure 3.1A), where the second action potential 
reached or exceeded 0 mV.  
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To fire an action potential it is necessary for the cell to possess the electrophysiological 
machinery for both voltage dependant depolarisation and repolarisation. In voltage clamp, 
the voltage step protocol was used to measure both the voltage activated Na+ and K+ 
currents simultaneously (see methods). Once the voltage step had reached approximately -
40 mV, the opening of voltage activated Na+ channels was observed as a rapidly activating 
and inactivating inward current (depolarising) at the start of the voltage step. K+ currents 
were observed at approximately -30 mV as a slower activating outward current 
(repolarising) that reached a plateau, and did not inactivate significantly during the voltage 
step. The currents were measured during each voltage step was then plotted against the 
voltage of the step, producing a current-voltage relationship graph for both the Na+ and K+ 
channels. Where comparing multiple cells, the currents were converted to current density 
(pA∙pF-1) and plotted against step voltage (figure 5). As a pharmacological confirmation for 
the voltage activated K+ current, the voltage step protocol was repeated with ECS containing 
10mM tetraethyl ammonium chloride (TEA), a potent voltage activated K+ channel blocker 
(figure 3.2 A). Using this solution, an almost complete ablation of the outwards current was 
observed (figure 3.2 A and 3.2 B), confirming this current represents voltage activated K+ 
channels in normal ECS. To confirm that the inward current was carried by Na+ current, a 
modified ECS was used, in which NaCl has been isoosomotically replaced with N-methyl-D-
glutamine chloride (NMDG), to which Na+ channels are impermeable (figure 4A – NMDG). 
Using this solution, the fast inwards currents (figure 3.2 A and 3.2 B) were entirely 
abolished, confirming this current represents voltage activated Na+ channels in normal ECS. 
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Figure 3.2: Confirming the identity of evoked fast voltage activating and inactivating 
depolarising currents and slower activating repolarising currents as Na+ and K+ channels, 
respectively using pharmacology and ionic substitution.  
A) Exemplar current recordings during a voltage step protocol in standard ECS, NMDG 
solution and standard ECS with the addition of 10mM TEA, with the voltage protocol at the 
bottom. Showing control cells at week 2.  
B) Example IV curves for the current recordings in 4A, showing the mean K+ current density in 
standard ECS and with TEA (top) and peak Na+ current in standard ECS and NMDG solution 
(bottom). Showing control cells at week 2. 
 
Even though around half of the cells at week 1 did not have the ability to fire action 
potentials (see Figure 3.1 B), the majority of cells in both the ACM and control medium 
expressed measurable voltage activated Na+ (73% (n = 11) in control and 88.9% (n = 27) in 
ACM, ns, chi2=1.66) and K+ (82% (n = 11) in control and 92.5% (n = 27), ns, chi2=0.96) 
currents. This observation was maintained at week 2 (Na+: 94% (n = 16) in control and 97% 
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(n = 32) in ACM, ns, chi2=0.26, and K+: 81% (n = 16) in control and 84% (n = 32) in ACM, ns, 
chi2=0.08) and 3(Na+: 92% (n = 12) in control and 91% (n = 11) in ACM, ns, chi2<0.01, figure 
3.3A). However, the magnitude of these currents (mean current densities) were very small 
at week 1 in both culture conditions (control: Na+ = -27.0 ± 5.0 pA.pF-1 (n = 11); K+ = 24.4 ± 
4.7 pA.pF-1 (n = 11), and in ACM: Na+ =  -37.6 ± 4.4 pA.pF-1 (n = 27), ns, T= 1.93, df=39; K+ = 
31.9 ± 4.8 pA.pF-1, ns, T=0.94, df=37, figure 3.4 C), perhaps explaining the disparity between 
the portion of cells with measurable Na+ and K+ currents and their ability to fire action 
potentials. Such a notion is confirmed by the transformed data in figure 3.3B, which shows 
frequency histograms of the magnitude of Na+ and K+ currents in the populations of cells 
either able or unable to fire action potentials within the total of  (818 cells in total, figure 3.3 
B).  
 
Figure 3.3: The number of cells showing observable Na+ and K+ channel currents over each 
week and how these current magnitudes are distributed between cells able and unable to 
generate action potentials. 
A) Bar graphs showing the portion of cells with appreciable Na (left) and K (right) currents 
over all 3 weeks (% cells) for ACM and control cells over all 3 weeks.  
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B) Frequency histograms (ranges of 5pA∙pF-1) showing the modulus of the Na (left) and K 
(right) magnitude for cells with an inducible action potential compared to this without in all 
weeks and all conditions (n = 818). 
 
Once the cells had reached week 2, both the Na+ (control: from -27.0 ± 5.0 pA.pF-1 (n = 11) 
to -58. ± 7.5 pA.pF-1 (n = 13); ACM: 31.9 ± 4.8 pA.pF-1 (n = 27) to 53.9 ± 5.2 pA.pF-1 (n = 32)) 
and K+ (control: from 24.4 ± 4.7 pA.pF-1 (n = 11) to 69.5 ± 8.3 pA.pF-1 (n =  13); ACM: 31.9 ± 
4.8 pA.pF-1 (n = 27) to 53.9 ± 5.2 pA.pF-1 ( n =  32), figure 3.4 D) current densities had 
increased, with significantly larger Na+ currents observed in the ACM-treated cells compared 
to control (Na+ P<0.05, T=2.05, df=46; K+ ns, T=1.52, df=46, figure 6 C and D). This is 
consistent with nearly all cells being able to fire action potentials at week 2, when the 
currents in very few cells fell below the minimal levels required for an action potential. It 
may also be expected, that a higher magnitude of voltage activated K+ current is required 
for cells to undershoot sufficiently to initiate a second action potential. Additionally, it was 
speculated that a higher minimal magnitude of Na+ current for a second action potential 
would be required, because a portion of the Na+ current will still be inactivated when the 
second action potential initiates. Therefore, it is not surprising that second, usually abortive, 
action potentials are only seen at week 2 and beyond, and are more prevalent in the ACM-
treated cells at week 2. At week 3, the voltage activated Na+ and K+ currents had increased 
somewhat in the control treated cells (Na+: -118.9 ± 24.9 pA.pF-1 (n = 12), and K+: 119.5 ± 
16.14 pA.pF-1 (n = 12), but not the ACM cells (Na+: -68.0 ± 7.9 pA.pF-1 (n = 11), and K+: 65.5 ± 
9.9 pA.pF-1 (n = 11), figure 3.4C), resulting in significantly larger K+ currents in the control 
cells (Na+: ns, T=1.79, df=20, and K+: P<0.01, T=2.85, df=20). However, this did not result in 
an apparent increase in second action potentials in the control cells compared to ACM 
(figure 3.1 A), in fact the opposite appeared true, implying undershoot by K+ current is not 
the only factor influence the ability to initiate a second action potential. 
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Figure 3.4: A comparison of the Na+ and K+ current densities in control and ACM treated cells 
across all 3 weeks of differentiation. 
A and B) Exemplar current recordings during a voltage step protocol (bottom) for ACM (B) 
and control cells (A) from each week of differentiation at all weeks. 
C and D) Mean current density against step voltage curves for the voltage activated Na+ 
(left) and K+ (right) currents from each week of differentiation, comparing the ACM (D) and 
control cells (C) at all weeks (n = 106 for each current). T-tests were performed comparing 
the mean peak currents. 
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Spontaneously generated action potentials and the membrane potential at rest 
Mature neurons of the central nervous system in vivo are not just able to fire induced action 
potentials; they produce spontaneous action potentials in response to synaptic stimuli. 
Neuronal networks of the central nervous system are constantly active with rhythmic action 
potentials. To assess the generation of spontaneous activity in the differentiating neurons, 
the native membrane voltages were measured in current clamp with no current injection. 
Whilst recording the native membrane potential, a spontaneous action potential would be 
represented by a sharp depolarising spike (arrow) from the resting membrane potential that 
reached at least 0 mV (figure 3.5 B and C).  
 
Figure 3.5: Observed spontaneous action potential generation in control and ACM-treated 
cells. 
A) A bar graph showing the proportion of cells showing spontaneous action potentials whilst 
being held at I=0 in current clamp for both ACM and Control cells from each week of 
differentiation (n = 147). Chi2 tests were performed at each week. 
  93 
B) Exemplary voltage recording during current clamp (I=0) demonstrating a typical control 
cell at week 3, showing sparse action potentials and no biphasic membrane potential. 
C) Exemplar voltage recording during current clamp (I=0) demonstrating a typical ACM-
treated cell at week 3, showing both short trains of action potentials (arrow) and a biphasic 
membrane potential. 
 
At week 1, very few cells showed any spontaneous activity (0% (n = 19) in control and 2.7% 
(n = 37) in ACM, ns, chi2=0.71). This increased significantly at week 2 (29% (n = 21) in control 
and 37% (n = 35) in ACM, ns, chi=0.43), but actually declined in the control cells by week 3 
(13% (n = 16), figure 7A). The ACM-treated cells showed a very similar trend at weeks 1 and 
2.  However, at week 3, a striking 74% (n = 19, P<0.001, chi2=13.1) of the ACM cells 
generated spontaneous action potentials (figure 3.5A). In addition to more cells showing 
some level of spontaneous activity, the ACM-treated cells showed increased rates of 
spontaneous activity and were unique in having a biphasic resting membrane potential with 
action potential trains observed in the “up-state” (figure 3.5 B and C). Indeed, all 74% (n = 
19) of the active ACM treated cells exhibited complex short trains of spontaneous activity 
and bi-phasic resting membrane potentials (figure 3.5 C). Although, as shown before with 
the current injection evoked action potentials, it is necessary for the cell to express a 
minimal level of Na+ and K+ current in order to fire an action potential, the development of 
the magnitude of these currents does not correlate temporally well with increases in 
spontaneous activity observed in ACM. Indeed, the control cells actually showed the larger 
Na+ and K+ currents at week 3, yet showed very low rates of spontaneous activity. Further, 
the ACM evoked no enhancement of the Na+ and K+ current densities at week 3, yet the 
result was a massive increase in spontaneous activity. This suggested that there were 
alternative mechanisms responsible for this ACM-evoked increase in spontaneous electrical 
activity, prompting an examination other cell physiological parameters in order to be able to 
explain this disparity.  
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Figure 3.6: The voltage-dependant activation and inactivation relationships for the Na+ 
currents observed in control and ACM-treated cells. 
A) An exemplar current recording (top) during a dual step voltage protocol (bottom), 
showing the Na current response used to measure activation (square) from the first step and 
the current response used to measure inactivation (circle) from the second step. Example 
recording is a control cell at week 2. 
B) An exemplar normalised conductance (calculated using the series resistance and junction 
potential compensated voltages and the observed currents) against step voltage (series 
resistance and junction potential compensated) graph, showing the fitted Boltzmann-
Sigmoid curves fitted to both the voltage profile for activation and inactivation of the Na+ 
current. 
C) Data plotted from Rush et al. 2005 showing the isolated voltage-dependant activation 
and inactivation (solid and dashed, respectively) profiles for 2 neuronal sub-types of voltage 
gated Na+ channel, Nav1.2 and Nav.1.6 (blue and red, respectively.   
D) A bar graph showing the mean voltage at which the hypothetical peak-window current 
would occur (where the activation and inactivation curves cross) for the ACM and control 
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cells at each of the 3 weeks of differentiation (n = 77). T-tests were used to compare the 
mean Na window current at each week. 
One property which may influence the generation of spontaneous activity in neurons is the 
voltage dependent activation and inactivation profiles for the voltage-activated Na+ 
channels. A narrower gap between resting membrane potential and the voltage dependent 
activation of the Na+ current could result in the cell becoming more sensitive to action 
potential propagation. However, if the gap between the resting membrane potential and 
voltage dependent inactivation of the Na+ current were too small this may inhibit action 
potential generation, since the Na+ current is inactivated. Additionally, cells with biphasic 
membrane potentials may actually benefit from the up-state approaching the threshold 
voltage for Na+ channel activation, whilst benefitting from the down-state removing the 
inactivation of these channels. Therefore, it was speculated that a hyperpolarising shift, due 
to changes in the expression of Na+ channel sub-types evoked by ACM, could increase the 
sensitivity of ACM-treated neurons to action potentials, especially during the up-state of 
their biphasic membrane potential. 
 The voltage-dependant profiles for both activation and steady-state inactivation of voltage 
activated Na+ channels were measured using a dual voltage step protocol (in the presence 
of 10 mM TEA to avoid the confounding effects of voltage activated K+ currents at more 
depolarised test potentials). From a holding voltage of -90 mV, the protocol started with a 
100 ms voltage step (increasing from -110 mV to 0 mV in 5 mV increments per sweep) was 
used to both assess the voltage-dependant activation (square) of the Na+ current and evoke 
inactivation (figure 3.6A). From this first step, the voltage was then immediately held at 0 
mV for 100 ms, this step would only activate a Na+ current if the first step had not already 
inactivated the channels (circle). The currents were then mathematically converted to 
normalised Na+ conductance (G/Gmax, see methods) and plotted against the voltage of the 
first step (adjusted for series resistance and junction potential). The resulting curves were 
then fitted with a Sigmoid Boltzmann equation (figure 3.6B). The curve representing 
inactivation is inverse, meaning it represents the proportion of the conductance not 
inactivated (so available) at that voltage, it starts at 1 (no steady-state inactivation) before 
falling sigmoidally (described by a Botlzman function) to zero at voltages between -55 and -
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40 mV (full steady–state inactivation. Conversely, the curve representing activation 
represents the proportion of the conductance opened by that voltage, before inactivation, it 
starts at zero and rises sigmoidally to 1 between -40 and -25 mV. Where the two curves 
meet is considered the voltage at which the peak Na+ window current occurs (from now on 
referred to as the Na+ window voltage); this is a voltage at which a hypothetical small 
continuous Na+ current would be observed if Na+ channels were transitioning from the 
closed to active states and from inactive to closed states. However, this does not occur 
because the transition from inactive to closed states also occurs at a much lower voltage 
and over a longer time scale. Using the Na+ window voltage as a measure for both the 
voltage activation and inactivation of the cells’ Na+ current, no significant changes over time 
were observed in either ACM or control medium treated cells (figure 3.6D). Figure 3.6C 
compares shows data from Rush et al. 2005 showing the activation and inactivation profiles 
for two neuronal subunits of Na+ channel Nav1.2 and Nav1.6, measured in isolation using 
genetically encoded TTX resistance 167. The voltage-dependant activation and inactivation 
profiles observed in the iPS-derived neurons used in this study were compared with the data 
from Rush et al. 2005, finding very similar voltage profiles to that of isolated Nav1.2 when 
treated with either ACM or control medium (figure 3.6B and 3.6C). This implies that the iPS-
derived neurons expressed primarily Nav1.2 over 1.6, as Nav1.6 shows voltage-dependant 
activation and inactivation over more polarised membrane potentials 167. 
The Na+ current-voltage activation profile is an important parameter to setting the voltage 
threshold for an action potential because an action potential is initiated at the voltage 
where the cells’ voltage activated Na+ channels open. Any depolarising current must 
therefore push the membrane voltage up from the resting membrane voltage to this 
threshold to start an action potential. As discussed previously, in the neuronal excitability 
section of the introduction, there are multiple factors which can potentially influence the 
sensitivity of a neuron to initiating an action potential. Firstly, the difference in the 
threshold voltage and the resting membrane potential, the larger the voltage change 
required reaching threshold the more current is required. 
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Figure 3.7: Calculating the threshold voltages for action potentials from cells differentiated 
with control or ACM treatment. 
A) Exemplar current recordings from a week 2 control cell showing an induced action 
potential (top) during a current step protocol (bottom), the grey box indicates the region 
used to produce an orbital graph (B). 
B) Exemplar action potential orbital graph, the first differential of voltage against time 
plotted against voltage. A line indicates the inflection used to approximate the threshold 
voltage and arrows indicate the direction of time on this graph. 
C) A bar graph showing the mean estimated threshold voltage for both ACM and control 
cells from weeks 2 and 3 of the differentiation protocol (n = 29). T- tests were performed at 
each week. 
The action potential threshold voltages were measured by analysing induced action 
potentials (figure 3.7A). The region of the voltage trace which contained an action potential 
was isolated and differentiated against time (dV/dT). The differential of voltage against time 
was then plotted against the voltage, resulting in an orbital graph of the action potential, 
which runs anticlockwise (figure 3.7B). The short, flat region at low voltages prior to the 
onset of the upstroke represents the slow rise in voltage caused by the membrane 
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capacitance charging across the input resistance during the start of the current step. 
Following this flat region, if an action potential was initiated, a sharp inflection was 
observed rising with time towards the top of the orbit. The inflection and linear rise 
represent voltage activated Na+ channels opening and the magnitude of the Na+ current 
increasing (so this occurs over a very short time scale). The top of the orbit represents the 
linear and maximal stage of depolarisation, the up-stroke of the action potential. Following 
the top of the orbit, the curve rapidly drops to the negative and starts to move in the 
opposite direction in the voltage axis. The rapid switch from positive to negative dV/dT 
represents the peak of the action potential, where the Na+ channels are inactivating and the 
K+ channels are opening. The negative peak of the orbit represents the maximal 
repolarisation by the K+ channels, which then begin to close again as the voltage approaches 
the initial threshold. The shape of the action potential was assessed using 3 quantitive 
measures. Firstly, the peak depolarisation, which measured how far the cell had depolarised 
during the action potential. Secondly, the width of the action potential at its half height, this 
is a measure of how rapidly the action potential occurred. Lastly, the area inside the orbital 
graph was measured using the modulus of the sum of the integrals from threshold to 
completion of the action potential as well as the peak rates of depolarisation and 
repolarisation. This measure has the benefit of being determined by both the speed and 
extent of the depolarisation, and is more sensitive to changes in depolarisation speed. By 
week 3 the ACM treated cells were showing evoked action potentials that were narrower at 
their half height (2.7 ± 0.7 ms (n = 10) in control vs. 1.9 ± 0.1 ms (n = 11) in ACM, P<0.05) 
and reached a more depolarised peak (+24.7 ± 2.7 mV (n = 10) in control vs. +33.4 ± 2 mV (n 
= 11) in ACM, P<0.0001, table 3.1). These measures correlated with increased rates of 
depolarisation at weeks 2 and 3 observed in ACM-treated cells (60.6 ± 4.8 Vs-1  (n = 12) in 
control vs. 86.5 ± 7.6 Vs-1  (n = 16) in ACM at week 2 (P<0.01), and 81.8 ± 14.3 Vs-1 (n = 10)  in 
control vs. 122.4 ± 11.5 Vs-1  (n = 11) in ACM (P<0.05) at week 3, table 3.2) and faster rates 
of repolarisation at week 3 (-36.3 ± 3.1 Vs-1 in control vs. -45.4 ± 2 Vs-1 in ACM (P<0.05), 
table 3.2). Using the area inside the orbit (sum of the modulus of the integrals of dV/dt 
against V during the action potential orbit), larger orbits by week 2 with the ACM (2700 ± 
310 mV2∙ms-1 (n = 12) in control vs. 4120 ± 410 mV2∙ms-1  (n = 16) in ACM, P<0.05), which 
became more pronounced by week 3 (3480 ± 450 mV2∙ms-1 (n = 12) in control vs. 6020 ± 700 
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mV2∙ms-1 (n = 16) in ACM, P<0.0001, table 3.3). This quantitatively demonstrated that which 
had been observed qualitatively in figure 1, that the ACM-treated cells produced sharper, 
faster action potentials at both weeks 2 and 3. Further, this demonstrates the utility of the 
area inside the orbit as a one-measure for comparing neuronal action potential spikiness 
and maturity. The threshold voltage was approximated by eye by drawing a line through the 
start of the inflection at the start of the rise of the orbit. This was considered more accurate 
than using the original voltage against time graph and more reliable than taking the second 
differential of voltage against time plotted against voltage. No appreciable change in the 
threshold voltage was observed over time, or by treatment with ACM (see table 2). 
Week Control ACM Statistics (T- test) 
- Peak (mV) Width (ms) Peak (mV) Width (ms) Peak Width 
1 14.7±2.1 (10) 13.4±1.5 (10) 15.7±2.3 (10) 11.7±1 (10) ns ns 
2 21.1±3.4 (12) 4.8±1.2 (12) 26.3±1.3 (16) 3.5±0.5 (16) ns ns 
3 24.7±2.7 (10) 2.7±0.7 (10) 33.4±2 (11) 1.9±0.1 (11) P<0.05 P<0.0001 
Table 3.1: The shape characteristics for both control and ACM, each is a mean with standard 
error, analysed with a T-test. Firstly the peak depolarisation, indicating the extent of an 
action potential, secondly the width of an action potential spike at half-height, indicating 
how rapidly the action potential occurred. Bold and underline text used to identify the 
significantly higher value in the comparison between ACM and control at the same week, 
sample sizes displayed in brackets. 
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Week Control ACM Statistics (T- test) 
- +dV/dt (V/s) -dV/dt (V/s) +dV/dt (V/s) -dV/dt (V/s) +dV/dt -dV/dt 
1 21.8±2 (10) -11.1±0.8 (10) 24.5±1.8 (10) -13.6±0.8 (10) ns ns 
2 60.6±4.8 (12) -31.3±2.3 (12) 86.5±7.6 (16) -36.7±3.1 (16) P<0.01 ns 
3 81.8±14.3 (10) -36.3±3.1 (10) 122.4±11.5 (11) -45.4±2 (11) P<0.05 P<0.05 
Table 3.2: Peak rates of depolarisation +(dV/dt) and repolarisation (-dV/dt) in control and 
ACM-treated cells.  The area inside the orbit is potentially useful measure for both the extent and speed of 
the action potential. Bold and underline text used to identify the significantly higher value in the 
comparison between ACM and control at the same week, sample sizes displayed in brackets. 
 
Week Control ACM Statistics (T- test) 
- Vthr (mV) A(mV
2
∙ms
-1
) Vthr (mV) A(mV
2
∙ms
-1
) Vthr  Aorb  
1 -34.8±2.2 (10) 1270±100 (10) -34.1±2.5 (10) 1470±140 (10) ns ns 
2 -33.3±0.6 (12) 2700±310 (12) -34.5±0.4 (16) 4120±410 (16) ns P<0.05 
3 -35±1 (10) 3480±450 (10) -33.7±0.7 (11) 6020±700 (11) ns P<0.0001 
Table 3.3: The mean voltage threshold (Vthr) for an action potential, approximated using an 
orbital graph, and the area inside the orbit (A(mV2∙ms-1)) of this graph. The area inside the 
orbit is potentially useful measure for both the extent and speed of the action potential. Bold 
and underline text used to identify the significantly higher value in the comparison between 
ACM and control at the same week, sample sizes displayed in brackets. 
 
These data demonstrate, that differentiating neurons develop action potentials with more 
mature shape over time, and that ACM-treatment is able to enhance the development of 
this property. These parameters are crucial to developing trains of action potentials and 
mature spontaneous activity, consistent with the nature of spontaneous activity observed in 
ACM-treated cells comparing more favourably with ex vivo neuronal cultures. However, as 
no change was observed in the threshold voltage, consistent with no observed change in the 
voltage-dependant activation of these cells’ Na+ current, this does not explain why more 
ACM-treated cells show spontaneous activity. Therefore, more electrophysiological 
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parameters affecting the propensity for neurons to produce spontaneous activity must be 
investigated in these cultures. 
As discussed in the introduction, the input resistance determines how far the voltage will 
change in response to a current after the membrane capacitance has charged, in accordance 
with Ohm’s law. This gives us the concept of the rheobase current, the minimal current of 
infinite length required to reach threshold. However, the capacitance of the membrane 
charging results in voltage changes occurring as a function of time. The time constant is a 
function of the capacitance and resistance (both synaptic channel resistance and input 
resistance). This means that the shorter the current, the more the magnitude of membrane 
capacitance determines the extent of depolarisation. The membrane capacitance was 
measured using the transient currents produced by the membrane capacitance at the start 
and end of a 10 ms, 10 mV step. The input resistance was calculated using the stable voltage 
change evoked by sub-threshold current steps. 
Surprisingly, no significant increase in membrane capacitance was observed from week 1 to 
week 2, or comparing control and ACM at these weeks (table 3.4). However, at week 3 the 
ACM evoked a significantly larger membrane capacitance (14.4 ± 1.6 pF (n = 16) in control 
cells vs 21.4 ± 1.4 pF (n = 19) in ACM cells, P<0.01, table 3.4). This implies a loss of neuronal 
complexity at week 3 in the control cells, but does not in itself explain changes in 
spontaneous activity. In fact, for a larger membrane capacitance it is required that the 
current must be larger, longer or more frequent (see introductions) to result in the same 
change in voltage, for membranes with the same input resistance. More surprisingly, no 
appreciable increase in input resistance was observed either over time, or with ACM-
treatment (see table 3.4). These data imply that from the same resting membrane potential 
one would expect a similar rheobasic current in ACM and control cells. However, due to a 
higher membrane capacitance in ACM-treated cells at week 3 a higher short-current 
requirement in ACM-treated cells. 
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Week Control ACM Statistics (T- test) 
- Cm (pF) Ri (MΩ) Cm (pF) Ri (MΩ) Cm Ri 
1 17.8±1.8 (25) 1128±181 (20) 18.6±1.5 (38) 1025±83 (20) ns ns 
2 22.8±2.3 (19) 940±61 (19) 19.5±1.7 (35) 1060±86 (22) ns ns 
3 14.4±1.6 (16) 993±130 (15) 21.4±1.4 (19) 1066±96 (14) P<0.01 ns 
 Table 3.4: Mean and standard error for membrane capacitance (Cm) and input resistance 
(Ri), and differences between ACM and control analysed by T-test. Bold and underline 
indicates the significantly higher value in the comparison between ACM and control –treated 
cells of the same week, sample sizes displayed in brackets. 
 
Although a resting membrane potential closer to the threshold voltage for an action 
potential will minimize the current required to reach threshold, the resting membrane 
potential must also be sufficiently hyperpolarised to remove the inactivation of the voltage 
activated Na+ current, this sets a practical limit on how close the threshold and resting 
voltages can be together. Considering that ACM does not evoke significant changes in the 
cell capacitance, threshold voltage or the voltage at which the Na+ current inactivates, it 
seemed logical that this increase in spontaneous activity was due to concordant changes in 
the resting membrane potential. Therefore, there could be two possible reasons for 
increased spontaneous activity in ACM based on the resting membrane potential alone. 
Firstly, if the ACM cells expressed more depolarised resting membrane potentials than 
control cells, but not so depolarised as to evoke inactivation of the Na+ current, this could 
result in these cells to be more sensitive to depolarising stimuli. Alternatively, compared 
with ACM cells, if the control cells were depolarised sufficiently to inactivate the Na+ 
current, then fewer of the control cells would be capable of firing spontaneous action 
potentials. 
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Figure 3.8: Comparing the resting membrane potential of control and ACM-treated cells 
across all 3 weeks, and then comparing the resting membrane potential of spontaneous 
active and non-spontaneous active cells. 
A) A graph showing the mean resting membrane potential, measured during current clamp 
at I=0, for ACM and control cells over all 3 weeks of differentiation. T-tests were performed 
comparing control and ACM at each week.  
B) A box and whisker plot for all cells showing the distribution of mean  resting membrane 
potentials for cells showing spontaneous action potentials compared to those without across 
all weeks and conditions (n = 298). 
 
The resting membrane potential of the cell was measured in current clamp by measuring 
the average voltage whilst the current was held at 0pA. The importance of the resting 
membrane potential is illustrated in figure 8 B, here the mean resting membrane potentials 
for cells which are spontaneous active and not spontaneous active are compared (P<0.0001, 
n = 298, figure 3.8B), independently of their time in culture or treatment. Importantly, these 
data show that the cells which were spontaneously active also had significantly more 
hyperpolarised resting membrane potentials (sAP vs no sAP). The resting membrane 
potentials of both ACM and control treated cells became more polarised from week 1 to 
week 2 (control: from -21 ± 3.2 mV (n = 19) to -41.3 ± 3.8 mV (n = 21), and ACM: from -31 ± 
2.6 mV (n = 37) to -49.2 ± 2.2 mV (n = 35), figure 3.8 A). At all weeks the resting membrane 
potential of ACM-treated cells was significantly more hyperpolarised than control cells 
(P<0.01, T=2.9, df=61 at week 1 and P<0.05, T=2.05, df=54 at week 2). Most strikingly, 
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where at week 3 the control treated cells actually became relatively depolarised (from -41.3 
± 3.8 mV (n = 21) to -30.5 ± 3.1 mV (n = 16)), the ACM-treated cells stayed remained 
relatively hyperpolarised (from -49.2 ± 2.2 mV (n = 35) to -50.0 ± 2.8 mV (n = 19)). This 
resulted in a large and significant 19.5mV difference between control and ACM cells at week 
3 (P<0.0001, T=4.87, df=33), which highly correlated with the pattern seen in the 
development of spontaneous activity over the 3 weeks (figure 3.8A and 3.5). These data are 
completely consistent with the Na+ current activation and inaction curves which show that 
the voltage window of maximum Na+ current is between -36 and -42 mV (figure 3.6B). 
Further, in the control cells, only 15% and 1% of the Na+ current is available at their mean 
resting membrane potentials at weeks 2 and 3, respectively. In contrast, approximately 60% 
of the Na+ current is available at both weeks 2 and 3 at their mean resting membrane 
potential for the ACM-treated cells. However, this cannot explain the large difference in 
spontaneous activity between weeks 2 and 3 in the ACM treated cells, suggesting that they 
have developed increased depolarising stimuli from synapapses, thus driving increased 
spontaneous activity. This notion is supported by the fact that biphasic resting potentials are 
seen exclusively in ACM-treated cells.  
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Voltage activated Ca2+ currents 
Voltage activated Ca2+ currents were recorded during a voltage ramp, where from a holding 
of -70 mV the voltage was stepped down to -120 mV, then continuously increased to +60 
mV during 500 ms. The voltage ramp resulted in the voltage activation of Na+, K+ and Ca2+ 
channels. However, the voltage activated Ca2+ channels were too small to be easily detected 
in standard solutions. To amplify the Ca2+ currents, the extracellular solution (ECS) was 
replaced with a modified external solution containing 27 mM BaCl2. The voltage activated 
Ca2+ current was usually not visible until after the addition of Ba2+, where it was represented 
by an inward current that activated at around -20 mV and did not rapidly inactivate (figure 
3.9A). The BaCl2 solution also resulted in a partial inhibition of the voltage activated K
+ 
current.  The current traces were then plotted against voltage during the ramp to produce a 
current-voltage relationship. The leak current was manually subtracted by linear regression 
using the voltage and current relationship during the ramp before activation of voltage-
dependant channels. The presence of L-type Ca2+ channels was confirmed by either a 
complete or partial inhibition of the Ba2+ current when 2 µM nifedipine was applied (figure 
3.9A). The current was normalised for cell surface area using the cell capacitance (pA∙pF-1). 
Peak, normalised inward current densities were quoted for each condition during the 
differentiation time-course. 
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Figure 3.9: The proportion of cells showing, and magnitude of, voltage activated Ca2+ 
channels in control and ACM-treated cells. 
A) Exemplar IV graph showing Ba2+ currents through voltage activated Ca2+ channels in BaCl2 
solution with and without 2µM nifedipine, from a control cell at week 2. 
B)  A bar graph showing the proportion of cells with voltage activated Ca2+ currents, and 
nifedipine sensitive Ca2+ currents in control cells from each week of differentiation at all 3 
weeks of differentiation.    
C) A bar graph showing the portion of cells with voltage activated Ca2+ currents, and 
nifedipine sensitive Ca2+ currents in ACM cells from each week of differentiation at all weeks 
of differentiation. T-tests were performed comparing ACM and control for all 3 weeks. 
D) A bar graph showing the mean current density of Ba2+ currents in ACM and control cells 
from each week of differentiation, error bars show SEM. 
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The control cells at week 1 showed no detectable voltage activated Ca2+ currents (0% (n = 
11), but slowly increased in both proportion and magnitude during the 3 week period 
(22.2% (n = 9), -1.9 ± 0.4 pA.pF-1 (n = 5) at week 2 and 41.7% (n = 12), -5.6 ± 1.3 pA. pF-1 (n = 
8) figure 3.9 B and C). L-type Ca2+ currents were only observable at week 3 in the control 
cells (40%, n = 5). In contrast, even at week 1, 80% (n = 15, P<0.001, chi2=16.34, 25% (n = 13) 
were L-type) of ACM-treated cells had detectable Ca2+ currents (-3.2 ± 0.6 pA. pF-1 (n = 15)). 
This trend continued into week 2 (93% (n = 23), P<0.01, chi2= 8.67, 50% L-type (n = 21)), and 
their current density was now significantly larger than control (-8.7 ± 1.9 pA. pF-1 (n = 12, P < 
0.05)). By week 3, almost all of the ACM-treated cells had not only Ca2+ currents but L-type 
Ca2+ currents (90.9% (n = 11), P<0.05, chi2=4.4, 83% were L-type), but the currents had not 
increased in magnitude significantly from week 2 (-9.2 ± 1.0 pA. pF-1 (n = 9, P < 0.05)) and 
the control cells had begun to catch up. This implies a very significant and immediate 
functional enhancement by ACM-treated cells. Over all 3 weeks, the ACM-treatment 
produced a higher proportion of cells expressing functional voltage activated Ca2+ currents 
that were, on average, larger in magnitude than control. However this effect was most 
striking at week 1, which does not correlate well with the temporal pattern of the ACM-
evoked increase in spontaneous activity. 
To produce a more complete characterisation of the Ca2+ channels which were being up-
regulated by ACM-treatment, Fura-2 Ca2+ imaging was employed. Fura-2 is a fluorescent 
reporter for Ca2+ concentration, excitation at two different wavelengths 340 nm and 380 nm 
results in a signal intensity for the molecule both bound to Ca2+ and unbound. Therefore, the 
ratio of emissions following excitation at each of those two wavelengths is proportional to 
the intracellular Ca2+ concentration. Voltage-activated Ca2+ channels were activated by 10 s 
pulses of a modified ECS, which had 50 mM KCl, isoosomotically replacing NaCl, resulting a 
shift of the K+ ion reversal potential, and consequent cell depolarisation. A sharp rise in the 
ratio of emission (i340/i380) was observed as soon as the KCl solution was applied, which 
then immediately began to decay. To allow for cell recovery, each pulse was separated by 
200 s, which was sufficient time to allow the Ca2+ concentration to return baseline. The area 
under the curve was calculated for each KCl solution application (see methods) and used as 
a measurement for the magnitude of the Ca2+ influx. Alternately antagonists to 4 different 
types of Ca2+ channel were added with the short pulses of high K+; 2 µM nifedipine, 0.1 µM 
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conotoxin, 0.1 µM agatoxin and 0.1 µM SNX482 for L-, N-, P/Q- and R- type channels, 
respectively, figure 3.10 A). T-type Ca2+ channels were not included due to their activation 
being at voltages far more hyperpolarised than the membrane potential of the week 1 cells. 
KCl applications in the absence of an antagonist were used both before and after to 
calculate the expected size the Ca2+ response to KCl when the antagonist had been added. 
The difference between the expected and observed response was considered to represent 
the contribution of that specific sub-type of Ca2+ channel to the overall Ca2+ influx. 
 
Figure 3.10: A Fura-2 Ca2+ imaging characterisation of week 1 Ca2+ currents in ACM and 
control-treated cells. 
A) Mean Fura-2 ratiometric fluorescent intensities graph (i340/i380), background 
subtracted, for ACM (upper) and control (lower) cells. Labels above show the times at which 
high K+ solution was applied, or high K+ solution with an antagonist for a specific sub-type of 
Ca2+ channel. The antagonists used were: 2µM nifedipine, 0.1µM agatoxin, 0.1µM conotoxin, 
0.1µM SNX482. 
B) A bar graph showing the mean (±SEM) Fura-2 radiometric area under curve response to 
high K+ solution, for both ACM and control cells at week 1 (n = 42). 
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C) A bar graph showing the portion of cells showing significant inhibition of the response to 
K+ by each antagonist, for ACM and control cells at week 1 (n = 42). 
D) A bar graph showing the mean (±SEM) percent inhibition of the K+ response by each 
antagonist, for both ACM and control cells at week 1 (n = 42).    
A further characterisation of the voltage gated Ca2+ channels was performed in ACM and 
control cells at week 1, at the time point where the most significant difference in the 
functional Ca2+ currents using patch clamp. This was also considered the most likely time 
point that Ca2+ influx from these channels influenced development. It was immediately 
evident that the ACM-treated cells had a much larger Ca2+ response to KCl solution (figure 
3.10A).  However, in contrast to data collected by patch-clamp, almost all of the cells from 
both treatments responded to high K+ (figure 3.10 A and B, control: 89% cells at 2.8±0.4 AUC 
n = 19, ACM:  100% cells at 6.1±0.7 AUC n = 24). This was attributed to the Ca2+ imaging 
being a far more sensitive approach to measuring voltage activated Ca2+ channels, a notion 
supported by the very small size of the currents measured during patch clamp (figure 3.9B). 
When using the specific antagonists to assess individual sub-types of Ca2+ channel, it was 
observed that in the ACM treated cells almost all were sensitive to nifedipine (91.3% (n = 
24)), conotoxin (95.7% (n = 24)) and SNX482 (91.3% (n = 24)), implying significant functional 
expression of L-, N- and R- type Ca2+ channels, respectively (3.10 C and D). In contrast, in the 
control treated cells, a significant number were conotoxin sensitive (58% (n = 19), P<0.01, 
chi2=9.22), fewer were nifedipine sensitive (31.3% (n = 19), P<0.0001, chi2=16.86) and 
virtually none were sensitive to SNX482 (5.3% (n = 19), P<0.0001, chi2=31.82). In both 
conditions very few cells showed any sensitivity to agatoxin (15.8% (n = 19) in control and 
12.5% (n = 24) in ACM, ns, chi2= 0.1)), an antagonist of P/Q-type Ca2+ channels (figure 3.10 C 
and D). Additionally, ACM increased significantly the magnitude of the inhibition caused by 
each of the specific channel blockers (Figure 4 C). Thus, nifedipine-sensitive AUC went from 
16.4 ± 10.7 % (n = 19) of the high K+ response to 40.8 % ± 7.5 % (n = 23, P < 0.001), 
conotoxin-sensitive AUC went from 22.2 ± 10.1 % to 70.2 ± 5.1 % (P < 0.001) and SNX482-
sensitive AUC went from 5.2 ± 11.7 % to 38 ± 10.4 % (P < 0.001). Importantly, these data 
show that a larger proportion of the ACM-treated cells had functional L-, N- and R- type Ca2+ 
channels, and that the ACM-treated cells had significantly larger functional responses from 
  110 
each of these channel types. Importantly, the short applications of these potent antagonists 
showed immediate effects on the magnitude of Ca2+ influx response, but these effects 
appeared entire reversible as the responses to high K+ alone showed relatively little run-
down.  This is consistent to studies which have shown that short applications of these 
antagonists result in a reversible blockade.  
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Ionotropic GABA elicited currents and GABA synapses 
In addition to voltage activated currents, neurons express ligand activated ion channels so 
that the cell is responsive to neurotransmitters. GABA as an inhibitory neurotransmitter is 
essential to striatal function, being an integral part to both the direct and indirect pathways 
for motor control. However, it is also likely that GABA has many roles in the development of 
neurons. As previously discussed, a significant increase in the functional expression of 
specific sub-types of Ca2+ channel was observed with ACM treatment. However, in the 
absence of a depolarising stimulus the Ca2+ channels alone will not function to allow Ca2+ 
influx.  
 
Figure 3.11: Measuring GABA-evoked currents in ACM and control treated cells. 
A) A bar graph showing the mean peak current density (±SEM) for GABA evoked currents in 
both the ACM and control cells. The inset shows an exemplar current evoked by 300µM 
GABA whilst being held at -70mV in a week 2 control cell. 
B) A bar graph showing the portion of cells with significant GABA evoked currents from both 
the control and ACM cells from each week (n = 95). 
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C) An exemplar current recording during a 10s voltage step protocol with a 5s addition of 
300µM GABA. 
D) An exemplar IV relationship curve for GABA evoked currents during a voltage step, 
showing a reversal potential close to 0mV. 
Demonstrating that the GABA-dependant current was carried by Cl- was achieved by 
applying GABA (5s, 300 µM) during a voltage steps (holding -70 mV, 10 s step increasing 
from -100 mV to 20 mV in 20 mV increments). The resulting GABA-dependant I-V current 
reversed at 0mV, as predicted in these solutions for a Cl- current. (figure 3.11 A and B).  
Whole cell ionotropic GABA currents were measured with cells voltage clamped at -70 mV, 
and during a 5s application of 300 µM GABA. At -70 mV, the GABA-dependant current was 
represented by a rapidly activating inward current which then slowly desensitised during the 
5s GABA application and reversed upon GABA wash off (figure 3.11 C  inset). Roughly half of 
the iPS cell derived neurons showed relatively small ionotropic GABA responses at week 1 in 
both cultures (control: 50% (n = 11), ACM: 63% (n = 24), ns, chi2=0.46; figure 3.11 C and D). 
By week 2, almost all of the ACM cells responded (70% (10) in control and 92% (25) in ACM 
P<0.05, chi2=4.54), whereas the control cells lagged slightly behind until week 3 (91% (12) in 
control and 85% (13) in ACM, ns, chi2=0.29, figure 3.11 C and D). The magnitude of the 
GABAA currents increased sharply from week 1 to week 2 (Control: week 1 = -22.1 ± 8.2 
pA.pF-1 (n = 6) to week 2 = -49.4 ± 14.9 pA.pF-1 (n = 7); ACM: week 1 = -24.8 ± 6.8 pA.pF-1 (n = 
8) to week 2 = -87.8 ± 12.5 pA.pF-1 (n = 20)), but showed no significant difference between 
culture conditions (figure 3.11 C). At week 3 little change in the current magnitudes were 
observed in either culture (control = -79.1 ± 20.7 pA.pF-1 (n = 11) vs. ACM = -44.9 ± 11.4 
pA.pF-1 (n = 7)).   
In culture or in vivo, the resting membrane potential and the Cl- concentration gradient 
determine whether GABA stimulation hyperpolarises or depolarises the cell. During patch-
clamp, both the Cl- gradient and the membrane potential are set, meaning it was not 
possible to measure the natural response of the cells to GABA. In order to determine 
whether GABA would cause an inhibitory or excitatory drive to neurons at each time point 
during different differentiation protocols “in situ”, Fura-2 Ca2+ imaging was employed. This 
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allowed measurement of GABA-evoked responses to GABA in the presence of 
quasiphysiological conditions (i.e with physiological Cl- gradient and Vm). Although GABA 
does not itself evoke a Ca2+ current, if GABA stimulation depolarised the cell, this was 
measureable as a Ca2+ influx through voltage activated Ca2+ channels. Confirmation that 
each cells did indeed, express voltage activated Ca2+ channels was achieved by an initial 
application of high KCl solution, as above. Further, the use of a modified low Cl- external 
solution to change the Cl-concentration gradient such that any Cl- response would become 
excitatory, ensured that any false negatives in normal Cl- could be excluded.  Thus, 10s 
applications of KCl solution identified cells without Ca2+ channels, GABA with low Cl- solution 
identified cells without GABAA receptors and GABA in normal ECS distinguished between 
cells which were inhibitory or excitatory to GABA. Where a cell responded to all 3 solutions 
the cell was considered to have an excitatory GABA response, where a cell only responded 
to KCl and GABA in low Cl- solution it was considered to have an inhibitory GABA response. 
Cells with no KCl or GABA in low Cl- response were removed from the analysis (figure 3.12 A 
inset).  
 
Figure 3.12: The proportion of cells showing excitatory GABA-evoked currents in control and 
ACM-treated cells across weeks 1 and 2 of differentiation. 
A) A bar graph showing the percent cells with excitatory GABA responses (in terms of Ca2+ 
influx evoked during Ca2+ imaging by GABA in standard ECS), for both ACM and control cells 
across weeks 1 and 2 of the differentiation protocol (n = 58). The inset shows exemplar Fura-
2 ratiometric fluorescent intensities graph (i340/i380) recordings, normalised against the 
background, the text indicating the addition of high K+ solution, GABA in ECS and GABA in 
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low chloride solution for a cell exhibiting an inhibitory and excitatory response. Note the 
absence of a GABA evoked Ca2+ response in the inhibitory cell in standard ECS.  
 
At week 1, almost all cells in either ACM and control cultures showed excitatory GABA 
responses, meaning that it produced a Ca2+ influxes to all 3 applications (100% (n = 17) in 
control and 87% (n = 15) in ACM, ns, chi2= 2.4, figure 3.12A). However, by week 2 less than 
half of the cells in each culture demonstrated excitatory responses (40% (n = 10) in control 
cells and 18% in ACM (n = 16), ns, chi2= 1.4), implying that already more than half of the 
cells had switched to become inhibitory. Further, a slight trend towards more cells having 
switched from excitatory to inhibitory GABA-responses in ACM may imply faster maturation 
in ACM-treated cells or simply increase Ca2+ responses to GABA in week 1, consistent with 
the observed increased Ca2+ channel function. This could potentially limit the ability of GABA 
to drive depolarisation-dependant Ca2+ influxes beyond week 2.  
 
Figure 3.13: Exemplar miniature synaptic currents observed in week 3 ACM-treated cells. 
A) Miniature spontaneous synaptic currents during voltage clamp at +20mV in standard ECS, 
and with the addition of 10µM bicuculline or 10µTTX from a week 3 ACM treated cell. 
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B) Miniature spontaneous synaptic currents from the same cell whilst being held at -20mV, 
from a week 3 ACM treated cell. 
Differentiating neurons must also develop functionally mature and spontaneously active 
synapses, a critical function allowing neurons to conduct electrochemical signals within 
circuits and potentially important in the pathobiology of many neurodegenerative diseases. 
Spontaneous post-synaptic currents were measured using voltage clamp at either -20 or +20 
mV, to ensure that the voltage activated Na+ current was inactivated, therefore removing 
the possibility of action potentials. Further, TTX was added to further ensure that the events 
being observed were not as a result of action potentials. During these patch clamp 
experiments it was not possible to distinguish an excitatory (cation) synaptic current (EPSC) 
or an inhibitory (Cl-) current (IPSC) as the reversal potentials of both cation-inselective 
channels and Cl- channels were approximately 0mV. Therefore, regardless of their identity 
we observed their reversal when moving from -20 to +20 mV (3.13 A and B). Therefore to 
identify the crucial GABA responses 10µM bicuculline was added, a potent and selective 
antagonist of GABAA channels. 
I compared the number of cells which showed some spontaneous synaptic currents over 10 
minutes at -20 mV, finding that a few ACM-treated cells (30% (n = 10)) had developed active 
synapses at week 3 where the control cells had not (0% (n = 14)). Pharmacological tools 
were then used to identify those synapses which were GABA-ergic using bicuculline, finding 
that the vast majority of spontaneous synaptic events were bicuculline sensitive, but TTX 
insensitive (figure 3.13 A).  
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Chapter 4: The development of electrophysiological function in iPS-
derived neurons is dependent on specific Ca2+ currents and GABA 
signalling.  
Specific Introduction: 
Ca2+ channel activity in ACM: 
During the characterisation of iPS cell-derived neurons treated with ACM, an immediate 
increase in the function of voltage activated Ca2+ channels was observed. More importantly, 
ACM evoked a significant increase in spontaneous activity and more hyperpolarised resting 
membrane potentials at week 3. However, the increase in Ca2+ channel function did not 
correlate temporally with the more crucial increase in spontaneous activity. Ca2+ influx 
provides a functional link between electrophysiological activity and gene expression. 
Further, previous work has implicated Ca2+ channel activity in development and 
neurogenesis (see introduction – voltage activated Ca2+ channels). Therefore, it was 
speculated that the functional increase in Ca2+ currents early in development by astrocyte 
secreted factors was actually a mechanism by which the ACM-treated cells matured. At 
week 1 especially, the ACM-treated cells produced a much larger Ca2+ influx response to 
depolarisation; this increase in Ca2+ could drive functional changes in the developing 
neurons.  
 
Effect of manipulation of GABA and Ca2+ channel function on differentiation 
and maturation 
 
Specific blockade of Ca2+ channels or GABAA receptors in ACM 
The hypothesis that the specific Ca2+ channels that are functionally up-regulated by ACM 
play a mechanistic role in the functional maturation observed with ACM-treatement was 
tested. Specific antagonists for each sub-type of Ca2+ channel that had been up-regulated by 
ACM were added individually: 2 µM nifedipine, 0.1 µM conotoxin and 0.1 µM SNX482 were 
added to the ACM to specifically antagonise L-, N- and R- type Ca2+ channels, respectively. 
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The electrophysiological function of the cells treated with ACM, and with each antagonist 
was assessed over 3 weeks of differentiation as previously described. Of particular interest 
was the function of differentiated cells at week 3, where the ACM-treated cells showed the 
most functional benefit from ACM and behaved most similar to the cells in vivo, with higher 
rates of spontaneous activity and hyperpolarised membrane potentials. Individual blockade 
of L-, N- or R- type Ca2+ channels were each sufficient to entirely inhibit the development of 
spontaneous activity (0% (n > 9) vs. 74% (n = 19), P< 0.0001, Chi2 >13, figure 4.1A). The loss 
of spontaneous activity also correlated with less polarised resting membrane potentials (-
50.8 ± 2.8 mV (n = 19) ACM, -27.3 ± 3.9 mV (n = 9) conotoxin, -21 ± 2.5 mV (n = 9) nifedipine, 
-25.5 ± 2.3 mV (n = 10) SNX 482, P<0.0001, T > 4.7, figure 4.1B). The hypothesis tested was 
that, at least one of the sub-types up-regulated by ACM would have such an effect on 
development. However, it is surprising that blockade of each of the 3 currents results in the 
same effect. 
 
Figure 4.1: A comparison of resting membrane potentials and spontaneous activity in ACM 
and ACM treated with each of the following antagonists: 2 µM nifedipine, 0.1µM SNX482, 
0.1µM conotoxin or 10µM. 
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A) A bar graph showing the portion of cells with spontaneous action potentials at week 3 in 
ACM, and with the addition of 2 µM nifedipine, 0.1 µM SNX482, 0.1 µM conotoxin or 10 µM 
bicuculline, compared by Chi2 test against ACM. 
B) A bar graph showing the mean resting membrane potential (±SEM) at week 3 in ACM, and 
with the addition of 2 µM nifedipine, 0.1 µM SNX482, 0.1 µM conotoxin or 10 µM bicuculline, 
compared by T-test against ACM. 
It was also speculated that GABA signalling provides an important stimulus for driving Ca2+ 
influx by providing frequent depolarisation stimuli to open voltage activated Ca2+ channels. 
Therefore the hypothesis was tested that pharmacological blockade of GABAA channels, 
using 10 µM bicuculline, would have a similar functional effect to blocking the voltage 
activated Ca2+ channels, as it would remove the depolarising stimulus which Ca2+ channel 
activation depends on. Consistent with this notion, GABAA blockade mimicked blockade of 
each of the voltage activated Ca2+ channels by entirely inhibiting the development of 
spontaneous activity (0% (n = 10) vs 74% (n = 19), P < 0.0001, Chi2 =15.2, figure 4.1A) and 
resulting in a depolarised resting membrane potential (-27.1 ± 1.2 mV (n = 10) vs -50.8 ± 2.8 
mV (n = 19), P < 0.0001, T = 5.9, figure 4.1B).   
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Manipulating Ca2+ influx using increased Ca2+ concentration and GABA  
Voltage activated Ca2+ channels and GABAA receptors are important in the mechanism by 
which ACM improves functional maturation, as their specific blockade significantly impaired 
maturation in ACM. Therefore, would it be possible to directly enhance functional 
maturation by manipulating Ca2+ influx? The first strategy for increase Ca2+ influx directly 
was to increase the concentration of Ca2+ in the culture medium, which would increase the 
magnitude of Ca2+ influx when voltage activated Ca2+ channels were opened (see figure 2.2). 
The addition of 0.6 mM CaCl2 and 1.2 mM CaCl2 to the standard differentiation medium 
(which contained 0.6 mM Ca2+), resulting in a 1.2 mM Ca2+ medium and a 1.8 mM Ca2+ 
medium. 
 
Figure 4.2: A schematic comparing the effect of increased ion channel density and increasing 
the external concentration gradient for the permeable ion, in this case calcium. 
The electrophysiological function of iPS cell-derived neurons differentiated in these media 
with varying Ca2+ concentrations was assessed over a 3 week differentiation protocol, as 
previously described. At week 1, a significant polarisation of the resting membrane potential 
in both the 1.2 and 1.8 mM Ca2+ medium was observed (-19.8 ± 2.6 mV (n = 25) in 0.6 mM 
vs -37.2 ± 3.8 mV (n = 13) in 1.2mM and -41.4 ± 3.2 mV (n = 16), P<0.0005, T > 3.7, figure 
4.3B). However, this did not evoke an increase in the proportion of cells firing spontaneous 
action potentials (0% (n = 25) in 0.6mM vs 7.6% (n = 13) and 0% (n = 16), figure 4.3C). 
Surprisingly, at week 1 the 1.8mM Ca2+ medium evoked a significant increase in the cells 
able to fire action potentials (50% (n = 22) in 0.6mM vs 58% (n = 12) and 88% (n = 16), P < 
0.01, Chi2=5.8, Figure 4.3A). At week 2, the control cells had improved and caught up with 
the higher Ca2+ media, meaning no differences were observed in the proportion of cells able 
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to fire induced action potentials (89% (n = 19) in 0.6 mM, 94% (n = 15) in 1.2 mM and 92% (n 
= 12) in 1.8 mM, figure 4.3A) and no significant differences in resting membrane potential (-
39.3 ± 3.7 mV (n = 21) in 0.6mM, -41.8±2.5 mV (n = 16) in 1.2 mM and -47.5 ± 4.4 mV (n = 
16), ns (P=0.09, T=1.3; P=0.17, Mann-Whitney U = 137), figure 4.3B). However, the 1.8 mM 
Ca2+ evoked a significant increase in the proportion of cells showing spontaneous activity at 
week 2 (29% (n = 21) in 0.6 mM Ca2+, 37.5% (n = 16) and 56% (n = 16) in 1.8 mM Ca2+, 
P<0.05, chi2=2.89, figure 4.3C). At week 3 the increased Ca2+ media showed a decline in 
function similar to that of the control cells, with relatively depolarised resting membrane 
potentials (-30.5 ± 3.1 mV (n = 16) in 0.6 mM, -33.2 ± 4.6 mV (n = 5) in 1.2 mM and -34± 5.9 
mV (n = 8) in 1.8 mM, figure 1B) and few cells showing spontaneous activity (12.5% (n = 16) 
in 0.6 mM, 20% (n = 5) in 1.2 mM and 25% (n = 8) in 1.8 mM, ns, figure 4.3C). Although 
increasing the driving force for Ca2+ did not reproduce exactly the effects of ACM, it did both 
increase spontaneous activity and polarised the resting membrane potential. The 1.8 mM 
Ca2+ medium also increased the rate at which cells were able to fire induced action 
potentials were generated. The discrepancy between ACM and increasing the Ca2+ 
concentration in the medium was that, like the control cells, the cells cultured in high Ca2+ 
medium functionally declined after week 2.  This implies that beyond week 2 there is some 
functional change that either results in Ca2+ influx being ineffective to drive functional 
maturation, or that Ca2+ influx is diminished, which will be examined later in this chapter. 
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Figure 4.3: The proportion of cells able to fire induced action potentials, proportion firing 
spontaneous action potentials and the resting membrane potentials of cells treated with all 
3 varying Ca2+ concentration media. 
A) A bar graph showing the proportion of cells capable of firing induced action potentials 
over the 3 weeks of differentiation in the 0.6 (control), 1.2 and 1.6 mM Ca2+ media, 
compared using Chi2 against 0.6mM medium. 
B) A graph showing the mean resting membrane potential (±SEM) over the 3 weeks of 
differentiation in the 0.6 (control), 1.2 and 1.8 mM Ca2+ media, compared using T-test 
against 0.6mM medium. 
C) A bar graph showing the portion of cells showing spontaneous action potentials over the 3 
weeks of differentiation in the 0.6 (control), 1.2 and 1.6 mM Ca2+ media, compared using 
Chi2 against 0.6mM medium. 
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The mechanisms driving Ca2+ influx in these cultures were investigated in the hopes of 
understanding why at week 3 the increased Ca2+ concentration ceased to enhance 
functional maturation. The functional Ca2+ channels using patch clamp and the function of 
GABAA channels using Ca
2+ imaging were examined over the first 2 weeks of differentiation 
to find any changes over time which may explain changes in the nature of native Ca2+ influx 
in these cells over time. Cells were differentiated in the control and 1.8 mM Ca2+ medium 
(now referred to as the high Ca2+ medium). Further cells were differentiated using the same 
high Ca2+ medium with 10 µM bicuculline to block GABAA receptors, therefore testing the 
hypothesis that GABA signalling itself was required for any changes in Ca2+ influx or GABAA 
function over time. Over the first 2 weeks of differentiation, the proportion of cells with 
measurable Ca2+ currents was assessed using patch clamp with a voltage ramp protocol 
using high BaCl2 solution to amplify and identify Ca
2+ channel currents. At week 1, no control 
cells showed significant Ca2+ currents (0% (n = 9)) and 20% of cells showed Ca2+ currents (n = 
10)) in high Ca2+ medium (figure 4.4A). However, at week 2, there was a significant increase 
in the proportion of cells with functional voltage activated Ca2+ channels in the high Ca2+ 
medium (22.2% (n = 9) in control medium and 100% (n = 7), P<0.01, Chi2=9.6, figure 4.4A), 
which was almost entirely blocked by bicuculline (42% (n = 12), P<0.05, Chi2=6.5, figure 
4.4A). The number of cells with inhibitory and excitatory GABA responses was then assessed 
using Ca2+ imaging (see methods). Crucially, the high Ca2+ medium had accelerated the 
switch from excitatory to inhibitory; at week 1 roughly half of the cells had already made the 
switch from excitatory to inhibitory by week 1 (100% (n = 17) excitatory in control vs 52% (n 
= 17) excitatory in high Ca2+ medium, P<0.01, Chi2=10.5), and were almost entirely 
inhibitory by week 2 (only 8.3% (n = 12) excitatory, figure 4.4B). In contrast, half of the cells 
were still excitatory at week 2 (40% (n = 10), P<0.05, Chi2=3.1) and bicuculline was sufficient 
to slow the switch down that 80% were still excitatory at week 2 (80% n = 15, P<0.001, 
Chi2=13.2, figure 4.4B).  
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Figure 4.4: The proportion of cells with voltage gated Ca2+ channels and excitatory GABA 
responses in control, high Ca2+ and high Ca2+ with bicuculline media.    
A) A bar graph showing the proportion of cells with a significant voltage activated Ca2+ 
current when measured using patch clamp at weeks 1 and 2 of differentiation, for cells 
cultured in control, 1.8 mM Ca2+ and 1.8 mM Ca2+ medium with 10 µM bicuculline (compared 
using Chi2 test). 
B) A bar graph showing the proportion of cells with excitatory GABA responses, measured 
using Ca2+ imaging, at weeks 1 and 2 of differentiation, for cells cultured in control, 1.8mM 
Ca2+ and 1.8 mM Ca2+ medium with 10 µM bicuculline (compared using Chi2 test). 
 
Increasing Ca2+ influx using the high Ca2+ medium resulted in increased functional expression 
of Ca2+ channels in differentiating neurons by week 2, similar to observations made in the 
ACM. However, the high Ca2+ medium also, and in contrast to ACM, significantly accelerated 
the switch from excitatory to inhibitory GABA responses; resulting in virtually no cells with 
excitatory GABA responses by week 2 in the high Ca2+ cultures. This has the functional 
consequence that by the second week, stimulation by GABA is no longer able to depolarise 
the membrane and drive Ca2+ influx in the high Ca2+ medium. This is consistent with both 
the control and high Ca2+ medium reaching a functional peak at week 2 and then declining, 
because GABA could no longer drive the Ca2+ influx to enable functional maturation.  
Further, blockade of GABAA receptors was sufficient to inhibit the development of 
functional Ca2+ currents and slow the switch from excitatory GABA to inhibitory GABA.  
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To test the hypothesis that GABA-evoked depolarisation specifically could drive Ca2+ influx 
dependant maturation, 300 µM GABA was added to the control (0.6 mM Ca2+) medium to 
stimulate GABAA receptors as a second strategy for increasing Ca
2+ influx. Also, testing the 
hypothesis in the increased Ca2+ medium that GABA stimulation is required for the Ca2+ 
influx, 10 µM bicuculline was added to the high Ca2+ medium again to block GABAA. 
 
Figure 4.5: The proportion of cells able to fire induced action potentials, and the magnitudes 
of both Na+ and K+ channel current densities in the control, GABA, high Ca2+ and high Ca2+ 
with bicuculline media. 
A) A bar graph showing the proportion of cells able to fire an induced action potential during 
a current step protocol in the control medium, high Ca2+ medium, high Ca2+ medium with 
10µM bicuculline and the control medium with 300µM GABA.  
B) A bar graph showing the mean peak Na current densities (±SEM) in the control medium, 
high Ca2+ medium, high Ca2+ medium with 10 µM bicuculline and the control medium with 
300µM GABA.  
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C) A bar graph showing the mean K current densities (±SEM) in the control medium, high 
Ca2+ medium, high Ca2+ medium with 10 µM bicuculline and the control medium with 300 
µM GABA.  
 
Consistent with observations made using the high Ca2+ medium (88% (n = 16) in high Ca2+ 
medium), the GABA medium also accelerated the generation of cells able to fire induced 
action potentials at week 1 (100% (n = 8) with GABA vs. 50%(n = 22) in control medium, 
P<0.01, Chi2=7, figure 4.5A). Further, blockade of GABAA receptors (using 10µM bicuculline) 
in the high Ca2+ medium inhibited the generation of cells able to fire action potentials at 
week 1 (88% (n = 16) in high Ca2+ medium vs 31%(n = 15) with bicuculline, P<0.001, Chi2=9.6, 
figure 4.5A). Therefore, demonstrating that like ACM, the functional enhancements driven 
by increased Ca2+ concentration are GABAA-dependant. These increases in cells able to fire 
action potentials also correlated well with increases in the magnitude of voltage activated 
Na+ and K+ currents in cells treated with either the high Ca2+ medium or GABA medium (Na+: 
-86.6 ± 18 (n = 8) with GABA or -67 ± 15 (n = 10) with high Ca2+ vs -37.3 ± 13 (n = 6) in high 
Ca2+ with bicuculline and -27.0 ± 5.0 (n = 11) in control medium; K+: 66.3 ± 10 (n = 8) with 
GABA or 76.6 ± 19 (n = 10) with high Ca2+ vs 47.9 ± 19 (n = 6) in high Ca2+ with bicuculline 
and 24.4 ± 4.7 (n = 11) in control medium (all pA.pF-1), figure 4.5B and C). Further, 
significantly more hyperpolarised membrane potentials were observed in both the high Ca2+ 
medium and GABA media at week 1 (-19.8±2.6 mV (n = 19) in control medium vs -42.4±3.3 
mV (n = 8) in GABA medium (P<0.001, T=4.3) and -41.4±3.2 mV (n = 16) in high Ca2+ medium 
(P<0.001, T=5.2)), which was blocked by bicuculline in the high Ca2+ medium (-41.4±3.2 mV 
(n = 16) vs -20.1±2.9 mV (n = 19) with bicuculline, P<0.001, T=5.3, figure 4.6B). Further, this 
improved resting membrane potential correlated with more cells showing spontaneous 
action potentials in the GABA medium (25% (n = 8) with GABA vs 0% (n = 25) in control, 
P<0.01, Chi2=6.9), but surprisingly not the high Ca2+ medium (6.3% (n = 16) in high Ca2+ vs 
0% (n = 25) in control, ns, Chi2=0.1, figure 4.6A). At week 2 both the control medium treated 
cells had caught up, now almost all cells in all conditions were able to fire action induced 
potentials (89% (n = 19) in control vs 92% (n = 12), figure 4.5A) and showed somewhat 
closer resting membrane potentials (-39.3 ± 3.7 mV (n = 21) in control vs -47.1 ± 4.4 mV (n = 
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16), ns (P=0.09, T=1.3; P=0.17, Mann-Whitney U = 137), figure 4.6B). In contrast, the 
bicuculline treated cells by contrast still showed somewhat depolarised resting membrane 
potentials (-25.3 ± 2.2 mV (n = 16) in high Ca2+ and bicuculline medium vs -47.1 ± 4.4 mV (n = 
16) in high Ca2+ medium, P<0.001, T=4.4; or -39.4 ± 3.7 mV (n = 21) in control medium, 
P<0.01, T=3, figure 4.6B), but were mostly able to fire action potentials (87.5% (n = 16) with 
bicuculline, figure 4.5A). This shows that blockade of GABAA had only ameliorated the 
effects of increased Ca2+ influx and had not stopped the cells from differentiating to cells 
with a basic neuronal phenotype. As previously discussed at week 2 the high Ca2+ medium 
evoked a significant increase in the portion of cells firing spontaneous action potentials. 
However, in the GABA medium similar levels of spontaneous activity moving from week 1 to 
week 2(25% (n = 8) to 33% (n = 9), figure 4.6A) were observed. 
 
Figure 4.6: A comparison of the proportion of cells showing spontaneous activity and the 
polarisation of the resting membrane potential for cells treated with control, GABA, high 
Ca2+ and high Ca2+ with bicuculline media. 
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A) A bar graph showing the proportion of cells showing spontaneous action potential during 
a current clamp I=0 in the control medium, high Ca2+ medium, high Ca2+ medium with 10µM 
bicuculline and the control medium with 300µM GABA (compared using Chi2 test).   
B) A bar graph showing the mean resting membrane potential (±SEM) during current clamp 
in the control medium, high Ca2+ medium, high Ca2+ medium with 10µM bicuculline and the 
control medium with 300µM GABA (compared using T-test).  
 
 
The high Ca2+ medium cells were then compared to control cells using 
immunohistochemistry at week 3 as another assay for neuronal development. 
Immunohistochemistry was performed using antibodies for β3 tubulin, map2ab as markers 
for young and more mature neurons respectively, and nestin for neural progenitor cells. 
Surprisingly, only approximately half of the cells stained positive for β3-tubulin, which was 
slightly increased with high Ca2+ medium compared to control (48.2% (n = 1129) vs 52.9% (n 
= 1158) P<0.05, Chi2= 5, figure 4.7 and 4.8). This perhaps suggests many immature glial cells 
were also present in these cultures; these may have contributed a significant number of the 
population not staining for β3 tubulin. Also surprisingly relatively few of the cells were 
positive for the more mature neuronal marker Map2ab, although this was again increased 
slightly with the high Ca2+ medium (7.3% (n = 2968) vs 11.3% (n = 2908), P<0.0001, Chi2=28, 
figure 4.7 and 4.8). A larger difference was observed when comparing the number of cells 
nestin positive, where significantly fewer cells were positive in the high Ca2+ medium (38.1% 
(n = 1129) vs 28.3% (n = 1158), P<0.0001, Chi2=24.5, figure 4.7 and 2.8). This is consistent 
with the notion that the increased Ca2+ influx has a significant role in pushing neural 
progenitor cells to differentiate into neurons.  
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Figure 4.7: Immunohistochemistry for β3-tubulin, Map2AB and Nestin in control and high 
Ca2+ medium-treated cells. 
A) Staining for DAPI (blue), β3-tubulin(red) and nestin (green) (top), and DAPI (blue), 
MAP2ab (red) and GFAP (green) (bottom) in cells differentiated for 3 weeks in the control 
medium. 
B) Staining for DAPI (blue), β3-tubulin(red) and nestin (green) (top), and DAPI (blue), 
MAP2ab (red) and GFAP (green) (bottom) in cells differentiated for 3 weeks in the 1.8mM 
Ca2+ medium. 
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Figure 4.8: A) Bar graphs showing the portion of cells under immunostain which were 
positive to Map2ab, β3-tubulin (Tuj) and Nestin as a percentage of total cells (using DAPI 
stain) (compared using Chi2 test). 
 
Manipulating specific ion channels in the high Ca2+ medium 
To assess the influence of each sub-type of voltage activated Ca2+ channel in the 
development of neuronal function in the high Ca2+ medium, each sub-type of Ca2+ channel 
was individually blocked. It was speculated that, similar to observations made in the 
astrocyte conditioned medium, that pharmacological blockade of specific sub-types of Ca2+ 
channel expressed in the control cells would have significant effects on the functional 
maturation of neurons in the high Ca2+ medium. Therefore the hypothesis was tested that 
blockade of either L- or N- type channels would block the development of spontaneous 
activity and result in a hyperpolarised resting membrane potential.  
At week 1, blockade of L- or N-type Ca2+ channels had no significant effect on development 
of cells able to fire induced action potentials in the high Ca2+ medium (79% (n = 15) when 
blocking L-type and 64% (n = 11) when blocking N-type vs 87.5% (n = 16) without either, 
figure 4.9A). By contrast, GABAA
 blockade significantly impaired the development of 
inducible action potentials (31% (n = 15) with bicuculline vs 87.5% (n = 16) without, P<0.001, 
Chi2=9.6, figure 4.9A), which it was thought drives Ca2+ influx by depolarising the cell in 
response to GABA. Therefore, it is surprising that N-, and L- type channel blockade appeared 
to not mimic GABAA blockade. However, blockade of P/Q-type Ca
2+ channels had a 
moderate but significant effect on cells showing inducible action potentials at week 1 (50% 
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(n = 10), P<0.05, Chi2=4.4, figure 4.9A). Which is further surprising as by the end of the first 
week very few cells were observed with functional P/Q-type Ca2+ channels; this could 
suggest a level of very early expression of P/Q-type channels, perhaps even at the neural 
progenitor cell stage. Into week 2, and the ability to fire induced action potentials was no 
longer inhibited by GABAA or Ca
2+ channel blockade (90% (n = 11), 82% (n = 11) and 100% (n 
= 9) when blocking L-, N- and P/Q-type channels (nifedipine, conotoxin and agatoxin, 
respectively) respectively, or 87.5% (n = 16) when blocking GABAA channels (bicuculline), 
compared to 92% in high Ca2+ medium (n = 12), ns, chi2<0.5, figure 4.9A). However, the 
blockade of L- or N-type Ca2+ channels did evoke a moderate depolarisation of the resting 
membrane potential at week 1 (-31.6 ±4 mV (n = 17) when blocking L-type and -32 ±4 mV (n 
= 12) when blocking N-type, vs -41.4 ±3.2 mV (n = 16) without, P<0.05, T>1.8, figure 4.9B). 
This is entirely consistent with GABAA channel blockade which resulted in a more significant 
depolarisation of the resting membrane potential (-20.1 ±2.9 mV (n = 19), P<0.001, T=5.3, 
figure 4.9B). A moderately depolarised resting membrane potential was also observed when 
P/Q-type Ca2+ channels were blocked (-32 ±4.8 (n = 10), P<0.05, T=1.88, figure 4.9B), again 
pointing to an early expression of these channels. By week 2, the cells treated with high Ca2+ 
medium and antagonists for L- or N-type Ca2+ channels showed even more depolarised 
resting membrane potentials (-21.8 ±2.8 mV (n = 13) when blocking L-type or -20.7 ±3.5 mV 
(n = 15) when blocking N-type, vs -47.1 ±4.4 mV (n = 16) without, P<0.001, T> 4.8, figure 
4.9B) and were now very reminiscent of cells treated with GABAA blockade (-25.3 ±2.2 mV (n 
= 16), figure 4.9B). Blockade of P/Q-type channels were no longer showing any effect on the 
resting membrane potential by week 2 (-42.2 ±3.2 mV (n = 9), ns, T=0.3), consistent with the 
notion that they were only expressed at a very early stage. Crucially, and consistent with 
GABAA blockade, there was a complete ablation of spontaneous activity by either L- or N-
type Ca2+ channel blockade (0% (n = 13) when blocking L-type or 0% (n = 10) when blocking 
N-type, vs 56% (n = 16) without, P<0.001, Chi2>12, figure 4.9C). This was not observed with 
P/Q- type Ca2+ channel blockade (44% (n = 9)), which developed similar levels of 
spontaneous activity to the high Ca2+ medium. 
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Figure 4.9: Comparison of proportion of cells showing spontaneous activity, proportion of 
cells showing induced action potentials and resting membrane potential of cells cultured in 
high Ca2+ medium and with the addition of 2 µM nifedipine, 0.1 µM agatoxin, 0.1 µM 
conotoxin or 10 µM bicuculline individually. 
A) A bar graph showing the portion of cells able to fire an induced action potential during a 
current step protocol in the 1.8 mM medium, and with the addition of 2 µM nifedipine, 0.1 
µM agatoxin, 0.1 µM conotoxin or 10 µM bicuculline (compared using Chi2 test) at weeks 1 
and 2. 
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B) A bar graph showing the portion of cells showing spontaneous activity in the 1.8mM 
medium, and with the addition of 2 µM nifedipine, 0.1 µM agatoxin, 0.1 µM conotoxin or 10 
µM bicuculline (compared using Chi2 test) at weeks 1 and 2. 
C) A bar graph showing the mean resting membrane potential (±SEM) for cells cultured in 
the high Ca2+ medium and with the addition of 2 µM nifedipine, 0.1 µM agatoxin, 0.1 µM 
conotoxin or 10 µM bicuculline (compared using T- test) at weeks 1 and 2. 
 
Increasing the Ca2+ concentration in the medium resulted in an immediate acceleration of 
the development to a basic neuronal phenotype, followed by a hyperpolarised resting 
membrane potential and a higher proportion of cells with spontaneous activity. It appears 
that at a very early stage P/Q- type Ca2+ channels contribute to the Ca2+ influx which drives 
the functional maturation. However, their expression has waned by the end of the first 
week. L- and N- type channel blockade do not appear to impact the initial development of a 
basic neuronal phenotype, in terms of generating an induced action potential. This is 
consistent with L- and N-type channels being only expressed in neurons, and so only after 
the development of a basic neuronal phenotype. Following this initial stage, the L- and N- 
type channels are both required for the neurons to mature from a basic phenotype to 
developing a polarised resting membrane potential and spontaneous activity. GABAA 
function appears to have a role at both stages. Firstly, blocking these channels slowed down 
the development of cells able to fire an inducible action potential. Following that, blockade 
of these channels entirely ablated the development of a more mature phenotype with a 
hyperpolarised resting membrane potential and spontaneous activity. This strongly suggests 
that GABA stimulation provides a pro-neurogenic, followed by a pro-maturation and pro-
synaptogenic stimulus by driving Ca2+ influx, initially through P/Q-type Ca2+ channels and 
then later using the more typically neuronal L- and N- type channels. Beyond the initial 
differentiation to a basic neuronal phenotype, the data then suggest that GABA continues to 
provide a stimulus to drive further functional maturation, producing more polarised 
membranes and permitting more spontaneous activity. With more time however, GABA 
becomes an inhibitory neurotransmitter, and is no longer able to drive functional 
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maturation, resulting in an eventual functional decline in both the high Ca2+ and control 
media. 
These data suggest that GABA signalling is central to the mechanism behind early functional 
maturation in iPS cell-derived neurons, as it provides a depolarising stimulus to activate 
voltage activated Ca2+ channels. For both L- and N- type Ca2+ channel blockade to 
individually have an equal effect on functional maturation to GABAA blockade, it seems 
appropriate to suggest that the two sub-types of Ca2+ channel have different, and equally 
critical roles in this mechanism. Previous studies have linked L-type Ca2+ channels to the 
post-synaptic membrane and provide Ca2+ influx in response to synaptic activity 116. In 
contrast, N-type Ca2+ channels are linked to the pre-synaptic membrane and respond to 
action potentials reaching the pre-synaptic membrane to mediate synaptic vesicular release 
85. Therefore, it seems probable that N-type channels are required in this mechanism 
because they mediate the endogenous release of GABA and L-type channels are required as 
they produce the Ca2+ influx at the post-synaptic membranes in response to GABA-
dependent depolarisation. 
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Figure 4.10: The ability of GABA to rescue functional development with conotoxin treatment 
and the ability of Bay K8644 to rescue functional development with niphedipine treatment. 
A) A bar graph showing the proportion of cells (%) showing spontaneous activity in 1.8mM 
Ca2+ medium, and with the following: 0.1µM conotoxin; 0.1µM conotoxin and 300µM 
GABA; 10µM bicuculline and 10µM Bay K8644 at week 2 (compared using Chi2 test).  
B) A bar graph showing the mean resting membrane potential (±SEM) in 1.8mM Ca2+ 
medium, and with the following: 0.1µM conotoxin; 0.1µM conotoxin and 300µM GABA; 
10µM bicuculline and 10µM Bay K8644 at week 2 (compared using T- test).  
 
Following the experiments described above, the hypothesis that the addition of GABA to the 
high Ca2+ medium with conotoxin (N-type Ca2+ channel antagonist) could replace the GABA 
that is not being secreted because the Ca2+ influx from N-type Ca2+ channels are not 
initiating GABA-vesicle release was tested. Indeed, 300µM GABA added to the 0.1 µM 
conotoxin and high Ca2+ medium rescued the development of spontaneous activity (from 0% 
(n = 15) with conotoxin to 50% (n = 10) with both GABA and conotoxin, P < 0.01, chi2 = 9.38, 
figure 4.10A) and a hyperpolarised resting membrane potential (from -20.7 ± 3.5 mV (n = 
15) with conotoxin to -47.6 ± 3.9 mV (n = 10) with both GABA and conotoxin, P < 0.001, 
T=5.1, figure 4.10B).  
Another hypothesis, that the addition of BayK 8644 to directly activate L-type Ca2+ channels 
would remove the need for GABA-dependant depolarisation for Ca2+ influx to enhance 
functional maturity was tested. 10µM BayK 8644 added to the 10µM bicuculline and high 
Ca2+ medium rescued the development of spontaneous activity (from 0% (n = 19) with 
bicuculline to 62.5% (n = 8) with Bay K8644 and bicuculline, P < 0.01, Chi2=14.6, figure 
4.10A) and a hyperpolarised resting membrane potential (from -25.1 ± 2.2 mV (n = 19) with 
bicuculline to -51.0 ± 4.4 mV (n = 8) with Bay K8644 and bicuculline, P < 0.001, T=6.4, figure 
4.10B).  
Since GABA or BayK 8644 were able to completely ameliorate the effects of either conotoxin 
or bicuculline, respectively this suggests an order of events in this maturation mechanism. 
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N-type Ca2+ channels, blocked by conotoxin, are required for GABA-secretion. The secreted 
GABA activates GABAA
 receptors providing depolarisation sufficient to stimulate L-type Ca2+ 
channel activity. This suggests direct activation of L-type Ca2+ channels, with BayK 8644, 
results in the most direct strategy for using Ca2+ influx to drive functional maturation. Using 
BayK 8644 to directly activate L-type Ca2+ channels also has the benefit of not being 
dependant on GABA-signalling, which means it does not become ineffective at the time 
point at which GABA becomes inhibitory. Therefore, BayK 8644 stimulation in conjunction 
with an increased Ca2+ concentration medium could provide a powerful, but defined, 
mechanism for driving functional maturation in pluripotent stem cell-derived neurons. One 
limitation may be that, at the very early stages of the differentiation protocol very few cells 
have functional L-type Ca2+ channels. However, both GABA-stimulation and increased Ca2+ 
concentration are effective, likely due to early P/Q-type channel function. Therefore, as a 
suggested protocol, the use of a high Ca2+ medium with GABA treatment initially which is 
replaced by Bay K8644 may be a very effective strategy for rapidly producing 
electrophysiologically functional neurons. 
 
Using dopamine in the differentiation protocol 
Dopamine is an important neurotransmitter for striatal function. Projections from the 
substantia nigra innervate the striatum allowing the TH (tyrosine hydroxylase) positive 
projections to secrete dopamine across the striatum 206. Medium spiny neurons of the 
striatum respond to dopamine which evokes different responses in each type of medium 
spiny neuron based on their expression of either D1 or D2 type dopamine receptors. Using 
the intermediate DARPP32, dopamine stimulation results in the attenuation of multiple ion 
channel currents crucial to medium spiny neuron function; these include NMDA-type 
glutamate receptors, L-type Ca2+ channels and GABAA receptors 
54. The attenuation of these 
currents by dopamine is different in each type of medium spiny neuron, acts as a fine-tuning 
mechanism for the two paths of motor control through the striatum; the direct and indirect 
pathways.  
Focussing on development and maturation, dopamine receptor stimulation has been linked 
to CREB phosphorylation and may play an important role in functional maturation in the 
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developing striatum 32,53.  Therefore as a potential strategy for functionally enhancing iPS 
cell derived neurons of a striatal lineage, dopamine or co-culture with dopaminergic 
neurons were considered.  
 
Figure 4.11: 
A) Stains for DAPI (blue), DARPP32 (green) and β3-tubulin (red) in week 2 control 
differentiated neurons, colour channels separated and labelled above.  
To determine if the differentiation protocol had indeed successfully specified a striatal 
lineage, the cells were immunologically studied for the presence of medium spiny neurons, 
the most numerous neuronal cell type in the striatum. Immunostains for DARPP32, an 
established cell marker for medium spiny neurons, revealed no detectable DARPP32 
expression in the control cultures at week 2 (figure 4.11). This is consistent with results 
showing that even in far lengthier differentiation protocols less than 10% of cells express 
DARPP32, meaning very poor yields of crucial medium spiny neurons8,29.  This implies the 
differentiation protocol had not specified a striatal lineage, and no medium spiny neurons 
were produced. However, despite DARPP32 playing a crucial role in the functional response 
of medium spiny neurons to dopamine, this does not rule out a separate developmental 
response to dopamine.   
Co-culture of iPS cell-derived neurons from which had been developed, using a typical 
midbrain dopaminergic neuron differentiation protocol and neurons from the control 
differentiation protocol was attempted. However, the dopaminergic differentiation protocol 
resulted in relatively low yields of TH+ neurons and a mixture of neuronal and glial sub-
types (data not shown). Therefore, to test only the effects of dopamine on development, 
avoiding the potential effects of neurons and astrocytes being added to the culture, 
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dopamine was added to the differentiation culture as a defined protocol. The hypothesis 
that 20 µM dopamine added to the differentiation medium could enhance neuronal 
function, of these none-striatal neurons, in terms of resting membrane potential and action 
potential generation was tested. 
 
 
 
Figure 4.12: The electrophysiological properties of iPS cell-derived neurons cultured in the 
standard differentiation protocol, and with dopamine. 
A) Bar graph showing the proportion of cells able to fire induced action potentials over 3 
weeks of differentiation in control medium and control medium with 10 µM dopamine. 
B) Bar graph showing the portion of cells showing spontaneous activity over 3 weeks of 
differentiation in control medium and control medium with 10 µM dopamine. 
C) A graph showing the mean resting membrane potential (±SEM) over 3 weeks of 
differentiation in control medium and control medium with 10 µM dopamine. 
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Differentiated iPS-cell derived neurons using the standard differentiation protocol and with 
20 µM dopamine added to the medium were compared electrophysiologically over the 3 
week protocol previously described. Both the control and dopamine medium followed a 
very similar pattern of development. At week 1, roughly half of the cells in both media (50% 
(n = 8) in control and 43% (n = 7, ns) with dopamine) had developed the ability to fire 
induced action potentials (figure 4.12A). This increased to almost all cells at week 2 (78% (n 
= 9) in control and 88% (n = 8, ns) with dopamine). Which essentially continued into week 3 
(88% (n = 8) in control and 85% (n = 7, ns) with dopamine, figure 4.12A). The dopamine also 
failed to evoke a significant change in the cell’s resting membrane potential at any week. 
Following the same pattern as control cells, the dopamine cells started depolarised (-23.5 
±2.5 mV (n = 8) in control  and -21.7 ±2.2 mV (n = 7), ns, figure 4.12B), then both produced a 
slightly more polarised membrane potential at week 2 (-39.5 ±3.2 mV (n = 9) in control and -
38.3 ±3.3 mV (n = 8) with dopamine, ns), and then declined at week 3(-28.6 ±2.9 mV (n = 9) 
in control and -30.8 ±2.1 mV (n = 9) with dopamine, ns, figure 4.12B). Correlating with the 
pattern of development observed in the resting membrane potential,  few cells were firing 
spontaneous action potentials at week 2 (22% (n = 9) in control and 12.5% (n = 8) with 
dopamine, ns, figure 4.12C), where the membrane potential was most polarised, however 
dopamine evoked no significant change. 
This disproved the hypothesis that the addition of dopamine to the medium, at a standard 
working concentration of 20 µM, could positively influence the electrophysiological 
maturation of iPS cell-derived neurons. The failure of dopamine to influence maturation is 
most likely attributable to the cells not having been specified down a striatal lineage, 
resulting in cells that do not express dopamine receptors. However, this strategy may be 
worth revisiting as a mechanism for improving functional maturity when differentiation 
protocols, or direct reprogramming techniques, are developed which efficiently specify 
striatal medium spiny neurons.  
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Comparing BayK 8644 and mACM in human embryonic stem cell derived 
neuronal differentiation 
Using the data described previously it is plausible that BayK 8644 treatment may be a viable 
strategy for producing a defined protocol to functionally enhance neurons, similar to ACM, 
or perhaps more rapidly. This protocol is based upon the notion that BayK 8644 will 
stimulate the previously investigated Ca2+ influx-dependant mechanism for functional 
maturation, but independently of GABA. Therefore, where GABA or increased Ca2+ 
concentration compared poorly to ACM-treatment at week 3, because of the GABA 
excitatory to inhibitory switch, BayK 8644 should continue to function. To further validate 
that this principle is sound, both BayK 8644 and mouse ACM were tested on human 
embryonic stem cells.  
Human embryonic stem cells from the H9-line were partially differentiated using an 
established protocol for EZ-sphere culture. These EZ-spheres were cultured through 
between 6 and 11 passages before being used for terminal differentiation. The standard 
differentiation protocol was employed and also with 10 µM BayK 8644 and the mouse ACM 
previously described. The functional maturity of these cultures was assessed using patch 
clamp for the first 2 weeks of differentiation. However, reproducibly the embryonic stem 
cell-derived differentiations showed very poor survival into week 3. 
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Figure 4.13: A comparison of the ability to fire induced action potentials, Na+ current density 
and K+ current density of human embryonic stem cell-derived (H9) neurons differentiated in 
control, BayK 8644 medium and ACM. 
A) A bar graph showing the portion of cells able to fire induced action potentials during 
weeks 1 and 2 of differentiation terminal of H9 derived EZ spheres in ACM, 10µ Bay K8644 
and control medium. 
B) A bar graph the mean peak Na+ current (±SEM) during weeks 1 and 2 of differentiation 
terminal of H9 derived EZ spheres in ACM, 10µ Bay K8644 and control medium. 
C) A bar graph the mean K+ current (±SEM) during weeks 1 and 2 of differentiation terminal 
of H9 derived EZ spheres in ACM, 10µ Bay K8644 and control medium. 
Similar to the pattern of maturation seen in the iPS cell-derived neurons, by week 1 40% (n = 
10) of the H9-derived neurons had developed the ability to fire induced action potentials. 
Again, similar to observations made in the iPS-cell derived cultures, the majority of the H9-
derived cells had both voltage activated Na+ and K+ currents (88% (n = 9) with Na+ currents, 
100% (n = 9) with K+ currents, figure 32A), but the magnitude of both current densities were 
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very small resulting in very immature shaped action potentials (-8.2 ± 2.1 pA∙pF-1 (n = 8) 
mean Na+ current density and 24.8 ±4.6 pA∙pF-1 (n = 9) mean K+ current density, figure 4.12 
B and C). In contrast to the iPS cell-derived neurons, the control H9-derived neurons did not 
show a significant increase in their Na+ and K+ currents from week 1 to week 2 (from -8.2 ± 
2.1 pA∙pF-1 (n = 8) to -8.9 ±4.2 pA∙pF-1 (n = 7) mean Na+ current density and from 24.8 ±4.6 
pA∙pF-1 (n = 9) to 28.3 ±8 pA∙pF-1  (n = 7) mean K+ current density, figure 32B and C). This 
resulted in no increase in the portion of cells able to fire action potentials (from 40% (n-10) 
to 37.5% (n = 9)). 
The ACM-treated cells from week 1 showed significantly larger Na+ current densities (-23.2 
±9.1 pA∙pF-1  (n = 9), P<0.05, T=1.8), and unsurprisingly most ACM-treated cells were able to 
fire action potentials by week 1 (73% (n = 11), P=0.0635, figure 32A, B and C). This trend 
continued into week 2, where the ACM-treated cells showed moderate functional increases 
in both their Na+ and K+ currents (-36.5 ±6.5 pA∙pF-1 (n = 7) mean Na+ current density and 
35.4 ± 6.4 pA∙pF-1 (n = 7) mean K+ current density at week 2), the Na+ currents were now 
much larger than control treated cells (P<0.001, T=6.1). Consequently all sampled ACM 
treated cells were able to fire action potentials (n = 8), compared to only 37.5% (n = 9) in 
control medium (P<0.01, Chi2=8.2, figure 14 A, B and C).  
 
 
Figure 4.15: Resting membrane potentials and spontaneous action potentials in h9-derived 
neurons treated with control, BayK and ACM. 
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A) A bar graph the mean peak resting membrane potential (±SEM) during weeks 1 and 2 of 
differentiation terminal of H9 derived EZ spheres in ACM, 10µ Bay K8644 and control 
medium. 
B) A bar graph showing spontaneous action potentials during weeks 1 and 2 of 
differentiation terminal of H9 derived EZ spheres in ACM, 10µ Bay K8644 and control 
medium. 
 
When examining the cells treated with BayK 8644, a pattern of development similar to that 
of the ACM-treated cells was observed. At week 1 the BayK 8644 medium evoked a 
significant increase in voltage activated Na+ currents (-17.5 ± 1.8 pA∙pF-1 (n = 8), P<0.01, 
T=3.3, figure 4.15B), which resulted in a significant increase in the portion of cells able to 
fire an induced action potential (78% (n = 9), P<0.05, Chi2=2.8, figure 4.15 A). This trend 
continued into week 2 where 100% (n = 8) of the BayK 8644 treated cells could fire induced 
action potentials and with a significantly larger Na+ current density (-22.9 ±2.6 pA∙pF-1 (n = 
7), P<0.05, T=2.8, figure 4.15 B). 
In contrast to the iPS-cell derived neurons, the control treated H9-derived neurons did not 
develop significant numbers of cells showing spontaneous activity. Even at week 2, none 
were firing spontaneous action potentials at week 2 (n = 9, figure 33B). This is consistent 
with the relatively few cells in the control medium able to fire induced action potentials at 
all. Further, this was confounded by the fact that those few which were able to fire an 
induced action potential generated, demonstrated very immature action potential shapes, 
likely due to the limited Na+ and K+ currents available. By contrast both the ACM and BayK-
treated cultures showed low, but existing populations of spontaneously active neurons 
(12.5% (n = 8) and 25% (n = 8) in ACM and BayK medium respectively). Crucial to the 
development of spontaneous activity is the resting membrane potential. At week 1, all 3 
cultures showed relatively hyperpolarised resting membrane potentials, which were 
sufficient to permit action potentials, assuming a cell has significant enough Na+ and K+ 
currents (-40 ±3.1 mV (n = 11) in control, -42.1 ±1.7 mV (n = 11) in ACM and -42.5 ±2.7 mV (n 
= 9) in BayK medium, figure 4.15A). However from week 1 to week 2, the control cells 
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actually became significantly less polarised (-26.2 ± 1.6 mV (n = 9), P<0.01, T=3.7), meaning 
virtually none of these cells had significant pools of closed, and not inactivate Na+ channels. 
By contrast both the ACM and BayK treated cells showed slightly more hyperpolarised 
membrane potentials at week 2 (-43.24 ± 3.073 mV (n = 8) and -44.45 ± 5.579 mV (n = 8), in 
ACM and BayK treated cells respectively, P<0.01, T>3.3, figure 4.15A). The combination of 
larger Na+ current and a hyperpolarised resting membrane potential therefore resulted in a 
few ACM and BayK treated cells being able to fire spontaneous action potentials. 
Unfortunately the H9-derived cells showed very poor survival over time, some were lost at 
week 2 and by week 3 insufficient cells were remaining for any meaningful observations. 
The H9-derived neurons from H9-derived EZ spheres showed very poor function and 
survivability compared to the iPS cell-derived cultures. Therefore, a comparable pattern of 
development to observations made in the iPS cell-derived cultures was not seen. The 
control H9-derived cells never developed an enriched population of cells able to fire action 
potentials with a mature shape, and showed a functional decline after week 1 showing very 
depolarised resting membrane potentials. The astrocyte conditioned medium also showed a 
different pattern of development in the H9-derived cells. No significant population of 
spontaneous active cells was generated using these differentiation protocols. However, the 
ACM did restore a significant population of cells able to fire induced action potentials and 
evoke a polarisation of the membrane. Perhaps, if the cells had survived beyond the week 2 
point, and continued to functionally develop, the ACM-treated cells would have generated a 
significant proportion of cells showing spontaneous activity by week 3. However, the BayK 
8644 treated cells showed a very similar pattern of development to the ACM-treated cells, 
in terms of proportion of cells able to fire induced action potentials and resting membrane 
potential.  
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Chapter 5: Generating cultures of human iPS cell-derived astrocytes 
which produce functional astrocyte conditioned medium. 
 
Specific introductions 
Astrocyte differentiation 
The mechanisms underlying many neurodegenerative diseases are not necessarily limited to 
neurons or single neuronal sub-types. Other cells of the central nervous system, including 
glial cells, play pivotal roles in these diseases. For example, in Huntington’s disease, the 
excitotoxic loss of medium spiny neurons is in all likelihood caused in part by the increased 
sensitivity of medium spiny neurons to extrasynaptic NMDA receptor-driven apoptosis, but 
also due to reduced glutamate uptake by astrocytes 61,146. Therefore, in many cases it will be 
crucial to incorporate astrocytes, or other glial cells, in models of neurodegenerative 
diseases in vitro. However, current protocols for stem cell derived astrogliogenesis are both 
lengthy and involve a significant time in co-culture with neurons. It may be very useful to 
produce enriched cultures of naïve astrocytes, which have not been cultured alongside 
neurons and do not risk introducing neurons or neural progenitor cells to the final model. 
This will allow clean integration of wild type astrocytes into a disease neuronal culture, or 
vice-versa, to produce the co-culture models that are experimentally appropriate.  
Therefore, a rapid protocol for differentiating astrocytes in the absence of neurons was 
developed, using a well-defined culture of neural progenitor cells and source of iPS derived 
neurons, the same EZ-sphere populations that used to derive neurons.  As a possible 
strategy for developing relatively pure iPS cell-derived astrocyte cultures, the following 
mechanism was considered: initially prevent neurogenesis by killing mitotic neural 
progenitor cells with Ara-C (cytosine arabinoside), followed be treatment with LIF-1 to 
initiate astrocyte differentiation 194.  Lif-1 was used in the second step to promote astrocyte 
differentiation, but producing an astrocyte precursor population which retains the ability to 
self-renew 96,19.  
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Specific methods 
Astrocyte differentiation 
Astrocyte differentiation was performed using the same EZ-sphere cultures of neural 
progenitor cells and plated on PLL-laminin coated coverslips (see methods). The base 
medium used was similar to neuronal differentiation, being based on DMEM:F12 (1:1) as 
well as 2% B27. However, differentiation occurred in 3 phases. Firstly neurogenesis was 
blocked using 10 µM Ara-C to inhibit the mitotic division necessary for neurogenesis for 1 
week. Following this 10 µM LIF-1 was used to promote astroglial precursor development, to 
produce a self-renewing GFAP positive population of cells. Following a week the iPS cell-
derived astroglial cell culture was transferred to more standard tissue culture flasks and 
cultured in FBS-based medium to allow the cultures to expand. The differentiation was 
assessed immunologically using antibodies for β3-tubulin, GFAP and S100β, for neurons, 
astroglial cells and more mature astroglial cells respectively. 
Human astrocyte conditioned medium (hACM) 
In addition to the presence of marker proteins for astrocytes, the ability of these iPS cell-
derived human astrocyte cultures to produce human astrocyte conditioned medium (hACM) 
was tested. Using the same protocol as developed using the mouse astrocyte cultures base 
neuronal differentiation medium was conditioned using the iPS cell-derived astrocytes. 
Using the same protocol as before iPS cell derived neuronal cultures treated with hACM and 
control medium were assessed electrophysiologically over a 3 week differentiation at weeks 
2 and 3. 
 
Astrocyte differentiation protocol 
Similar to the neuronal differentiation, a single cell suspension of dissociated EZ-spheres 
was plated onto PLL-laminin coated coverslips. The wells were flooded with a base medium 
known to allow survival of both neurons of astrocytes using the B27 supplement. To 
selectively kill mitotic cells, Ara-C (cytosine arabinoside) was added, a compound toxic to 
mitotic cells 194. A cell-survival based dose response curve was produced for 1 week of Ara-C 
treatment with concentrations of (from 0.3 to 300 µM, expressed in the figure as log [Ara-C 
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(mM)]). Immunostaining for β3 tubulin was also used to assess the development of 
immature neurons in these cultures. A concentration of 10 µM Ara-C was then chosen as 
this resulted in sufficient cell survival, reducing the total cell pool to only half compared to 
control, but generated very few β3 tubulin positive cells (figure 5.1 A and B).  
 
 
Figure 5.1: The survival and propensity to produce β3-tubulin positive cells with 1 week of 
Ara-C treatment. 
A) A graph showing the mean cell count (±SEM) following 1 week of culture in varying 
concentrations of Ara-C. 
B) Exemplar DAPI nuclear stain (blue), β3-tubulin immunostain (red) and GFAP immunostain 
(green) for cells in control medium (left) and treated with 10µM Ara-C (right) after 1 week. 
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The second stage of the new astrocyte differentiation protocol focused on maturing 
astroglial precursor cells with 10 µM human recombinant leukaemia inducible factor (LIF-1) 
in the same base medium, using the principle that Lif-1 induces the development of a self-
renewing population of GFAP (glial fibrilary acidic protein) positive astroglial sub-type that 
may exhibit best neurogenic properties due to their developmental stage 19,122. Following 1 
week of LIF-1 treatment, 91% (n = 416) of cells were positive for the astrocyte marker GFAP, 
showing a highly enriched culture of astrocytes after only a total of 2 weeks in culture 
(figure 5.2). Further, although some GFAP positive cells were also weakly β3 tubulin positive, 
only 4% of the population were β3 tubulin positive but GFAP negative, indicating a very low 
rate of neurogenesis in these cultures (figure 5.2).  
 
Figure 5.2: The production of highly pure GFAP+ cultures following 1 week Ara-C treatement 
and then 1 week Lif-1 treatment (total of 2 weeks). 
A) DAPI, GFAP and β3-tubulin (Tuj) stains, blue, green and red respectively, for cells treated 
with Ara-C for 1 week followed by Lif-1 for 1 week at 5x and 10x magnification, colour 
channels have been split blue, green, red and merge respectively. 
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The 2 week protocol was repeated, but this time without the Ara-C treatment during the 
first week. This change to the first medium resulted in an obvious increase in total cells, but 
crucially an increase in β3 tubulin positive cells even following 1 week of LIF-1 treatment 
(figure 5.3 B). This demonstrates the importance of the initial treatment with Ara-C to limit 
neurogenesis to produce a more pure population of astrocytes. 
 
Figure 5.3: A comparison of GFAP+ and β3-tubulin+ cells using this protocol with and without 
Ara-C treatment. 
A) DAPI, GFAP and β3-tubulin (Tuj) stains, blue, green and red respectively, following the 2 
week protocol 1, colour channels have been split blue, green, red and merge respectively. 
B) DAPI, GFAP and β3-tubulin (Tuj) stains, blue, green and red respectively, following the 2 
week protocol 1 but without Ara-C treatment during the first week, colour channels have 
been split blue, green, red and merge respectively. 
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Following the 2 week protocol, the cells were then passaged and transferred to standard 
tissue culture flasks and the B27 in the base medium replaced with 10% FBS, which is known 
to support astroglial growth but not neurons or neuronal progenitor cells (see specific 
introductions – astrocyte differentiation). Following 1 week in the new FBS medium, 100% 
(n = 211) of cells were GFAP positive and 0% were β3 tubulin positive but GFAP negative. 
However, a low level of β3 tubulin was still observed in many GFAP positive cells. Further, 
immunostaining for GFAP and S100β, a second marker for astrocytes that is expressed later 
in development (figure 5.4A), again showed 100% of the cells were GFAP positive (n = 301) 
but, crucially, 91% of the cells were both S100β and GFAP positive (figure 5.4A). This is a 
clear indication that by week 3 this protocol had produced a highly enriched culture of 
mature astrocytes. The astrocytes were then cultured in the same medium for an additional 
5 weeks, passaging the cells once per week, resulting in a total of 8 weeks differentiation. 
Again, almost all cells were both S100β and GFAP positive (figure 5.4B). This shows that the 
new protocol is capable of producing enriched cultures of astrocytes and can be expanded 
for at least 5 passages.  
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Figure 5.4: The expression of GFAP+ and S100B in these cultures following 3 and 8 weeks of 
culture. 
A) DAPI, GFAP and S100B stains, blue, green and red respectively, following 1 week in the 
FBS and Lif-1 medium, colour channels have been split blue, green, red and merge 
respectively. 
B) DAPI, GFAP and S100B stains, blue, green and red respectively, following 5 weeks (8 
passages) in the FBS and Lif-1 medium, colour channels have been split blue, green, red and 
merge respectively. 
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Differentiation using human iPS cell derived astrocyte ACM (hACM) 
Using a similar protocol to chapter 3, human iPS cell-derived astrocytes were used to 
condition base differentiation medium (human ACM, or hACM) for culturing iPS cell-derived 
neurons. The iPS-cell derived neurons treated with control medium and human iPS cell-
derived astrocyte conditioned medium were compared electrophysiologically at weeks 2 
and 3 of the differentiation protocol. Similar to the previous differentiation protocols, 
almost all cells were able to fire induced action potentials by week 2 (90% in control (n = 10) 
and 93% in human ACM (n = 15)) which was maintained to week 3 (80% in control (n = 10) 
and 100% in hACM (n = 9), figure 5.5 C). Consistent with results using mouse ACM, the 
human ACM did not accelerate the development of an induced action potential. However, 
although the control cells showed an equal proportion of cells able to fire action potentials 
we did observe a difference in the shape of action potentials in human ACM cells. Consistent 
with mouse ACM, we saw more mature action potentials in the human ACM-treated cells by 
week 3. The shapes of induced action potentials elicited in control and human ACM-treated 
cultures were compared quantitatively using the previously described method using the 
area inside orbital plots (figure 5.5 D).  At week 2, the control and human ACM-treated cells 
exhibited relatively similar shape action potentials (2186 ± 395 mV2 ∙ ms-1 (n = 8) in control 
vs. 2526 ± 350 mV2 ∙ ms-1 (n = 9) in human ACM, ns). At week 3 however, the human ACM-
treated cells exhibited a more mature shape (3419 ± 338 mV2 ∙ ms-1 (n = 8) vs. 4725 ± 549 
mV2 ∙ ms-1 (n = 8) in human ACM, P<0.05, figure 5.5 A and F). In addition to the shape of the 
induced action potentials the threshold voltage at which the action potentials were initiated 
was estimated from the orbital plots. However, and in contrast to data using mouse ACM, 
this increased spikey-ness did not result in a significant proportion of cells firing a second 
action potential event following an induced action potential (0% (n = 8) in control vs. 12.5% 
(n = 8) in human ACM, ns). Consistent with previous data with the mouse ACM, the human 
ACM elicited no change in the action potential threshold at week 2(-31.4 ± 1.2 mV (n = 8) in 
control vs. -31.8 ± 0.8 mV (n = 9) in human ACM, ns) or week 3 (-32.9 ± 1 mV (n = 8) in 
control vs. -33.7 ± 1 mV (n = 8) in human ACM, ns, figure 5.5 E). 
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Figure 5.5: The development of induced action potentials in control and human ACM treated 
cells. 
A) Exemplar voltage recordings from week 2 and 3 control treated cells during a current step 
protocol eliciting an action potential. The protocol is shown at the bottom. 
B) Exemplar voltage recordings from week 2 and 3 human ACM treated cells during a current 
step protocol eliciting an action potential. The protocol is shown at the bottom. 
C) A bar graph showing the portion of cells (%) showing induced action potentials (iAP) at 
weeks 2 and 3 for both control and human ACM treated cells. 
D) An exemplar orbital graph (differential of voltage against time plotted against voltage) 
for a single action potential generated by a human ACM-treated cell at week 3. The 
approximate threshold voltage is indicated as a line. 
E) A bar graph showing the mean (±SEM) estimated threshold voltages for elicited action 
potentials from both control and human ACM-treated cells at weeks 2 and 3. T-tests were 
performed for statistical differences between control and human ACM at each week. 
F) A bar graph showing the mean area inside the orbit (see panel D for an example) for 
control and human ACM-treated cells at weeks 2 and 3, calculated using the sum of the 
modulus of the integrals of the orbital graph. T-tests were used to compare the control and 
human ACM-treated cultures at each week. 
Using voltage clamp, the voltage activated Na+ and K+ currents responsible for action 
potential generation were measured (figure 5.6 A to D). By week 2, almost all cells in both 
the control and human ACM-treated cells developed significant voltage activated Na+ and K+ 
currents, consistent with their ability to fire induced action potentials. Consistent with 
similar shape induced action potentials in both control and human ACM cultures at week 2, 
both cultures showed every similar magnitude of both Na+ and K+ current densities (Na+: -
65.8 ± 11.1 pA∙pF-1 (n = 7) in control vs. -61.9 ± 5.8 pA∙pF-1 (n = 9) in human ACM, ns, and K+: 
43.3 ± 5.2 pA∙pF-1 (n = 7) in control vs. 41.4 ± 5 pA∙pF-1 (n = 9) in human ACM, ns, figure 5.6 
E). At week 3, the human ACM had evoked a significant increase in the Na+ current density 
compared with control (-89 ± 8.4 pA∙pF-1 (n = 8) in control vs. -112.4 ± 7 pA∙pF-1 (n = 8) in 
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human ACM, P<0.05). These data are consistent with faster depolarisation rates observed in 
week 3 human ACM-treated cells compared with control (29 ± 2.9 V∙s-1 (n = 8) in control vs. 
48.4 ± 4.6 V∙s-1 (n = 8) in human ACM, P<0.01) and therefore an increase in the area inside 
the orbit (3419 ± 338 mV2 ∙ ms-1 (n = 8) vs. 4725 ± 549 mV2 ∙ ms-1 (n = 8) in human ACM, 
P<0.05, figure 5.5 F). However, magnitude of K+ current density did not appreciably increase 
at week 3, which was not altered by human ACM (45.5 ± 4.6 pA∙pF-1 (n = 8) in control vs. 
48.4 ± 3.2 pA∙pF-1 (n = 8) in human ACM, ns, figure 5.6F). Consequently, human ACM did not 
enhance the rates of repolarisation at week 3 (-27.9 ± 2.5 V∙s-1 (n = 8) in control vs. -29.8 + 
2.9 V∙s-1 (n = 8) in human ACM, ns). This perhaps explains why few cells in control or human 
ACM were able to fire second full, or even abortive induced action potentials, because the 
K+ current was relatively small resulting in slower repolarisation which did not undershoot 
as far (-3.8mV ± 2.6 mV (n = 7) in control vs. -2.9 ± 3.1 (n = 7) in human ACM, ns).  
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Figure 5.5: Na+ and K+ voltage activated currents evoked in neurons differentiated with 
human ACM (hACM). 
A) Exemplar voltage recordings (top) in control cells at weeks 2 and 3 during a voltage step 
protocol (bottom), eliciting both voltage activated Na+ and K+ currents. 
B) Exemplar voltage recordings (top) in human ACM-treated cells at weeks 2 and 3 during a 
voltage step protocol (bottom), eliciting both voltage activated Na+ and K+ currents. 
C) Exemplar current density (pA∙pF-1) against voltage graphs plotted for Na+ (squares) and K+ 
(circles) currents from control cells at weeks 2 and 3. 
C) Exemplar current density (pA∙pF-1) against voltage graphs plotted for Na+ (squares) and K+ 
(circles) currents from human ACM-treated cells at weeks 2 and 3. 
E) A bar graph showing the mean (±SEM) maximum peak negative Na+ current density 
elicited in both control and human ACM-treated cells at weeks 2 and 3. T-tests were 
performed for statistical differences between control and human ACM at each week. 
F) A bar graph showing the mean (±SEM) maximum mean K+ current density elicited in both 
control and human ACM-treated cells at weeks 2 and 3. T-tests were performed for 
statistical differences between control and human ACM at each week. 
Similar to previous differentiations in the absence of protocols designed to enhance Ca2+ 
influx, relatively little spontaneous activity was present at week 2 in either culture (16% (n = 
12) in control and 26% in human ACM (n = 15), figure 5.7A). Critically though, by week 3 the 
human ACM evoked a significant increase in the proportion of cells firing spontaneous 
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action potentials (0% (n = 10) in control vs. 66% (n = 9) in human ACM, p<0.01, figure 5.7A). 
However, unlike mouse ACM-treated cells, development of the biphasic resting membrane 
potentials and membrane potential trains was not evoked with human ACM (figure 5.7B to 
D). This is perhaps consistent with the data observing the evoked K+ currents in these cells 
and the rates of repolarisation which were not enhanced by human ACM. By contrast, the 
mouse ACM had evoked a significantly enhanced rate of repolarisation at week 3, resulting 
in larger voltage-undershoots and greater recovery of the cells Na+ current for further action 
potentials. 
 
Figure 5.7: Spontaneous action potential generation in neurons differentiated using human 
ACM (hACM). 
A) A bar graph showing the portion of cells (%) showing spontaneous activity in the human 
ACM and control treated cells at weeks 2 and 3 of differentiation, Chi2 test was used to 
compare human ACM and control treated cells. 
B) An exemplar voltage recording during current clamp I=0, showing spontaneous action 
potentials in a control treated cell at week 2. 
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C) An exemplar voltage recording during current clamp I=0, showing spontaneous action 
potentials in a human ACM treated cell at week 2. 
D) An exemplar voltage recording during current clamp I=0, showing spontaneous action 
potentials in a human ACM treated cell at week 3. 
The resting membrane potential was shown to be an important electrophysiological 
parameter which was enhanced by mouse ACM, and which contributed to the increase in 
spontaneous activity. In a similar pattern, the control treated cells showed a decline in 
resting membrane potential between week 2 and 3 (from -35.8 ± 2.2 mV (n = 12) to -31 ± 
2.3 mV (n = 10)) where the ACM-treated cells showed a continued hyperpolarisation of the 
membrane potential from week 2 to week 3 (from -42.6 ± 4.5 mV (n = 15) to -44.9 ±1 mV (n 
= 9), figure 5.8A). This results in a significantly more hyperpolarised resting membrane 
potential in human ACM-treated cells at week 3 (-31 ± 2.3 mV (n = 10) in control vs. -44.9 ±1 
mV (n = 9) in human ACM, P<0.05, figure 5.8A) compared to control cells. These data, with 
data demonstrating that the Na+ current voltage dependant activation and inactivation 
profiles correlates had not changed over time or with human ACM, suggests greater Na+  
current availability in human ACM-treated cells at week 3 (figure 5.8 C and D). Therefore, 
this correlates well with both the increase in spontaneous activity observed at week 3 in 
human ACM treated cells and decline in spontaneous activity in control cells.  Comparing 
these resting membrane potentials values to activation-inactivation profiles of the Na+ 
current in these cells (figure 5.8 C and D), suggested that at the only 5% of the Na+ current 
would be available in control cells whilst it would be 45% in human ACM-treated cells.  
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Figure 5.8: Resting membrane potentials and the voltage dependant profiles for activation 
and inactivation in iPS cell derived neurons treated with hACM and control. 
A) A graph showing the mean resting membrane potential (whilst in current clamp at I=0) for 
both control and human ACM-treated cells at weeks 2 and 3. T-tests were performed to 
compare the mean resting membrane potential of control and human ACM-treated cells at 
each week. 
B) Exemplar current recordings (top) during a dual-step voltage protocol (bottom) showing 
currents elicited by each step from a week 3 control cell. The first step is a variable and 
increasing step and the elicited current is used to measure voltage-dependant activation of 
Na+ channels (square). The second step is static at 0mV and is used to measure the voltage-
dependant inactivation of Na+ channels as a result of the first step (circles). 
C) Using the data from panel B, normalised conductance (G/Gmax) curves are plotted against 
the voltage of the first step (adjusted for junction potential and series resistance) for both 
the inactivation (circles) and activation (square) voltage relationships. Sigmoid-Boltzmann 
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curves were then fitted to each relationship allowing for the hypothetical peak Na+ window 
voltage to be estimated. 
D) A bar graph showing the mean (±SEM) voltage of the hypothetical peak Na+ window for 
both control and human ACM-treated cells at weeks 2 and 3. These values, as previously 
discussed in chapter 3, are used as a barometer for changes in both the activation and 
inactivation voltage profiles and consequently changes in the proportions of neuronal Na+ 
channel sub-types. 
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Chapter 6: Using astrocyte secreted factors and manipulation of Ca2+ 
influx to develop a more functionally mature and consistent model for 
Huntington’s disease. 
Specific Introductions: 
Having shown that neuronal maturation could be enhanced in iPS cell-derived cultures, 
these differentiation protocols were then tested on iPS cells derived from Huntington’s 
disease (HD) patients. Firstly, it is important to develop a protocol which produces neuronal 
cultures which are more functional and is important in developing iPS cell-derived models 
for the disease. Secondly, the HD genotype could have an effect on the profile of functional 
development observed in these neurons, which could have a mechanistic role in the 
development of the disease. However, this also presents a challenge for using iPS cell 
models, as cells developing or maturing at different rates could influence the results when 
modelling the disease using stressors 218. Therefore, assessing protocols for their functional 
consistency at a set time point is also important. Ideally a protocol should be chosen which 
results in similar levels of functional maturity across multiple patient and wild type –derived 
lines at a specific time point. This should be a standardised time point for disease modelling 
or drug testing experiments can be best performed. 
Specific Methods: 
Initially, three lines from a previous iPS derived HD study where disease-relevant 
phenotypes were observed 218. A control 33 repeat line (the control line used previously, a 
HD-line developed from a sibling of the control line with HD (60 CAG repeats (Q60)) and a 
childhood onset line with 180 CAG repeats (Q180) 218. These iPS cell lines were 
reprogrammed using an the older integrating protocol, characterised for a normal karyotype 
and pluripotency and then partially differentiated to a neural progenitor cell state grown in 
“EZ spheres” (see methods).  These cells were differentiated using a standard differentiation 
protocol, with a physiological concentration (1.2 mM) Ca2+ in preference to the low Ca2+ 
medium used previously (0.6 mM). The change in Ca2+ concentration was expected to have 
little effect functionally; a comparison between 0.6 mM, 1.2 mM and 1.6 mM Ca2+ medium 
was performed in control cells in chapter 5. The lines were also differentiated using mouse 
astrocyte conditioned medium to enhance the functional maturation of the generated 
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neurons. However, the very high repeat line, the Q180 line, showed very poor survival 
beyond week 2 in control medium and fared worse still in ACM.  
Advances in reprogramming and differentiation protocols were then tested, including 
manipulation of the Ca2+ influx dependant mechanism discussed in chapter 5. Firstly, new, 
none-integrating, iPS cell lines from the same HD patients and wild type individual were 
used, thus avoiding the effects of any genetic bleed through of the reprogramming factors 
affecting differentiation and maturation. In addition to these lines a second childhood onset 
line with 109 CAG repeats (Q109), this line allows a more continuous series of CAG-repeat 
lengths and could serve as a replacement for the poorly surviving Q180 line. Secondly, a 
neural-rosette differentiation protocol was employed in preference to EZ-sphere 
generation. The neural rosettes were generated using a small molecule based dual SMAD 
inhibition protocol to produce neural-rosettes (see methods), which unpublished data from 
our lab suggests is more efficient. Lastly, terminal differentiation was performed with the 
addition of the glycogen synthase kinase-3 inhibitor CHIR 99021, the cyclin dependant 
kinase-6 inhibitor PD0332991 and forskolin to increase cAMP synthesis at week 1 and 
increase CREB-phosphorylation (see methods) 9,106,145. The hypothesis was tested that the 
combination of increased Ca2+ concentration and GABA in the medium to improve 
functional maturation and consistency across these HD-lines and in conjunction with the 
newer differentiation protocol. Another key difference between the standard differentiation 
protocol and this new protocol is the removal of the non-essential amino acids supplement, 
crucially removing 100µM L-glutamate, which by excitotoxicity could have led to the poor 
survival of the Q180 line in the previous protocol. This newer protocol will be regarded as 
the “advanced” protocol from now on.  
The electrophysiological function of iPS-derived neurons from 
Huntington’s disease patients. 
Using the standard differentiation protocol, from EZ-spheres, iPS cell-derived neurons were 
generated from 3 iPS lines (see specific methods). The control line used previously, an adult 
onset HD line (Q60) and lastly a childhood onset line (Q180). The HD109 line was not 
developed using the older and integrating reprogramming protocol, so therefore was not 
used when comparing the older standard protocol. The cells were terminally differentiated 
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in a standard differentiation medium and characterised electrophysiologically using patch 
clamp over the 3 week differentiation protocol. However, 180 repeats cell did not survive on 
coverslips to week 3, so for this line the characterisation was performed over the first 2 
weeks only. 
 
Figure 6.1: Induced action potentials and voltage activated currents in neurons differentiated 
from the HD lines. 
A) An exemplar voltage recording (top) during a current step protocol (bottom) showing an 
evoked action potential generated in a week 2 Q60 neuron.  
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B) A bar graph showing the proportion of cells (%) able to fire action potentials in the control 
(Q33), Q60 and Q180 lines over 3 weeks of differentiation using the standard differentiation 
protocol. 
C) Exemplar current recordings (top) during a voltage clam protocol (bottom) showing 
evoked voltage activated Na+ and K+ currents of a week 2 Q60 neuron. 
D) Exemplar current density against step voltage plot for both the peak negative Na+ current 
and mean plateaux of the K+ current of a week 2 Q60 neuron. 
E) A bar graph showing the mean K current density (±SEM) in the control (Q33), Q60 and 
Q180 lines over 3 weeks of differentiation using the standard differentiation protocol. 
F) A bar graph showing the mean peak Na current density (±SEM) in the control (Q33), Q60 
and Q180 lines over 3 weeks of differentiation using the standard differentiation protocol. 
 
The ability of differentiated cells to fire induced action potentials was assessed using a 
current steps protocol. In the control cultures (carrying HD33), at week 1 only 30% (n = 13) 
could fire induced action potentials, but by week 2 that had increased to 100% (n = 12), 
which was then essentially sustained in week 3 (92.3% n = 13, figure 6.1A).  By contrast, 
more cells differentiated from either of the HD lines were able to fire action potentials by 
week 1, 50% (n = 10) in the Q60 line and, significantly, 100% (n = 8, P<0.05, Chi2=3.03) in the 
Q180 line. However, at week 2 both of the HD lines showed the opposite trend to control, a 
static or declining proportion of cells able to fire induced action potentials, only 55.6% (n = 
18, P<0.01, Chi2=7.3) cells in the Q60 and 40% (n =  10, Chi2=9.9) in the Q180 line could fire 
action potentials (figure 6.1A). At week 3, the Q60 line had caught up with the control line, 
showing 100% (n = 13) cells could fire an action potential and cells from the Q180 line had 
died. 
The voltage activated K+ and Na+ channels which are required for action potential 
generation were examined using a voltage step protocol in voltage clamp. Consistent with 
this notion, the magnitude of Na+ current densities correlated with the proportions of cells 
able to generate induced action potentials. As with the proportion firing induced action 
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potentials the magnitude of Na+ currents observed correlated with CAG repeat length, such 
that the Na+ current densities in the Q180 line were very large compared to the Q60 line, 
which was still significantly larger than control (-27.6±4.7 pA∙pF-1 (n = 11) in the control line -
45±5 pA∙pF-1 (n = 10, P<0.05, T=2.6) in the Q60 line and -114.6±28.6 pA∙pF-1 (n = 9, P<0.01, 
T=3.6) in the Q180 line, figure 6.1E). Again correlating with the proportion of cells showing 
induced action potentials, the 180 repeat cell line also showed a much larger K+ current 
compared with control (39.5±8.8 pA∙pF-1 (n = 11) in the control line, 39.9±7.9 pA∙pF-1 (n = 10, 
ns) in the Q60 line and 80.1±18.1 pA∙pF-1 (n = 9, P<0.05, T=2.3) in the Q180 line, figure 6.1F). 
This suggests the HD cells exhibited an accelerated functional maturation in terms of the 
functional expression of both Na+ and K+ channel function where the control cells showed a 
more gradual gain of functional Na+ and K+ channel function compared with control. This 
resulted in both HD lines producing more cells capable of firing induced action potentials at 
week 1. However, from week 1 to 2 the control cells exhibited an appreciable increase in 
both Na+ and K+ current densities, by contrast Na+ and K+ currents in the Q60 and Q180 lines 
had remained static and declined, respectively. This meant no appreciable differences in 
terms of Na+ current (-67.9±12.3 pA∙pF-1 (n = 13) in the control line, -40.9±9.7 pA∙pF-1 (n = 
19) in the Q60 line and -48.3±23 pA∙pF-1 (n = 8) in the Q180 line) and K+ current (64.2±12.9 
pA∙pF-1 (n = 13) in the control line, 52.9±7.4 pA∙pF-1 (n = 19) in the Q60 line and 70.9±22 
pA∙pF-1 (n = 8) in the Q180 line, figure 6.1 E and F) were observed. Interestingly, despite 
relatively similar mean Na+ and K+ currents a significant deficit in the proportion of HD cells 
able to fire induced action potentials was observed. This appeared to have been as a result 
of what few cells in the HD lines had Na+ and K+ were large enough for action potential 
generation, but many cells showed neither and were therefore not excitable.  
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Figure 6.2: Resting membrane potential and spontaneous activity in neurons differentiated 
from the HD lines. 
A) A graph showing the mean resting membrane (±SEM) in the control (Q33), Q60 and Q180 
lines over 3 weeks of differentiation using the standard differentiation protocol. 
B) An exemplar voltage recording (whilst I=0) showing a spontaneous action potential from a 
week 2 Q60 neuron.  
C) A bar graph showing the proportion of cells (%) firing spontaneous action potentials in the 
control (Q33), Q60 and Q180 lines over 3 weeks of differentiation using the standard 
differentiation protocol. 
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To be an effective model of Huntington’s disease in a dish these cells must behave like cells 
in vivo, which means being more than just able to fire action inducible action potentials but 
firing them spontaneously in response to synaptic input. However, in both the control and 
HD lines very low rates of spontaneous activity are observed. The control cells showed no 
spontaneous activity at week 1 (n = 20), but reached their most spontaneously active at 
week 2 (23.5% (n = 17)) and then declined in week 3 (11.8% (n = 17), 6.2B and C). By 
contrast, both HD lines showed spontaneous activity at week 1 (14.3% (n = 14) and 20% (n = 
15) in the Q60 and Q180 lines respectively, P<0.05, Chi2>3). At week 2 however, the Q180 
cells lost all spontaneous activity (n = 11, P<0.05, Chi2=2.4 compared to control) and were 
dead by week 3 (figure 6.2C). The Q60 line maintained a low level of spontaneous activity at 
all 3 weeks (14.3% (n = 14), 10% (N = 30) and 13.3% (n = 15) at weeks 1, 2 and 3, 
respectively, figure 6.2 B and C). This supports the notion that the high repeat line, Q180, 
started with a rapidly accelerated development and then declined. However, this also 
presents a problem for modelling the disease using these lines, there is no one time point 
where all 3 lines show a significant or consistent level of functional maturity. 
Key to firing spontaneous action potentials is the ability to maintain a polarised resting 
membrane potential. The membrane potential must be sufficiently polarised to remove the 
inactivation of voltage activated Na+ channels, leaving a large enough pool of closed and not 
inactivated Na+ channels which can respond to a depolarisation. The control neurons 
showed a steady hyperpolarisation of their membrane potential across all 3 weeks from 
very depolarised at weeks 1 and 2 (-36.8±3.7 mV (n = 21) and -37.6±3 mV (n = 25) at week 1 
and 2 respectively) to being relatively hyperpolarised at week 3 (-43.5±3.4 mV (n = 15), 
figure 6.2A). The Q60 line derived cells showed very similar membrane potentials to control 
across all weeks (-40.5 ± 5.5 mV (n = 16 at week 1, -32 ± 3.2 mV (n = 11) at week 2, and -43.5 
±3.5 (n = 15), figure 6.2 A). Compared to a neuron in vivo, and more importantly the 
inactivation voltages of Na+ channels these membrane voltages are too depolarised, and will 
not leave a significant pool of Na+ channels ready for an action potential. Curiously however, 
it is at week 2 where most spontaneously active control neurons were observed, but the 
resting membrane potential was most hyperpolarised at week 3. The Q180 line at week 1 
showed a hyperpolarised resting membrane potential (-46.7±2.9 (n = 16), P<0.05, Mann-
Whitney-U = 90.5). However, still depolarised compared to in vivo, but sufficiently 
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hyperpolarised compared to the inactivation voltages of voltage gated Na+ channels to allow 
action potential generation, as discussed in chapter 3. At week 2, the Q180 line showed a 
declining resting membrane potential that could not support spontaneous activity, and then 
died at week 3.  
In addition to voltage activated Na+ and K+ channels, neurons also express voltage activated 
Ca2+ channels. These channels function in many ways as a link between electrophysiological 
function and molecular function, for example regulating gene expression, vesicular release 
at synapses and cytoskeletal modifications. A voltage ramp protocol with high Ba2+ solution 
was used to measure and identify voltage activated Ca2+ channels; from a holding of -70mV, 
the voltage was stepped down to -120mV which then continuously ramped to +60mV over 
1s, which separated the voltage activated Na+ and Ca2+ currents. An inward current 
observed from around -30mV during the voltage ramp that significantly gained magnitude in 
the BaCl2 solution was taken to be a voltage activated Ca
2+ current.  
 
Figure 6.3: Voltage activated Ca2+ currents and GABA evoked currents in neurons 
differentiated from the HD lines. 
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A) An exemplar current against voltage plot for evoked voltage activated Ca2+ channel 
current during a voltage ramp protocol and enhanced by the addition of Ba2+ions from a 
week 2 Q60 neuron.  
B) A bar graph showing the portion of cells (%) with significant voltage gated Ca2+ currents in 
the control (Q33), Q60 and Q180 lines over 3 weeks of differentiation using the standard 
differentiation protocol. 
C) An exemplar current recording during voltage clamp whilst being held at -70mV, a GABAA 
current was evoked by a 5s addition of 300 µM GABA marked above from a week 2 Q60 
neuron. 
D) A bar graph showing the portion of cells (%) with significant GABA evoked currents in the 
control (Q33), Q60 and Q180 lines over 3 weeks of differentiation using the standard 
differentiation protocol. 
 
The control cells showed no voltage (n = 11) activated Ca2+ currents at week 1 that were 
large enough for measurement using this method, this increased significant at week 2 
(22.2% (n = 9), figure 6.3B) and again at week 3 (42% (n = 12)). In contrast, both of the HD 
lines showed a significant number of cells with Ca2+ currents by week 1, and most especially 
in the Q180 line (50% (n = 8, P<0.01, Chi2=7.2) in the Q60 line and 100% (n = 8, P<0.001, 
Chi2=19) in the Q180 line, figure 6.3B). This increase was maintained at week 2 in the Q60 
line (57% (n = 14), P<0.05, Chi2=2.7) and the Q180 line had declined (from 100% to 50% (n = 
8)). At week 3 the Q60 line showed a slightly increased proportion of cells showing Ca2+ 
currents, but the control cells had essentially caught up, and there was no significant 
difference between the lines (42% (n = 12) and 72% (n = 11), ns).  
In addition to voltage activated ion channels a neuron must also be responsive to 
neurotransmitters, showing functional ligand gated ion channels. GABA is an early-
expressed neurotransmitter and key to striatal function. Both the control and the Q60 lines 
showed significant functional GABAA currents by week 1 (60% (n = 15) in control and 90% (n 
= 10) in the Q60 line, P=0.0505 Chi2=2.7, figure 6.3D). This increased to almost all cells in 
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both the Q60 and control lines by week 2 (100% (n = 10) in control and 92.8% (n =  14) in the 
Q60 line in the control), which continued to week 3 (92% (n = 13) in control and 100% (n = 
11) in the Q60 line). In contrast, the Q180 line showed virtually no GABA currents during the 
two weeks they survived (11.1% (n = 9) and 16.7% (n = 6) at week 1 and week 2 respectively, 
P<0.05, Chi2>3.2, figure 6.3D). This implies a functional abnormality with either the Q180 
line specifically, or which occurs with extremely high CAG repeats. 
These data demonstrate that all although these 3 are fundamentally capable of generating 
cells which exhibit basic neuronal electrophysiological features, there are serious potential 
limitations to using these cells as a disease model. Firstly, the extent of functional 
maturation is very limited, resulting in few spontaneously active cells and a culture of 
neurons which do not favourably compare to in vivo. Secondly, the profile of functional 
maturation in many aspects is wildly different for each line across the 3 week protocol, 
meaning there is no time point where a comparison could be drawn for disease modelling 
with similarly functional neurons.  
 
Astrocyte conditioned medium and Huntington’s disease iPS derived 
neurons. 
Using the control (Q33) line in chapter 3 and ACM, cultures of neurons were generated with 
significantly enhanced functional properties. Ideally this protocol should be transferable to 
all 3 lines, producing functionally mature neurons at week 3 for disease modelling. 
Therefore the HD lines were also treated with mouse ACM developed using the same 
protocol as in chapter 3, except with a physiological Ca2+ concentration in the medium 
(1.2mM instead of 0.6).  
Interestingly, both of the HD derived lines showed with immediate up-regulation in Ca2+ 
channel expression, which was also observed in the control line when treated with ACM. 
Consistent with the findings of chapter 4 the HD lines, especially the Q180 line, exhibited a 
short term functional enhancement in terms of spontaneous and induced action potential 
generation, and resting membrane potential. The short term nature of this enhancement 
was entirely consistent with artificial manipulation of Ca2+ influx using increased Ca2+ 
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concentration in the medium and the addition of GABA and found to be essentially as a 
result of the nature of GABA signalling becoming inhibitory over excitatory. However, 
although ACM acts in part by increasing the magnitude of an endogenous Ca2+ influx-
dependant mechanism for functional maturation, its effects are sustained and presumably 
not limited by GABA signalling. The mechanism by which the HD cells exhibit an initial 
functional benefit is most likely as a result of their increased Ca2+ channel function,  it is less 
clear though what causes the functional decline. Firstly, the two HD lines demonstrate very 
different developmental profiles. Both lines are initially accelerated and show a plateaux or 
decline at week 2, but at week 3 the Q60 line retained some function whereas the Q180 line 
died entirely. It is entirely probable that the Q60 line reached a functional plateaux as a 
result of the GABA switch, however few of the Q180 cells exhibited ionotropic GABA 
responses. In the case of the Q180 line it is perhaps more plausible that their decline is as a 
result of selective apoptotic loss of maturing neurons. Therefore, it appears perhaps more 
plausible that ACM-treatment would be effective on the Q60 line, but perhaps less so with 
the Q180 line.  
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Figure 6.4: The electrophysiological properties of ACM-treated Q60 neurons. 
A) An exemplar voltage recording (top) showing an induced action potential during a current 
step protocol (bottom) from a control Q60 neuron at week 3.  
B) A bar graph showing the proportion of cells able to fire and induced action potentials 
during a current step protocol, from Q60 neurons treated with both control medium and 
ACM. 
C) Exemplar voltage recording during current clamp (I=0) showing spontaneous action 
potentials from a week 3 control-treated Q60 neuron. 
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D) Exemplar voltage recording during current clamp (I=0) showing spontaneous action 
potentials from a week 3 ACM-treated Q60 neuron. 
E) A bar graph showing the portion of cells (%) firing spontaneous action potentials in the 
Q60 line over 3 weeks of differentiation using the standard differentiation protocol and 
ACM. 
F) A graph showing the mean resting membrane potential of Q60 neurons treated with both 
control medium and ACM over all 3 weeks of differentiation. 
 
Both HD lines were cultured with ACM-treatment using a protocol similar to chapter 3. 
However, the Q180 line showed insufficient survival at even week 1 to conduct the 
experiments. Therefore, only the Q60 line could be assessed electrophysiologically over all 3 
weeks of differentiation. Like ACM treatment with the control line, no effect on the most 
basic neuronal electrophysiological phenotype was observed, the ability to fire an action 
potential. In contrast to the Q33 cells analysed in chapter 3, a slower increase to the 
majority of cells able to fire induced action potentials was observed, starting with roughly 
half in week 1 (50% (n = 10) vs. 44% (n = 18) with ACM) and week 2, (55.6% (n = 18) vs. 59% 
(n = 17) with ACM) increasing to the majority at week 3 (100% (n = 13) vs. 100%(n = 6) with 
ACM, figure 6.4B).  
However, consistent with the notion that ACM improves the extent of functional maturation 
but does not accelerate it, a significant increase in the portion of cells firing spontaneous 
action potentials at week 3 (13.3% (n = 15) vs. 50% (n = 6) with ACM, P<0.05, Chi2=3.9, 
figure 6.4E). This correlated with a slightly more polarised membrane potential developed 
with ACM treatment at week 3 (-44.4±3.6 mV (n = 18) vs. -51.7±6.1 mV (n = 6) in ACM, 
P<0.05, Mann Whitney U = 13.5, figure 6.4F). Also consistent with mouse ACM used in the 
Q33 (control) cells, a few of the Q60 ACM-treated cells exhibited biphasic resting membrane 
potentials (33% (n = 6), 6.4C vs D) and enhanced rates of spontaneous activity. 
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GABA and Ca2+ differentiation protocol and HD iPS cell-derived neurons: 
As discussed in the specific methods for this chapter an entirely new protocol was 
investigated, integrating advances in reprogramming, neuralisation and terminal 
differentiation. Additionally, a second childhood onset HD line (Q109) was incorporated for 
comparison with the Q180 line which had shown survival issues and very altered functional 
maturation in previous experiments. Also, amongst these changes, the glutamate 
concentration in the medium was reduced, which may help to alleviate the survival 
problems previously observed in the Q180 line. Using this new protocol as a control the 
functional benefits of using GABA and increased Ca2+ in the medium (from 1.2mM to 
1.8mM) were assessed, based on data from chapter 5. The hypothesis that a combination of 
GABA and Ca2+ could accelerate and enhance functional maturation, resulting in an early 
time point which showed consistently mature neurons across all, or most lines.  Therefore, 
cells from all 4 lines (Q33 (control), Q60, Q109 and Q180) were differentiated in the new 
control medium (using the advanced protocol) and with both 300 µM GABA and 0.6 mM 
Ca2+ added to the medium (resulting in 1.8 mM Ca2+), this medium is further referred to as 
the GABA + Ca2+ medium.  
At week 1,  the GABA + Ca2+ medium evoked a significant increase in the proportion of cells 
able to fire action potentials across genotypes, other than the Q180 line (100% (n = 8, 
P<0.01, Chi2=7.3) in the Q33 line, 88% (n = 8, P<0.05, Chi2=3.4) in Q60 line, 100% (n = 9, 
P<0.05, Chi2=2.9) in the Q109 line and 92% (n = 13, ns) in the Q180 line) compared to 
control (40% (n = 10) in the Q33 line, 44% (n = 9) in the Q60 line, 73% (n = 15) in the Q109 
line and 82% (n = 11) in the Q180 line, figure 6.5B). Further, a similar increase in the rates of 
spontaneous activity in the GABA + Ca2+ medium was observed (25% (n = 8, P<0.05, Chi2= 
2.8) in the Q33 line, 33% (n = 9, P<0.05, Chi2=3.6) in the Q60 line, 41% (n = 12, P<0.05, 
Chi2=4.7) in the Q109 line, 31% (n = 13, ns) in Q180 line), compared to control (0% (n = 10) in 
the Q33 line, 0% (n = 9) in the Q60 line, 7% (n = 15) in the Q109 line and 18% (n = 11) in the 
Q180 line, figure 6.5E). This correlated with a hyperpolarisation of the resting membrane 
potential evoked by the GABA + Ca2+ medium (-45.1±4.5 mV (n = 8) in the Q33 line, -
44.7±3.2 mV (n = 9) in the Q60 line, -47.4±3.2 mV (n = 12) in the Q109 line and -47.0±2.4 mV 
(n = 13) in the Q180 line) compared to control (-31.1±4.2 mV (n = 10) in the Q33 line, -
36.5±2.5 mV (n = 9) in the Q60 line, -41.5±4.3 mV (n = 15) in the Q109 line and -38.8±2.8 mV 
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(n = 11) in Q180 line, figure 6.5F). By week 2, the control cells had caught up with the GABA 
and Ca2+ treated cells with regards to inducible activity, in the GABA + Ca2+ medium (88% (n 
= 9, ns) in the Q33 line, 86% (n = 7, ns) in the Q60 line, 91% (n = 11, ns) in the Q109 line and 
59% (n = 12, ns) in the Q180 line) compared with control (89% (n = 9, ns) in the Q33 line, 
100% (n = 10, ns) in the Q60 line, 100% (n = 8, ns) in the Q109 line and 28% (n = 7, ns) in the 
Q180 line, figure 6.5B). However, in terms of spontaneous activity the GABA + Ca2+ medium 
still evoked an increase (55% (n = 11, P<0.05, Chi2= 3.3) in the Q33 line, 40% (n = 10, ns) in 
the Q60 line, 75% (n = 8, P<0.05, Chi2=5.1) in the Q109 line, 14% (n = 7, ns) in the Q180 line) 
compared to control (25% (n = 12) in the Q33 line, 13% (n = 8) in the Q60 line, 30% (n = 10) 
in the Q109 line and 8% (n = 12) in the Q180 line, figure 6.5E). This correlated with a 
continued hyperpolarisation of the resting membrane potentials in the GABA + Ca2+ medium 
(-51±3.1 mV (n = 11) in the Q33 line, -48.7±5.2 mV (n = 10) in the Q60 line, -59.4±4.6 mV (n = 
8) in the Q109 line and -35.3±7 mV (n = 7) in the Q180 line) compared with control (-
39.1±2.7 mV (n = 12) in the Q33 line, -37±5.2 mV (n = 8) in the Q60 line, -43.4±4 mV (n = 10) 
in the Q109 line and -34.5±2.5 mV (n = 12) in the Q109 line, figure 6.5FC). However, 
specifically the highest repeat line, the Q180 line showed diminished spontaneous activity 
and a more depolarised membrane potential. Into week 3 and apart from in the Q180 line, 
almost all cells were still able to fire action potentials in the GABA + Ca2+ medium (100% (n = 
8) in the Q33 line, 100% (n = 10) in the Q60 line, 83% (n = 6) in the Q109 line and 66% (n = 3) 
in the Q180 line) and control (90% (n = 10) in the Q33 line, 86% (n = 7) in the Q60 line, 100% 
(n = 7) in the Q109 line and 25% (n = 4) in the Q180 line, figure 6.5BA). The Q33, Q60 and 
Q109 lines also still retained a significant portion of cells showing spontaneous activity at 
week 3, especially in the GABA+Ca2+ medium (50% (n = 8, ns) in the Q33 line, 57% (n = 7, 
P<0.05, Chi2=2.8) in the Q60 line, 33% (n = 6, ns) in the Q109 line and 0% (n = 4, ns) in the 
Q180 line) compared with control (33% (n = 9) in the Q33 line, 50% (n = 8) in the Q60 line, 
14% (n = 7) in the Q109 line and 0% (n = 5) in the Q180 line, figure 6.5E).  Similarly, the 
resting membrane potential of cells derived from the Q33, Q60 and Q109 lines was still 
significantly hyperpolarised although there was a smaller difference between the cells 
differentiated in the GABA + Ca2+ medium (-46.2±3.5 mV (n = 8) in the Q33 line, -48.1±2.5 
mV (n = 7) in the Q60 line, -45.2±3.1 mV (n = 6) in the Q109 line and -24.5±6 mV (n = 4) in 
the Q180 line) compared to control (-40.3±2.6 mV (n = 9) in the Q33 line, -39.8±2 mV (n = 7) 
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in the Q60 line, -40.1±1.7 mV (n = 7) in the Q109 line and -21±7.7 (n = 4) in the Q180 line, 
figure 6.5F). By contrast the Q180 line showed very significant decline at week 3, in terms of 
induced action potentials, spontaneous activity and resting membrane potential, which 
could perhaps attributed to selective loss of mature neurons from this line. 
In addition to enhancing the proportion of cells able to fire action potentials the GABA and 
increased Ca2+ also enhanced the shape of evoked action potentials. At week 1, induced 
action potentials showed immature shape, which is quantitatively compared using the area 
inside orbital plots (426 ± 59 mV2∙ms-1 (n = 6) in Q33 neurons, 790 ± 197 mV2∙ms-1 (n = 7) in 
Q60 neurons, 968 ± 208 mV2∙ms-1 (n = 7) in Q109 neurons and 868 ± 114 mV2∙ms-1 (n = 7) in 
Q180 neurons, figure 6.5C). The GABA and Ca2+ medium evoked a significant improvement 
in the shape of evoked action potentials in the Q33 and Q60 lines, but not the Q109 and 
Q180 lines (966 ± 169 mV2∙ms-1 (n = 7), P<0.01, in the Q33 line, 1349 ± 283 mV2∙ms-1 (n = 8), 
P<0.05, in the Q60 line, 1275 ± 252 mV2∙ms-1 (n = 8), ns, in the Q109 line, and 1107 ± 150 
mV2∙ms-1 (n = 8), ns, in the Q180 line, figure 6.5C).  At week 2, all of the lines apart from the 
Q180 line showed more mature action potential shapes (1898 ± 367 mV2∙ms-1 (n = 7) in the 
Q33 line, 2159 ± 340 mV2∙ms-1 (n = 8) in the Q60 line, 2221 ± 306 mV2∙ms-1 (n = 9) in the 
Q109 line, and 1034 ± 81 mV2∙ms-1 (n = 6) in the Q180 line). Further, the GABA and Ca2+ 
medium continued to enhance the shape of induced action potentials at week 2 in the Q33, 
Q60 and Q109 lines (2765 ± 466 mV2∙ms-1 (n = 7), P<0.05, in the Q33 line, 2666 ± 441 
mV2∙ms-1 (n = 9), P<0.5, in the Q60 line, 3220 ± 400 mV2∙ms-1  (n = 6), P<0.05, in the Q109 
line, and 1107 ± 150 mV2∙ms-1 (n = 5), ns, in the Q180 line, figure 6.5C). At week 3 however, 
this trend ended, resulting in no appreciable difference evoked by the GABA + Ca2+ medium 
(2310 ± 222 mV2∙ms-1 (n = 5) vs. 2571 ± 241 mV2∙ms-1 (n = 6), ns, in the Q33 line, 1957 ± 494 
mV2∙ms-1 (n = 5) vs. 2077 ± 482 mV2∙ms-1 (n = 5), ns, in the Q60 line, 1635 ± 142 mV2∙ms-1 (n 
= 5) vs. 1572 ± 115 mV2∙ms-1 (n = 5), ns, in the Q109 line), the Q180 line cultures were 
almost entirely dead by this time point (figure 6.5C).  
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Figure 6.5: Action potential generation and resting membrane potential of HD neurons 
differentiated in the new protocol, both with and without GABA and increased Ca2+. 
A) Exemplar voltage recordings (top) showing induced action potentials during a current step 
protocol (bottom), also represented as an orbital plot (graphs), for a week 2 Q33 control-
treated neuron (right) compared to a week 2 Q33 neuron treated with 300µM GABA and 
1.8mM Ca2+ (left). 
B) A bar graph showing the proportion of cells able to fire induced action potentials across 3 
weeks of differentiation treated with control medium and with the addition of 300µM GABA 
and 1.8mM Ca2+. 
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C) A bar graph comparing mean area inside orbital graphs (±SEM) which represent induced 
action potentials from neurons treated and control medium and with the addition of 300µM 
GABA and 1.8mM Ca2+. 
D) Voltage recordings during current clamp (I=0) showing spontaneous action potentials 
from Q33 neurons at week 2 treated with control medium and with the addition of 300µM 
GABA and 1.8mM Ca2+. 
E) A bar graph showing the proportion of cells showing spontaneous action potentials across 
3 weeks of differentiation in control medium and with the addition of 300µM GABA and 
1.8mM Ca2+. 
F) A bar graph showing the mean resting membrane potential (±SEM) of cells differentiated 
across 3 weeks of differentiation in control medium and with the addition of 300µM GABA 
and 1.8mM Ca2+. 
 
Consistent with the observation that the proportion of cells able to fire action potentials 
and the shape of induced action potentials, the GABA + Ca2+ medium also enhanced 
functional Na+ and K+ currents during the course of development.  At week 1, Na+ currents 
were significantly enhanced in the Q33 and Q60 lines in the GABA + Ca2+ medium (-27.7 ± 
2.5 pA∙pF-1 (n = 8) vs. -45 ± 6.3 pA∙pF-1 (n = 8), P<0.05, in the Q33 line, -32.9 ± 6.3 pA∙pF-1 (n = 
8) vs. -46.3 ± 7 pA∙pF-1 (n = 8), P<0.05, in the Q60 line, -50.4 ± 9.5 pA∙pF-1 (n = 9) vs. -45.3 ± 
8.6 pA∙pF-1 (n = 8), ns, in the Q109 line, and -42.8 ± 6.4 pA∙pF-1 (n = 7) vs. -39.5 ± 3.6 pA∙pF-1 
(n = 8), ns, in the Q180 line, control followed by GABA+ Ca2+ in each case, figure 6.6B). 
Similarly, the magnitude of K+ currents were also augmented in the Q33 and Q60 lines at 
week 1 (21.5 ± 2.9 pA∙pF-1 (n = 8) vs. 45.5 ± 7.9 pA∙pF-1 (n = 8), P<0.05, in the Q33 line, 27.9 ± 
5 pA∙pF-1 (n = 8) vs. 39 ± 6.1 (n = 8), P<0.05, in the Q60 line, 39.6 ± 8.3 pA∙pF-1 (n = 8) vs. 49.7 
±11.1 pA∙pF-1 (n = 8), ns, in the Q109 line, 38.2 ± 7.7 pA∙pF-1 (n = 7) vs. 43.6 ± 5.3 pA∙pF-1 (n = 
8), ns, in the Q180 line, control followed by GABA+ Ca2+ in each case, figure 6.6C). At week 2, 
Na+ currents were significantly enhanced in the Q33, Q60 and Q109 lines in the GABA + Ca2+ 
medium (-67.6 ± 6.7 pA∙pF-1 (n = 8) vs. -84.3 ± 10.2 pA∙pF-1 (n = 8), P<0.05, in the Q33 line, -
66.1 ± 6.7 pA∙pF-1 (n = 8) vs. -87.5 ± 7.7 pA∙pF-1 (n = 8), P<0.05, in the Q60 line, -62.1 ± 7.4 
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pA∙pF-1 (n = 9) vs. -94.9 ± 6.8 pA∙pF-1 (n = 8), P<0.05, in the Q109 line, and -43.5 ± 3.5 pA∙pF-1 
(n = 6) vs. -42.2 ± 5 pA∙pF-1 (n = 7), ns, in the Q180 line, control followed by GABA+ Ca2+ in 
each case, figure 6.6B). Similarly, the magnitude of K+ currents were also augmented in the 
Q60 and Q109 lines at week 2 (59.6 ± 10 pA∙pF-1 (n = 8) vs. 76.8 ± 13 pA∙pF-1 (n = 8), ns, in 
the Q33 line, 51.5 ± 9.3 pA∙pF-1 (n = 8) vs. 81.2 ± 12.5 (n = 8), P<0.05, in the Q60 line, 60.5 ± 
9.3 pA∙pF-1 (n = 9) vs. 79.7 ± 3.9 pA∙pF-1 (n = 8), P<0.05, in the Q109 line, 41.7 ± 5.3 pA∙pF-1 (n 
= 6) vs. 43.6 ± 5.3 pA∙pF-1 (n = 7), ns, in the Q180 line, control followed by GABA+ Ca2+ in 
each case, figure 6.6C). At week 3, no significant alteration of the  Na+ currents were 
observed in the GABA + Ca2+ medium (-73.3 ± 2.2 pA∙pF-1 (n = 7) vs. -79.6 ± 9.2 pA∙pF-1 (n = 
7), ns, in the Q33 line, -80.6 ± 6.2 pA∙pF-1 (n = 8) vs. -78.7 ± 10.8 pA∙pF-1 (n = 8), ns, in the 
Q60 line, -56.2 ± 3.8 pA∙pF-1 (n = 7) vs. -59 ± 4.7 pA∙pF-1 (n = 7), ns, in the Q109 line, and -13 
pA∙pF-1 (n = 1) vs. -22 ± 10 pA∙pF-1 (n = 2), ns, in the Q180 line, control followed by GABA+ 
Ca2+ in each case, figure 6.6B). Similarly, no alteration in the magnitude of K+ currents was 
observed (76 ± 15.5 pA∙pF-1 (n = 7) vs. 73.1 ± 11.2 pA∙pF-1 (n = 7), ns, in the Q33 line, 88.5 ± 
14 pA∙pF-1 (n = 7) vs. 72.3 ± 10.9 (n = 7), ns, in the Q60 line, 44.5 ± 3.9 pA∙pF-1 (n = 7) vs. 
41.8 ± 3.1 pA∙pF-1 (n = 7), ns, in the Q109 line, 10 pA∙pF-1 (n = 1) vs. 18.5 ±  3.5 pA∙pF-1 (n = 
2), ns, in the Q180 line, control followed by GABA+ Ca2+ in each case, 6.6C). 
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Figure 6.6: Voltage activated Na+ and K+ currents evoked in neurons differentiated in the HD 
lines using the new protocol, and with the addition of GABA and increased Ca2+. 
A) Exemplar current recordings from a week 2 control Q33 neuron (top) showing voltage 
activated Na+ and K+ currents evoked by a voltage step protocol (bottom), and represented 
as a current density against step voltage graph for both currents (Na+ as circles and K+ as 
squares, left). 
B) A bar graph comparing the mean magnitude (±SEM) of voltage activated Na+ currents 
across all 3 weeks of differentiation, in control medium and with the addition of 300µM 
GABA and 0.6mM CaCl2.  
C) A bar graph comparing the mean magnitude (±SEM) of voltage activated K+ currents 
across all 3 weeks of differentiation, in control medium and with the addition of 300µM 
GABA and 0.6mM CaCl2.  
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Figure 6.7: Voltage activated Ca2+ and GABAA currents evoked in neurons differentiated in 
the HD lines using the new protocol, and with the addition of GABA and increased Ca2+. 
A) Exemplar current recording during a voltage ramp protocol showing a voltage activated 
Ca2+ current from a week 2 Q33 neuron treated with 300µM GABA and 0.6mM CaCl2. 
B) Exemplar current recording with a 5s application of 300µM GABA whilst being held at -
70mV, from a week 2 Q33 neuron treated with 300µM GABA and 0.6mM CaCl2. 
C) A bar graph showing the proportion of cells with significant voltage activated Ca2+ 
currents across 3 weeks of differentiation in the new small molecule differentiation, and with 
the addition of 300µM GABA and 0.6mM CaCl2. 
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D) A bar graph showing the proportion of cells with significant GABA evoked currents across 
3 weeks of differentiation in the new small molecule differentiation, and with the addition of 
300µM GABA and 0.6mM CaCl2. 
 
Further, the hypothesis that the GABA and Ca2+ medium would increase the functional 
GABAA and Ca
2+ currents across these lines was tested. At week one, consistent with data in 
the previous differentiation medium an increase the function of Ca2+ channels with lines 
with increasing CAG repeats was observed (0% (n = 8) in the Q33 line, 38% (n = 8) in the Q60 
line, 88% (n = 14) in the Q109 line and 90% (n = 10) in the Q180 line, figure 6.7B). No 
appreciable difference in the function of Ca2+ channels was evoked by the GABA + Ca2+ 
medium at week 1 (28% (n = 7) in the Q33 line, 50% (n = 8) in the Q60 line, 100% (n = 8) in 
the Q109 line and 85% (n = 13) in the Q180 line, figure 6.7B). However, at week 2, the Q33 
and Q60 lines showed an increased proportion of cells with Ca2+ channels, which was 
increased further by the GABA + Ca2+ medium (82% (n = 11, P<0.05, Chi2=4.7) in the Q33 
line, 90% (n = 10, P<0.05, Chi2=3.8) in the Q60 line, 100% (n = 8, ns) in the Q109 line and 
50% (n = 6,ns) in the Q180 line) compared to control (36% (n = 11) in the Q30 line, 50% (n = 
10) in the Q60 line, 80% (n = 10) in the Q109 line and 50% (n = 6) in the Q180 line, figure 
6.7B). In contrast the Q180 line showed fewer cells with Ca2+ currents at week 2. Into week 
3 and no appreciable difference was observed between the Q33, Q60 or Q109 lines, or with 
the application of GABA and Ca2+ (75% (n = 8, ns) in the Q33 line, 71% (n = 7, ns) in the Q60 
line, 67% (n = 7, ns) in the Q109 line and 0% (n = 3, ns) in the Q180 line in the Q33, Q60, 
Q109 and Q180 lines respectively) compared to control (66% (n = 9) in the Q33 line, 58% (n 
= 7) Q60 line, 57% (n = 7) Q109 line and 0% (n = 3) in the Q180 line, figure 6.7B). By contrast 
the Q180 line showed continuing decline. 
No significant differences in the proportion of cells showing functional GABA-evoked 
currents in the GABA+Ca2+ medium compared with control was observed at any week in 
most of the lines, the one exception being the Q180 line at week 1 (Week 1: 50% (n = 8) vs. 
71% (n = 7) in the Q33 line, 88% (n = 9) vs. 77% (n = 9) in the Q60 line, 92% (n =  13) vs. 100% 
(n =  8) in the Q60 line, 20% (n = 10) vs. 69% (n = 13, P<0.001, Chi2=5.5) in the Q180 line; 
Week 2: 100% (n = 6) vs. 86% (n = 7) in the Q33 line, 100% (n = 7) vs. 90% (n = 10) in the Q60 
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line, 100% (n = 10) vs. 100% (n = 8) in the Q109 line and 10% (n = 10) vs. 17% (n = 6) in the 
Q180 line; Week 3: 89% (n = 9) vs. 100% (n = 9) in the Q33 line, 100% (n = 7) vs. 100% (n = 7) 
in the Q60 line, 83% (n = 6) vs. 50% (n = 6) in the Q109 line and 0% (n = 3) vs. 0% (n = 3) in 
the Q180 line (control followed by GABA + Ca2+ for each), figure 6.7C). Consistent with 
findings in the standard differentiation an increase in the number of cells with GABAA 
currents in the Q60 and Q109 lines was observed compared to Q33. The Q180 lines again 
showed very few cells with GABAA currents which was ameliorated by the GABA and Ca
2+ 
medium at week 1, but then declined to almost none in week 2 and 3 similar to the Q180 
line in the control medium. By week 2, and continuing into week 3 almost all of the cells 
from the other 3 lines showed functional voltage activated GABAA currents.   
In answer to the hypotheses set, the GABA and Ca2+ added to the medium did result in a 
more mature and consistent electrophysiological phenotype, especially at week 2. At this 
week cells of all 3 genotypes exhibited consistently hyperpolarised membrane potentials, 
almost all cells able to fire inducible action potentials, significant Ca2+ currents, significant 
GABAA currents, and crucially, a significant proportion of cells firing action potentials 
spontaneously. As an exception, the Q180 line consistently showed a deteriorating function 
following week two, which was not seen in even the other childhood onset line, the Q109s. 
However, this could simply be a reflection of the extreme severity of 180 CAG repeats. 
These data suggest that manipulation of Ca2+ influx with GABA and additional Ca2+, or 
perhaps using Bay K8644, it is possible to functionally enhance neurons for an iPS cell-
derived model for Huntington’s disease whilst retaining a defined protocol. Further, 
combining these protocol developments with other technological advances in iPS 
reprogramming, neuralisation and differentiation it is possible to produce cultures of 
neurons across multiple disease-lines which are consistently somewhat mature at a set time 
point. Although this technology has yet to provide enriched cultures of medium spiny 
neurons, and which are as fully functional as in vivo. 
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Chapter 7: Overall discussions: 
 
Astrocyte conditioned medium and electrophysiological function: 
Astrocyte conditioned medium (ACM) was used as a tool for transferring a complete mixture 
of astrocyte secreted factors as a strategy for enhancing the differentiation of iPS cell-
derived neurons in a short protocol. The hypothesis that this cocktail of factors would 
accelerate the functional development of iPS cell-derived neurons and result in an 
electrophysiological phenotype which compares better to that seen in vivo was tested. 
Firstly, ACM did not accelerate the development of the fundamental machinery required to 
generate an action potential. At week 1, both the ACM treated and control cells showed 
very similar peak voltage activated Na+ and K+ currents that were too small to deliver action 
potentials with a mature shape. Therefore, at week 1 both cultures showed induced action 
potentials that were slow, with very little overshoot above 0 mV or undershoot below the 
threshold voltage. This also resulted in no cells at week eliciting a second abortive, or 
complete, action potential. From week 1 to 2, both ACM treated and control medium 
appreciably increased the magnitude of their Na+ and K+ currents which produced faster 
induced action potentials with limited attempts at producing a second action potential, as 
the K+ current was now significant enough result in the voltage undershooting the threshold 
voltage significantly. Additionally by week 2, the ACM treated cells showed sharper action 
potential shapes than control, which correlated with an increase in cells showing abortive 
second action potentials in ACM. This improvement correlated with an increase in Na+ 
current in the ACM treated cells at week 2. However, at week 3 an increased K+ current was 
observed in the control cells over the ACM treated cells. More surprisingly, and incongruous 
with the notion that action potential shape is entirely determined by the magnitude of Na+ 
and K+ currents, more mature and faster action potentials were actually seen in the ACM 
treated neurons at week 3, of which most cells fired a second full action potential instead of 
an abortive attempt.  
Key to our initial hypothesis that ACM could evoke significantly more functional neurons in 
this short protocol, was the observation that the ACM evoked a remarkable increase in 
spontaneous activity by week 3. At week 3 most of the ACM-treated cells showed high rates 
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of spontaneous activity in short bursts at the top of the up-states of a biphasic membrane 
potential. This activity is far more reminiscent of the activity expected of neurons in vivo or 
recorded ex vivo in slices of neuronal tissue, including medium spiny neurons of the striatum 
176. Multiple parameters of excitability were examined including the threshold for action 
potentials, voltage dependent profiles for the voltage activated Na+ current (in terms of 
both Na+  activation profile and action potential threshold), membrane input resistance, 
membrane capacitance and resting membrane potential. No appreciable changes in the 
threshold voltage, input resistance, membrane capacitance or voltage dependant profiles 
for activation or inactivation of the Na+ current were observed. Only the resting membrane 
potential of ACM-treated neurons showed a significant difference compared to the control 
cells, a hyperpolarisation of the membrane potential evoked by ACM correlated temporally 
with the enhanced levels of activity. The resting membrane potential was significantly more 
polarised at all weeks in ACM-treated cells. However at week 3, this difference was 
particularly large. This suggests that the resting membrane potential enabled increased 
spontaneous activity by removing the inactivation of voltage activated Na+ currents. This 
notion is supported by comparing the mean resting membrane potential of control and 
ACM-treated cells with the voltage dependant profile for inactivation of the Na+ current for 
these cells. Additionally, the biphasic membrane potential of these cells means that prior to 
the bursts of action potentials initiated at the start of the up-state, the down-state voltage is 
further hyperpolarised than the mean resting membrane potential. This provides a best of 
both voltages situation, where the down-state removes the inactivation of the Na+ current 
and the up-state brings the membrane voltage very close to the threshold voltage for an 
action potential. Examining the voltage dependant profiles for activation and inactivation of 
these cells Na+ current, showed these relationships to be highly consistent with the activity 
of Nav1.2 channels, and not Nav1.6 167. This is interesting, because even with the enhanced 
membrane potential observed in ACM-treated cells, Nav1.6 would be functionally impotent 
as these channels would be mostly inactivated at the resting membrane potential.  
The resting membrane potential alone does not appear to entirely explain the complete 
contrast in spontaneous activity observed in ACM-treated neurons compared with control. 
Firstly, although cells showing more hyperpolarised membrane potentials from the control 
cultures did show spontaneous activity, these were disperse individual events and no 
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biphasic membrane potentials were observed. This implies another electrophysiological 
development in ACM-treated cells. The biphasic membrane potential appears to provide a 
very plausible explanation, where the down-state reduces Na+ inactivation, followed by the 
up-state which brings the voltage very close to the threshold for an action potential. Studies 
agree that biphasic membrane potentials in medium spiny neurons of the striatum are 
orchestrated and limited by the collective depolarising currents form glutamatergic synaptic 
drive and the repolarising M-channel K+ currents 176,209. However, when recording the 
synaptic input of ACM-treated cells relatively few cells with spontaneous EPSCs or IPSCs 
were observed.  This is still in contrast to the control-treated cells, where no spontaneous 
synaptic currents were observed at all. However, it may be possible that these biphasic 
membrane potentials were actually led by a GABAergic drive. Using Ca2+ imaging, a 
significant switch to inhibitory GABA responses was observed by even week 2. However, 
during patch clamp experiments GABA stimulation is always excitatory, regardless of 
developmental stage, because the patch solutions used ensured a Cl- reversal potential near 
to 0mV. The notion that spontaneous activity and the biphasic membrane potentials are 
driven by GABAergic drive is supported by the data showing bicuculline sensitive 
spontaneous synaptic currents in the week 3 ACM cells. It is also notable that although 
these membrane potentials were highly polarised compared to the control iPS-derived 
neurons, they were still relatively depolarised compared to neurons in vivo. As an 
alternative explanation, could the slow activation of T-type Ca2+ channels within this voltage 
range be an alternative explanation for a biphasic membrane potential? In which case these 
biphasic membrane potentials are as a result of a mechanism more similar to thalmic 
neurons, but in the absence of the competing voltage regulatory action of glutamatergic and 
GABAergic synaptic input 43. However, at present the pharmacological tools used for T-type 
Ca2+ channel blockade, mainly mibedrafil, are not selective enough to test this hypothesis.  
A significant increase in the function of voltage activated Ca2+ channels was also observed in 
ACM-treated cells, right from week 1. Further characterisation revealed that L-, N- and R-
type Ca2+ channels were specifically up-regulated. This temporal increase did not correlate 
well with the enhanced spontaneous activity in ACM and the control treated cells did catch 
up in terms of voltage activated Ca2+ channel function by week 3. However, this represents a 
significant functional development since voltage activate Ca2+ channels are crucial to linking 
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electrophysiological activity to multiple other cell-processes, including gene expression, cell-
skeletal remodelling, synaptic plasticity and even synaptic vesicular secretion 15,45,157,207. 
Both N- and L-type Ca2+ channels are present on neurite outgrowths and are likely to play a 
role in orchestrating synaptic integration 202. Less is known about R-type Ca2+ channels in 
development, but they have been implicated in synaptic plasticity and are also localised to 
neurite outgrowths 211. This is however somewhat inconsistent with the lack of Nav1.6 
functional expression observed in these cells, as these Na+ channels are localised to 
dendrites and are implicated in increasing the sensitivity of dendritic membranes to action 
potential generation, somewhat like a pre-amplifier to the cell 26. This discrepancy may be 
explained by the developmental stage, the cells had not yet developed a membrane 
potential that would be able to support Nav1.6 activity, and we may reasonably speculate 
that membrane potential development and Nav1.6 expression are in some way 
synchronised. 
The increased rates of spontaneous activity atop a biphasic membrane potential and the 
recordings of spontaneous synaptic events strongly suggest the existence of functional 
synapses in ACM-treated cultures. This is functionally very important to modelling 
neurodegenerative diseases and implies the beginnings of a functional neuronal network in 
vitro. Further characterisation was performed which showed significant bicuculline 
sensitivity, indicating the presence of GABAergic synapses. This is partially consistent with 
previous work that showed that ACM or Thrombospondin-1,  was sufficient to enhance the 
development of morphologically distinct synapses  of cultured retinal ganglion cells 40. 
However, in contrast to astrocyte co-culture, and use of  hiPS derived neuronal cultures in 
ACM reported here,  the synapses in the  of cultured retinal ganglion cell cultures were 
silent, showing no post synaptic activity40.  
In addition to driving functional maturity, many reports have also shown that astrocytes 
promote neuronal survival both in vivo and by co-culture in vitro44,127. Astrocyte secreted 
factors, including neurotrophins, have also been shown to promote neuronal survival73. Wnt 
proteins are also thought to regulate neuronal differentiation and survival as well as 
synapse formation and maintenance, and are secreted by adult astrocytes 34,112,150. This is all 
consistent with the notion that astrocyte secreted factors are helping neurons to become 
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integrated synaptically, become spontaneous active and survive much longer, in part due to 
the increased activity. 
 
Induced pluripotent stem cell derived astrocytes 
In addition to the use of mouse isolated astrocytes a protocol for rapidly producing enriched 
and proliferative populations of hiPS cell-derived astrocytes was developed. Another 
intention of this protocol was to develop cultures of astrocytes in the absence of neurons, 
therefore allowing the astrocytes to be used in co-culture experiments with no risk of 
introducing new neuronal types. This could make these cultures a powerful tool for creating 
disease models which utilise a mix of wild-type and patient-derived astrocytes (or 
conditioned medium) with wild-type or patient-derived neurons. The protocol has two 
stages, and uses iPS-derived EZ-sphere cultures, as the starting cell population 56. EZ-spheres 
represent an established and easily grown and expanded source of neural progenitor cells. 
The first step was to prevent neurogenesis by killing mitotic cells during the first week by 
treating the cells with Ara-C. During the following week LIF treatment was used to induce 
astrocyte precursor development 19. Immunostaining found that by the end of the second 
week cultures were enriched in GFAP-positive cells, with no obvious population β3-tubulin 
positive neurons. However, repeating the protocol without Ara-C treatment for the first 
week yielded a somewhat enriched culture of astrocytes, albeit morphologically different, 
but also with a high concentration of differentiating neurons. This is consistent with the 
notion that for a pure population of astrocytes it is necessary to first or simultaneously 
prevent initially high rates of neurogenesis, and in this protocol we employ the strategy of 
killing cells that enter mitosis, an essential step in neurogenesis. However, astrogliogenesis 
also requires cell division, which means that using the tactic of killing mitotic cells at the 
same time as pushing astrocyte differentiation would be counterproductive. Therefore, the 
key aspect of Ara-C treatment in this protocol is timing, early neural progenitor cells are 
readily neurogenic, but due to DNA methylation of certain astrocyte genes cells are 
insensitive to astrocyte differentiating factors and unable to generate astrocytes. For 
example, despite a normal response of STAT3 phosphorylation to CNTF/LIF signalling, 
phospho-STAT3 fails to regulate GFAP gene expression  in neurogenic neural progenitors 
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due to CpG methylation within the STAT3 binding sites in the gene promoter 137. Over time, 
notch signalling, retinoic acid signalling and hypoxia inducible factor (HIF) activity participate 
to regulate the epigenetic chromatin remodelling of gliogenic genes, a process that involves 
activation of the transcription factor NFIA 6,137.  This means that neural progenitor cells are 
not immediately responsive to LIF, and not capable of making astrocytes, until NFIA 
activation has unmethylated gliogenic genes. However, by killing mitotic cells it is possible to 
prevent a population of neurons being developed. During this time the surviving neuronal 
progenitor cells become more able to produce astrocytes and responsive to astrocyte 
differentiation factors, presumably mediated by retinoic acid (AKA. vitamin A, contained in 
the B27 supplement) and hypoxia inducible factor. A one week delay in Ara-C treatment was 
sufficient to allow a highly enriched culture of GFAP positive cells without killing too many 
cells for the culture to be expanded. However, this protocol could potentially have been 
enhanced by incubation with cilliary neurotrophic factor (CNTF), changing the incubator 
oxygen concentration and altering the length of time Ara-C is used for 137,165. BMP-4 also 
promotes astrocyte differentiation, but results in a different population of astrocytes with 
less capacity for self-renewal 19,136.  
Following the first two weeks, in Ara-C followed by LIF, the iPS cell-derived astrocyte 
cultures were expanded in a foetal bovine serum (FBS) based medium. This medium is 
effective for astrocyte growth and is similar to the protocol used to expand the mouse 
astrocyte cultures. Therefore, this allowed the expansion and continued development of the 
astrocyte cultures without developing populations of neurons, because FBS based medium 
is insufficient for efficient neuronal survival and differentiation. Following a further week in 
the FBS based medium, these cells became almost entirely both GFAP and S100β (a more 
mature astrocyte marker) positive and could be expanded for at least 8 weeks. 
In order to test the function of the iPS cell-derived astrocytes, the same protocol for 
generating astrocyte conditioned medium as used with the mouse isolated astrocytes to 
generate conditioned medium from the iPS cell-derived astrocytes. As a primary assay for 
the effectiveness of this conditioned medium, the levels of spontaneous activity and resting 
membrane potential were measured in iPS cell-derived neurons treated with this human 
astrocyte conditioned medium and compared with control. The conditioned medium, 
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consistent with data using mouse ACM, evoked a significant hyperpolarisation of the 
membrane potential and increased rates of spontaneous activity. However, in contrast to 
differentiation using mouse ACM the development of a biphasic membrane potential was 
not observed. This developmental difference between the iPS-derived ACM and mouse ACM 
could be as a result of either the developmental stage or regional identity of the iPS cell-
derived astrocytes. Less is known about the regional specification of astrocytes compared to 
neurons. However, using LIF in the absence of BMP-4, most likely produces a population of 
astrocytes which have astrocyte progenitor traits and self-renewal, and therefore are 
perhaps not ideal for generating conditioned medium. This is consistent with the ability of 
these cultures to be passaged at least 8 times without an appreciable loss of markers. 
Treatment with BMP-4 before being used to condition medium might produce a culture 
with a larger population of more mature astrocytes 19. Another potential difference 
between these iPS cell –derived astrocytes and the mouse isolated astrocytes is that these 
human astrocytes have developed in the absence of neurons, which are known to influence 
astrocyte development 31,137,165. This may suggest that using neuron conditioned medium in 
the protocol may allow us to generate more mature iPS cell-derived astrocytes. 
This new protocol for generating iPS cell-derived astrocytes is potentially very useful for 
generating iPS cell-derived astrocytes from patient derived iPS lines. Further, the purity of 
these differentiated astrocyte cultures will allow for the easy integration of neurons and 
astrocytes differentiated from different iPS cell lines without cell-type contamination. This 
could provide a powerful tool for modelling mechanisms in neurodegenerative diseases 
within astrocytes. For example, in Huntington’s disease many studies have shown 
alterations in glutamate and release up-take by astrocytes, however these observations 
have not yet been observed using human iPS cell-derived cultures109,113,169. The ability to 
test these astrocytic functional deficits on human HD astrocytes in co-culture with wild type 
human neurons would allow studies to specifically target the mechanisms of the disease in 
astrocytes. 
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Manipulating voltage activated Ca2+ influx 
Ca2+ has numerous non-electrophysiological roles in cell signalling and can influence, for 
example gene transcription and cell morphology15. Further, L-type Ca2+ channel activity has 
been shown to exert a pro-neurogenic influence on neural progenitor cell differentiation 
and further enhance neurogenesis45.  The ACM evoked an immediate increase in the 
function of voltage activated Ca2+ channels, specifically L-, N- and R-type. This is potentially 
important, as it suggests more mature development of neurite outgrowths earlier. However, 
this also presents an activity dependant mechanism for Ca2+ influx that is amplified by 
astrocyte secreted factors, which could be implicated in activity dependant functional 
development 45,50,51. Using selective antagonists to these voltage activated Ca2+ channels in 
ACM cultures, blockade of L-, N- or R-type channels entirely blocked the development of 
spontaneous activity. This showed that all 3 channels were required for the development of 
spontaneous activity.  
Therefore, it was hypothesised that Ca2+ influx could be directly used to enhance functional 
maturation. In an attempt to directly increase Ca2+ influx, the Ca2+ concentration in the 
culture medium was increased which increased the driving force for Ca2+ across the 
membrane, allowing for larger Ca2+ currents when Ca2+ channels open. A high concentration 
(1.8mM Ca2+ ) caused acceleration in the generation of a generic neuronal phenotype with 
increased inducible activity and a hyperpolarised resting membrane potential and inducible 
activity by week 1, and further increased spontaneous activity by week 2. However, in 
contrast to ACM, by week 3 these same cultures showed a loss of spontaneous activity and 
membrane depolarisation, similar to the control cultures. 
Using subtype-specific antagonists for voltage activated Ca2+ channels, it was determined 
which channels were responsible for the accelerated and enhanced functional development 
observed with increased Ca2+ concentration in the medium.  Antagonism of P/Q type Ca2+ 
channels resulted in an inhibition of inducible activity and a slight depolarisation of the 
membrane potential at week 1, but no effects subsequently. By contrast, addition of 
antagonists to L- or N- type channels resulted in no significant loss of inducible activity and a 
slight depolarisation of the membrane at week 1. But at week 2, they significantly 
depolarised the membrane and blocked the development of all spontaneous activity. Taken 
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together, these data suggest that P/Q type Ca2+ channels could be involved in the very early 
drive from neural progenitor cells to generic neurons, but not in their functional 
development. Further supporting this notion, no significant P/Q-type currents were 
observed when fully characterised at week 1 in the control or ACM-treated cells.  By 
contrast L- and N- type channels are intimately involved in promoting the functional 
maturation of neurons, were significantly expressed at week 1 and synaptogenesis may 
require both of these channels. 
 
GABA and functional maturity 
In ACM treated cells, an increase in the functional expression of ionotropic GABA receptors 
at week 2 was observed. Ionotropic GABA receptors (GABAA) are GABA sensitive ligand 
gated chloride channels and are, therefore, inhibitory or excitatory dependant on the 
concentration gradient of chloride and the resting membrane potential. During 
development, GABA stimulation evokes an decrease in the expression of the ionic co-
transporter NKCC1, which pumps Cl- ions out of the cell, and an increase in another ionic co-
transporter, KCC2, which pumps Cl- ions into the cell (figure 7.1 B) 67.  This change in the net 
direction of Cl- transport shifts the reversal potential for chloride such that GABAA currents 
are hyperpolarising not depolarising (figure 7.1 B). Since GABA is an early excitatory 
neurotransmitter, it seemed plausible that GABA stimulation could provide an early 
depolarising stimulus for activation of voltage activated Ca2+ channels.  
The development of spontaneous activity appears dependent on the function of both L- and 
N- type Ca2+ channels. Therefore, it seems likely that they play different roles in the GABA-
dependant mechanism which drives functional maturation. L- type channels tend to be 
localised near the post synaptic membrane and cause Ca2+ influx in response to 
depolarisation, whilst N- (and P-) type channel activity mediate the release of GABA vesicles 
in response to depolarisation, and have further been shown to inhibit induced synaptic 
transmission in hippocampal excitatory synapses158. However, in the absence of a 
depolarising stimulus voltage activated Ca2+ channels remain closed, as they are gated by 
the cell membrane depolarising.  Supporting this, the addition of GABA, as an excitatory 
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stimulus in the control culture medium, was sufficient to evoke an increase in inducible 
activity and hyperpolarise the resting membrane potential of the cells, similar to that seen 
with high Ca2+. However, GABA evoked a moderate increase in spontaneous activity at week 
1, but not at week 2. This suggests GABA had initially accelerated neuronal maturation at 
week 1, to a greater extent perhaps than increased extracellular Ca2+. However, this had 
then declined by week 2, whilst increased Ca2+ did not show a decline until week 3. Further, 
blockade of GABAA channels in the high Ca
2+ medium using bicuculline had the same effect 
as the sum of blockade of P/Q-, L- and N- type channels, in that it depolarised the resting 
membrane potential, inhibited the generation of induced action potentials and blocked all 
development of spontaneous activity. This suggests a mechanism whereby N-type Ca2+ 
channels mediate GABA release from very immature synapses, resulting in a GABA elicited 
depolarisation, dependant on Ca2+ influx through L-type Ca2+ channels, which is essential for 
the functional maturation of neurons and early synaptogenesis (figure 7.1 A). This model is 
consistent with the data showing the requirement of the electrophysiological functions of N- 
and L- type Ca2+ channels and GABAA being absolutely required for the development of 
spontaneous activity. Additionally, inhibition of functional maturation, by blockade of N-
type Ca2+ channels and GABAA, could each be rescued by the addition of GABA and Bay-K (a 
potent agonist of L- type Ca2+ channels), respectively. These data further validate this model 
by showing that GABA is down stream of N-type Ca2+ channel activity and that L-type Ca2+ 
channel activity is down stream of GABAA dependant depolarisation (figure 7.1 A). Further, 
this opens a potential mechanism for the apparent plateau of functional maturity seen in 
the absence of ACM, because as soon as the GABA response becomes inhibitory then the 
GABA dependant excitation driving functional maturation will cease (figure 7.1 B and C). The 
timescale of the switch from GABA being excitatory to inhibitory in these iPS-derived 
neuronal cultures has been found to be between weeks 1 and 2, this is consistent with the 
loss of function beyond week 2 in the control and high Ca2+ treated cells. Therefore it is 
plausible that in cultures supplemented with Ca2+ or GABA, that this switch would occur 
more rapidly, and that in the presence of antagonists to L- or N- type Ca2+ channels, or 
GABAA receptors the switch would be delayed or prevented. 
  194 
 
 
  195 
 
Figure 7.1: 
A: A schematic showing a proposed mechanism for GABA evoked depolarisation evoked Ca2+ 
influx-dependant functional maturation, and the potential influence of ACM at week 1.At 
very early stages P/Q-type Ca2+ channels may act in a similar manner as L- or R- type do in 
this schematic.  
B: A schematic showing how alterations to Cl- transporters result in GABA becoming an 
inhibitory neurotransmitter. 
A: A schematic showing a proposed mechanism for how GABA ceases to be an effective 
stimulus for Ca2+ dependent functional maturation following the GABA switch. Also, 
potential reasons for BayK 8644 and ACM continuing to be effective. 
 
The effects of Ca2+ influx on functional maturation and neuronal differentiation is consistent 
with work showing that synaptogenesis is activity-dependant in culture175. Adult in vivo 
studies in mice have also shown synaptic activity to be crucial to synaptic remodelling and 
synaptogenesis, repeat stimulation of a specific whisker over a 24 hour time period resulted 
in a 35% increase in the synaptic density of GABAergic synapses in the layer 5 neuropil when 
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the animal was dissected95. Conversely, removal of specific whiskers, and any stimulation 
from them, was found to result in the loss of stabilised spines in the neocortex, associated 
with stable synapses82. Further it was found that whisker stimulation induced 
synaptogenesis was BDNF-dependant, in that increased stimulation was less effective at 
inducing new synapses in heterozygous BDNF mutants70. In vitro studies have also 
demonstrated that BDNF, along with other neurotrophic factors, show greater pro synaptic 
effectiveness and increased expression as a result of neuronal activity21,114,174. Increased 
BDNF secretion and activity is also linked to excitatory GABA signalling as studies have 
shown to be reversed when GABA becomes inhibitory and unable to activate voltage 
activated Ca2+ channels by depolarisation13. The pro-synaptogenic response from BDNF is as 
a result of BDNF binding to the TrkB receptor and subsequent phosphorylation of TrkB, 
activating the receptor. However phosphorylation of TrkB in response to BDNF binding is 
cAMP (cyclic adenosine monophosphate) dependant; this is a very powerful and specific 
“gating” mechanism as the absence of c-AMP will stop propagation of a BDNF response at 
its own receptor90. Other studies have shown a depolarisation driven, Ca2+ influx dependant 
increase in cAMP concentration due to calmodulin stimulation of certain adenylyl cyclase 
isoforms in neurons, as well as an integration between calmodulin and cAMP in driving CREB 
activity 42,48,159,172. Membrane recruitment of TrkB has also been shown to be activity and c-
AMP dependant129. There are also many TrkB-independent links between Ca2+ influx and 
CREB activity that provide activity dependant but BDNF-independent mechanisms for 
functional maturity  168. Importantly, Ca2+ influx acts as a direct activity dependant stimulus 
for CREB phosphorylation, which in immature neurons is led by GABA stimulation 
18,28,80,99,191. However, an important distinguishing factor between mature and immature 
neurons appears to be whether CREB is stably phosphorylated or transiently phosphorylated 
in response to electrophysiological activity 128. Therefore, the GABA and Ca2+ likely provide a 
gain in the function of activity-linked CREB phosphorylation which allows functional 
maturation to proceed when BDNF is alone unable to do so. This is perhaps due to a 
combination of both the cAMP gating at the TrkB receptor being increasingly activity-
dependant, and a change in the role of CREB phosphorylation to become more transient 
and activity linked. This gain of function is then immediately terminated when GABA 
becomes an inhibitory neurotransmitter. 
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In addition to functional maturation, activity and neurotrophins are also required for the 
survival of mature neurons during development 71,104,126,160. Which again, when considering 
the link between neurotrophin receptor activity and electrophysiological activity, this 
entirely complements studies finding that electrical activity is essential for neuronal survival. 
This also provides a second implication to activity-dependant maturation; if the neurons are 
surviving to reach maturity we would expect an increase in functional neurons over time.  
 
ACM and Ca2+ influx driven effects 
Blocking GABAA, L-, N- or R- type Ca
2+ channels in the ACM cultures resulted in reduced 
generation of induced action potentials, depolarised membrane potentials and complete 
block of spontaneous action potentials by week 2. Therefore, it seems plausible that in the 
ACM treated cells, R- type Ca2+ channels play a similar role to L- type channels in producing 
GABAA excitation dependant Ca
2+ influx, and driving neurogenesis. This shows that there are 
pro-synaptogenic effects of ACM that are dependent on Ca2+ influx. Studies have also 
showed that ACM-dependant synaptic formation and maintenance in isolated rat 
hippocampal neurons was dependant on TrkB expression, and therefore BDNF signalling 58. 
So ACM dependant synaptogenesis is BDNF dependant and BDNF driven synaptogenesis is 
dependent on Ca2+ influx, which is dependent on some excitatory stimulus. This 
demonstrates that ACM does not act through similar mechanisms to BDNF, but is actually 
influencing something downstream.  
As previously discussed, ACM evokes functional enhancements in the basic 
electrophysiological properties of these differentiating neurons.  The enhanced resting 
membrane potential, functional GABAA expression and functional Ca
2+ channel expression 
will have a dramatic effect on activity dependant mechanisms. Taken together these 
enhanced electrophysiological properties will result in a gain in the GABA evoked 
depolarisation-dependant Ca2+ influx. This provides a novel mechanism for secreted factors 
by astrocytes to contribute to enhanced neuronal functional maturity of neurons and 
synaptogenesis by increase in a GABA dependant mechanism.  
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In addition to ACM increasing the activity-dependant maturation of neurons ACM will also 
greatly enhance the survival of maturing neurons 198. ACM itself has been shown to protect 
neurons from apoptosis through secretion of neurotrophins and wnt 35. Further, activity is 
key to neurotrophin dependant survival and therefore through gain of electrophysiological 
activity-dependant Ca2+ influx ACM will enhance activity-dependant neuronal survival as 
well as functional maturation.  
To further develop these protocols, differentiation was tested using the human embryonic 
stem cell line H9. The EZ-sphere protocol was followed by the standard differentiation 
protocol, with ACM as a positive control for enhanced functional maturation and BayK 8644 
to increase functional maturation by increased L-type Ca2+ channel activity. However, the H9 
–derived neurons showed a relatively poor profile of functional development compared to 
the iPS cell-derived neurons and poor survival. This implies that this standard differentiation 
protocol or EZ sphere generation is poorly optimised for H9 cells. When examining the ACM 
and BayK 8644-treated cells there was an appreciable hyperpolarisation of the resting 
membrane potential and increase in the proportion of cells able to fire induced action 
potentials. Crucially, the BayK 8644-treated cells closely mimicked the ACM-treated cells. 
This implies that BayK 8644 could provide a powerful, defined, protocol which enhances the 
extent of functional maturation in stem cell-derived neurons.  
 
Function of iPS cell-derived HD neurons: 
The standard differentiation protocol was used to generate cultures of neurons from 
Huntington’s disease iPS cell lines. Interestingly, the HD lines showed significant differences 
in the profile of electrophysiological development compared with control. Initially, both HD 
lines exhibited a significant increase in the function of voltage activated Ca2+ channels. 
These data correlated with an increase in the cells able to fire induced action potentials, 
increase in spontaneous activity and a more polarised membrane potential.  This is 
consistent with increased Ca2+ channel function resulting in improved functional maturity. 
However, although the very high repeat line, the Q180 line, showed the most extreme 
functional enhancement at week 1, they then rapidly declined and died. Most noticeable 
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was the almost total lack of cells with a functional GABAA current in the Q180 line, implying 
either that the cells were unable to develop this function or that a specific loss of cells which 
develop GABA currents. This is perhaps consistent with the idea that the differentiated HD-
cells are more sensitive to Ca2+ influx-dependant apoptosis, which could be driven by GABA 
excitation driving Ca2+ currents. However, synaptic activity appears to be neuroprotective in 
mature neurons, and extrasynaptic NMDA-receptors activity is considered to be the source 
of Ca2+ driving apoptosis in Huntington’s disease, but it is plausible that an entirely immature 
neuron, without mature dendritic structures might be susceptible to any or other Ca2+ 
influxes.  It was also speculated that glutamatergic drive would have the same effect. 
However, in the absence of the formation of active synapses no balance can develop 
between synaptic and post-synaptic Ca2+ influxes. To augment this imbalance by increasing 
synaptogesis, the HD cells were differentiated in ACM. However, although ACM-treatment 
enhanced the functional outcome of iPS cell-derived neurons of the Q60 line, in the Q180 
line it resulted in the cells dying.  
Using a more up to date small molecule-based differentiation protocol (currently 
unpublished, developed by A. Harrison, P. Kemp and N. Allen in our lab), non-integrated iPS 
cells and reduced L-glutamate concentration in the medium. Improved survival was 
observed across all HD lines. Further, the addition of both GABA and increased Ca2+ 
concentration was tested in the medium as a method for accelerating functional 
maturation. Using GABA and Ca2+ medium, more cells were obseved with functional Ca2+ 
currents, induced action potentials, more mature shaped action potentials, more 
spontaneous activity and hyperpolarised resting membrane potentials. Contrary to the 
notion that GABA elicits Ca2+ dependant apoptosis in the HD cells, no appreciable loss of 
survivability was observed in the high repeat lines with the addition of GABA and Ca2+. Also 
surprisingly, the Q109 line showed no lack of survival compared to the lower repeat lines. 
Therefore, this high rate of cell death is either specific to the Q180 line in these media or 
there is an appreciable increase in the severity of phenotype between 109 and 180 CAG 
repeats. 
Most importantly, the new protocol with the GABA and Ca2+ resulted in both the greatest 
consistency and functional maturity across all 4 lines at week 2. This is an important 
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consideration in developing an iPS cell-derived model for Huntington’s disease. Previous 
studies either haven’t sufficiently investigated the functional maturity of iPS-cell derived HD 
models, or use differentiated cultures which show very different functional development 
8,29,217,218. This presents a challenge in interpreting the results of experiments performed on 
iPS-cell derived HD models. For example, with a lack of functional maturity might not yield 
results which are consistent with in vivo, and using a model where the control and disease 
lines exhibit different levels of functional maturity would only add to this problem. 
 
Conclusions 
In these experiments it was observed that increased Ca2+ influx due to increased driving 
force for Ca2+ across the membrane or increased stimulation by GABA accelerated and 
enhanced the development of a neuronal phenotype. Further, the development of 
spontaneous action potentials was found to be dependent on: functional N- type Ca2+ 
channels evoke release of GABA vesicles; GABAA channels to initiate depolarisation in 
response to GABA, and; L- or R- type Ca2+ channels to provide depolarisation dependant Ca2+ 
influxes and evoke non-electrophysiological responses to intracellular Ca2+. These findings 
were reproducible in the ACM and high Ca2+ medium, which implies that increased 
functional Ca2+ channel expression and increased functional GABAA expression, elicited by 
treatment with ACM, acts to amplify GABA evoked depolarisation-dependant Ca2+ rises in a 
similar to increased medium Ca2+ concentration in the medium. Astrocyte secreted factors 
drive the functional expression of GABAA and specific Ca
2+ channel subtypes, and it seems 
very likely that this acts to amplify an intrinsic activity dependant mechanism for functional 
maturation and survival in neurons. Given that ACM treated cells continue to show 
increased functional maturity beyond week 2 implies this is only part of the influence 
provided by ACM.  Indeed, in the absence of ACM it is only possible for the above 
mentioned activity dependant mechanism to function whilst GABA remains an excitatory 
neurotransmitter. Therefore, it seems plausible that ACM provides another source for 
continued depolarisation, perhaps rhythmic action potentials due to biphasic resting 
membrane potentials and more functional synapses, both observed in the ACM-treated 
cultures. Additionally, it should also be noted that as well as providing an increased activity-
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dependant stimulus for functional maturity, ACM could provide increased activity-
dependant mechanism for neuronal survival. Therefore an alternative explanation for the 
functional disparity between ACM, control and high Ca2+ treated neurons at week 3 could be 
that in the presence of ACM more mature neurons are protected from apoptosis which 
means they become enriched in week 3.  
In conclusion, ACM is a powerful means to improving the functional quality of iPS derived 
neurons, enhancing their accuracy as a model for neurodegenerative diseases. Further, ACM 
has the capacity to enhance activity-dependant pro-synaptogenic and pro-survival 
mechanisms and that these are GABA dependant in the early stages of neurogenesis. But, 
no defined cocktail of astrocyte secreted factors has yet been able to entirely recapitulate 
these effects, and therefore ACM remains an undefined protocol.  This makes manipulating 
Ca2+ concentration, GABA and Bay-K 8644 an attractive option for accelerating functional 
maturation. 
Further, this study demonstrates that GABA and increased Ca2+ can be used as a defined 
addition to existing differentiation protocols. Crucially these additions were able to produce 
more consistent and mature neurons across different HD lines within only 2 weeks of 
terminal differentiation. Using this simple protocol, cultures of neurons were generated 
from multiple HD lines at the same time-point which were mostly able to fire induced action 
potentials, showed significant rates of spontaneous activity and hyperpolarised membrane 
potentials. Using both small molecules to synchronise neurogenesis, removing progenitor 
cell populations and directly stimulating activity-dependant maturation with GABA and Ca2+ 
provides the best current protocol for consistency and maturity of differentiated neurons, 
without the disadvantages of using an undefined medium such as ACM.   
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